non-small cell lung carcinoma: A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditions
|
2271 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2271 |
4. Check minimum number of eventsNone |
2271 |
5. Include endpoints |
2271 |
6. Filter based on genotype QC (FinnGen only) |
2198 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
- Control conditions
- not HLP_C3_NSCLC_SQUAM
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Non-small cell lung cancer, squamous
based on the number of shared cases.
Similar with more cases:
- Non-small cell lung cancer, squamous, helper endpoint
- Non-small cell lung cancer
- Non-small cell lung cancer, including Hilmo
- Malignant neoplasm of bronchus and lung
- Malignant neoplasm of bronchus and lung, including Hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2198 | 363 | 1835 |
| Unadjusted period prevalence (%) | 0.72 | 0.13 | 0.84 |
| Median age at first event (years) | 72.29 | 71.25 | 72.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2271
- Matched controls
- 22710
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z51.5
ICD-10 Finland
Palliative care
10.1
307.7
503
623
UGC12
NOMESCO Finland
Flexible bronchoscopy
20.5
307.7
1058
927
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
76.8
307.7
747
144
A04AA01
ATC
ondansetron; systemic, rectal
26.1
307.7
355
160
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
307.7
636
*
H02AB02
ATC
dexamethasone; systemic
84.8
307.7
592
94
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
124.4
307.7
293
27
XX3DW
NOMESCO Finland
Time consuming IT work
11.7
307.7
386
391
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
17.8
307.7
1192
1327
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
307.7
849
*
8070/3-C34.3
ICD-O-3
Squamous cell carcinoma, NOS, of lower lobe, lung
+∞
307.7
475
*
8070/3-C34.1
ICD-O-3
Squamous cell carcinoma, NOS, of upper lobe, lung
+∞
307.7
583
*
8070/3-C34.9
ICD-O-3
Squamous cell carcinoma, NOS, of lung, NOS
+∞
307.7
1086
*
WF002
NOMESCO Finland
Radical radiotherapy
352.1
307.7
331
11
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
1050
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
307.7
641
*
A03FA01
ATC
metoclopramide; systemic, rectal
11.5
307.7
839
1104
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
23.2
307.7
242
116
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
307.7
466
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
243.5
307.7
220
10
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
307.7
315
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2846.7
278.8
264
*
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
+∞
276.9
260
*
N02AA05
ATC
oxycodone; systemic
5.0
269.7
794
2217
WF004
NOMESCO Finland
Palliative radiotherapy
2721.7
268.0
254
*
L01CA04
ATC
vinorelbine; systemic
+∞
261.6
246
*
GDC00
NOMESCO Finland
Lobectomy of lung
929.8
258.6
249
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
4.2
231.1
903
3078
JN4BD
NOMESCO Finland
Extensive body CT
8.0
228.0
335
479
GD1AD
NOMESCO Finland
Thorax CT examination
7.5
225.3
356
552
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
224.8
212
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
222.6
210
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
8.3
219.9
311
425
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2174.4
219.3
209
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
62.7
214.6
119
20
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
214.0
202
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
20.1
211.7
165
88
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
1112.6
210.8
203
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
2079.6
210.7
201
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
66.0
205.6
113
18
WX302
NOMESCO Finland
Thoracal epidural anesthesy
13.3
204.4
200
164
A04AA02
ATC
granisetron; systemic, transdermal
1076.5
204.4
197
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
2094.7
190.3
182
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
176.4
167
*
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
+∞
176.4
167
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
215.7
174.8
179
9
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
173.2
164
*
JN4AD
NOMESCO Finland
Body CT examination
5.9
172.8
343
664
A04AA55
ATC
palonosetron, combinations; systemic
+∞
172.1
163
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
168.9
160
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
52.1
165.4
95
19
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.1
165.1
235
321
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
+∞
163.5
155
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
159.3
151
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
330.6
152.7
153
5
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
150.7
143
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
40.0
132.7
81
21
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
132.6
126
*
N02AA01
ATC
morphine; systemic, rectal
9.4
125.1
154
175
R84
ICPC
Malignant neoplasm bronchus/lung
321.9
120.5
121
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.0
118.2
704
2943
R03BB04
ATC
tiotropium bromide; inhalant
3.2
114.6
579
2198
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
+∞
112.4
107
*
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
+∞
110.3
105
*
116
Kela drug reimbursment
Prostate cancer
+∞
110.3
105
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
10.5
108.7
122
122
WZC30
NOMESCO Finland
Teaching
3.6
105.2
394
1236
1623A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA EPIDERMOIDES]
+∞
104.0
99
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
104.0
99
*
R04.2
ICD-10 Finland
Haemoptysis
5.0
103.8
239
521
L03AA13
ATC
pegfilgrastim; parenteral
531.5
103.5
102
*
H02AB06
ATC
prednisolone; systemic
2.6
103.1
1270
7528
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
1033.4
102.0
99
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
95.5
91
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
476.8
93.0
92
*
GEA00
NOMESCO Finland
Mediastinoscopy
46.1
91.5
54
12
TGD00
NOMESCO Finland
Needle biopsy of lung
119.8
85.6
92
8
D70.82
ICD-10 Finland
Drug-induced neutropenia
34.5
85.0
54
16
A06AH03
ATC
naloxegol; oral
20.6
83.8
64
32
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
82.8
79
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
82.8
79
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
143.5
78.5
83
6
WF003
NOMESCO Finland
Adjuvant radiotherapy
784.5
77.8
76
*
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
6.4
77.4
132
217
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
76.5
73
*
5826
FHL
Lobectomy or bilobectomy
390.2
76.2
76
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
29.0
76.1
51
18
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
163.6
75.5
79
5
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
75.4
72
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
8.1
73.9
101
130
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
73.3
70
*
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
193.8
72.6
75
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
731.0
72.6
71
*
J01MA12
ATC
levofloxacin; systemic
2.5
72.5
583
2749
GDD00
NOMESCO Finland
Pneumonectomy
368.7
72.1
72
*
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
4.0
72.0
217
580
N07BA03
ATC
varenicline; oral
6.2
71.9
127
216
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
71.8
1066
6515
8070/3-C34.0
ICD-O-3
Squamous cell carcinoma, NOS, of main bronchus
+∞
71.2
68
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
69.1
66
*
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
+∞
64.9
62
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
6.7
64.1
104
162
ZX070
NOMESCO Finland
Intensity modified radiotherapy
326.0
63.8
64
*
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
4.5
62.5
159
373
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
61.7
59
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
10.8
61.4
67
64
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
17.6
61.1
50
29
ZX120
NOMESCO Finland
Intravenous
3.3
60.7
248
810
KCD02
NOMESCO Finland
Transurethral resection of bladder
13.6
60.6
57
43
L02AE02
ATC
leuprorelin; implant, parenteral
159.3
59.2
62
*
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.7
59.1
383
1614
L03AA02
ATC
filgrastim; parenteral
94.1
58.2
64
7
J01MA14
ATC
moxifloxacin; systemic
2.9
57.2
291
1079
JN4CD
NOMESCO Finland
Very extensive body CT
7.6
57.0
82
112
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.4
56.7
148
354
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
8.3
56.5
75
93
1625A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA EPIDERMOIDES]
+∞
56.5
54
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
5.6
55.3
108
202
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
54.9
1123
7491
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.8
54.8
127
276
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
+∞
53.3
51
*
R03AC02
ATC
salbutamol; inhalant
2.0
52.6
1126
7592
B02AA02
ATC
tranexamic acid; systemic
3.0
52.5
259
942
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
14.0
52.0
48
35
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
10.2
51.5
58
58
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
51.2
49
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
50.2
48
*
N02AX02
ATC
tramadol; systemic, rectal
1.9
49.5
969
6301
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.7
49.2
165
473
A04AD12
ATC
aprepitant; systemic
+∞
49.1
47
*
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
+∞
49.1
47
*
A79
ICPC
Malignancy NOS
133.0
49.0
52
*
8070/3-C34.2
ICD-O-3
Squamous cell carcinoma, NOS, of middle lobe, lung
+∞
46.0
44
*
L02BB03
ATC
bicalutamide; oral
+∞
46.0
44
*
1240
FHL
Bronchoscopy
5.6
45.0
87
161
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.6
45.0
300
1272
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
43.9
42
*
JN6AD
NOMESCO Finland
CT of torso and neck
12.5
43.6
43
35
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.8
43.1
137
378
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
42.5
469
2466
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
41.8
40
*
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
+∞
41.8
40
*
WX600
NOMESCO Finland
Single shot through catheter
16.1
40.9
35
22
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
40.7
39
*
WW500
NOMESCO Finland
Blood transfusion
5.0
40.7
88
180
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
40.7
347
1641
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
404.5
40.2
40
*
Z72.0
ICD-10 Finland
Tobacco use
5.3
40.0
82
160
ZX050
NOMESCO Finland
Stereotactic radiotherapy
76.6
40.0
45
6
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
+∞
39.7
38
*
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
11.6
39.6
41
36
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
5.5
39.1
77
145
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
38.6
37
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.8
38.0
197
733
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
37.6
36
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
37.6
36
*
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.1
37.5
436
2328
ZXC96
NOMESCO Finland
Robot assisted procedure
15.2
37.4
33
22
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
373.3
37.1
37
*
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
373.3
37.1
37
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
36.4
558
3279
A98
ICPC
Health maint/preventive medicine
0.6
36.3
1150
14574
Z51.0
ICD-10 Finland
Radiotherapy session
362.9
36.1
36
*
XG410
NOMESCO Finland
Flow-volume spirometry
3.4
35.9
135
416
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
128.8
35.8
38
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
6.7
35.8
57
87
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
35.6
505
2888
GDC10
NOMESCO Finland
Bilobectomy of lung
+∞
35.5
34
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
53.4
35.5
42
8
N06DX01
ATC
memantine; oral
0.2
34.6
35
2081
5828
FHL
Pneumectomy
177.7
33.8
35
*
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
38.9
33.4
42
11
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
33.4
32
*
115
Kela drug reimbursment
Breast cancer
+∞
33.4
32
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
8.3
33.4
44
54
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
3.7
33.4
110
311
PJA12
NOMESCO Finland
Sentinel node biopsy
331.8
33.0
33
*
Y77
ICPC
Malignant neoplasm prostate
91.5
32.8
36
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
118.5
32.7
35
*
1CD01, ,
NOMESCO Finland
+∞
32.4
31
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
32.0
316
1578
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
31.3
30
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
31.3
30
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
31.3
30
*
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
4.5
31.2
77
176
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
30.3
29
*
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
+∞
30.3
29
*
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
6.8
30.2
47
70
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
7.2
30.1
45
64
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
306.4
29.9
30
*
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.3
29.8
94
2778
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
108.2
29.7
32
*
WW200, ,
SPAT
0.4
29.7
173
3839
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
+∞
29.2
28
*
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.2
28.5
265
1290
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
28.5
390
2189
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
28.2
27
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
28.2
27
*
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
8.9
28.1
35
40
R03BB01
ATC
ipratropium bromide; inhalant
2.3
28.0
227
1043
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
43.1
27.8
34
8
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
47.8
27.5
33
7
191
Kela drug reimbursment
Erlotinib
+∞
27.1
26
*
B01AB05
ATC
enoxaparin; parenteral
1.8
27.0
567
3626
TGA30
NOMESCO Finland
Thoracocentesis
6.0
26.5
47
80
J86.9
ICD-10 Finland
Pyothorax without fistula
5.7
26.2
49
88
GDC20
NOMESCO Finland
Lobectomy of lung and sleeve resection of bronchus
+∞
26.1
25
*
J01AA02
ATC
doxycycline; systemic
1.7
26.0
1593
13302
NK6AN
NOMESCO Finland
Total body bone isotope imaging
44.8
25.5
31
7
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
25.4
25.3
35
14
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
+∞
25.0
24
*
1622A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA EPIDERMOIDES]
+∞
25.0
24
*
1628A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA EPIDERMOIDES]
+∞
25.0
24
*
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
6.3
24.9
42
68
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
10.1
24.7
28
28
WX250
NOMESCO Finland
Intercostal blockade
48.9
24.3
29
6
P20
ICPC
Memory disturbance
0.4
24.3
134
3071
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
24.2
41
1743
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
24.0
23
*
GD002
NOMESCO Finland
Radical radiotherapy of trachea, bronchi and lungs
+∞
24.0
23
*
GCA05
NOMESCO Finland
Bronchoscopic laser therapy of lesion of bronchus
+∞
24.0
23
*
SFA20
NOMESCO Finland
Two-surface restoration
0.6
24.0
395
6218
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.4
23.9
87
263
I10
ICD-10 Finland
Essential (primary) hypertension
0.6
23.8
966
12215
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
23.1
863
6347
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.2
23.0
23
1400
L01XE03
ATC
[U] erlotinib
+∞
23.0
22
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
6.8
22.5
35
52
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
45.5
22.4
27
6
J94.8
ICD-10 Finland
Other specified pleural conditions
3.8
22.3
67
178
TGC00
NOMESCO Finland
Bronchial lavation
3.5
22.3
77
225
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
8.0
22.2
30
38
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
21.9
21
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
21.9
21
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.4
21.9
43
81
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.8
21.6
109
399
B01AB04
ATC
dalteparin; parenteral
2.7
21.4
117
447
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.1
20.9
89
296
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
60.6
20.9
24
*
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
+∞
20.9
20
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
20.9
20
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
20.9
20
*
D38.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Larynx
21.7
20.8
30
14
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
77.5
20.7
23
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
20.7
445
2840
N06DA02
ATC
donepezil; oral
0.2
20.5
38
1533
ZZR00
NOMESCO Finland
Flap of skin
7.5
20.4
29
39
J61
ICD-10 Finland
Pneumoconiosis due to asbestos and other mineral fibres
4.1
20.3
56
140
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
19.8
19
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
19.8
19
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
19.8
19
*
G30.8
ICD-10 Finland
Other Alzheimer disease
0.1
19.8
5
643
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
15.4
19.7
32
21
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
19.6
621
8437
L02BG04
ATC
letrozole; oral
106.0
19.6
21
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
201.7
19.6
20
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
201.7
19.6
20
*
Z2446
NOMESCO Finland
Social worker
2.5
19.5
128
534
WX892
NOMESCO Finland
Monitored bed care
2.1
19.4
191
947
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
55.5
18.9
22
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
55.5
18.9
22
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
18.8
18
*
1BC05, ,
NOMESCO Finland
+∞
18.8
18
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
18.8
18
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
18.8
18
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
70.5
18.7
21
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
18.7
260
1455
R85
ICPC
Malignant neopl respiratory other
38.7
18.6
23
6
SFA10
NOMESCO Finland
One-surface restoration
0.6
18.3
411
6065
F03
ICD-10 Finland
Unspecified dementia
0.2
18.2
33
1352
J43.9
ICD-10 Finland
Emphysema, unspecified
2.8
18.1
90
327
A02BX02
ATC
sucralfate; oral
2.4
17.9
123
525
R03AK07
ATC
formoterol and budesonide; inhalant
1.7
17.9
339
2083
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.6
17.8
106
423
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
67.1
17.7
20
*
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
+∞
17.7
17
*
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
+∞
17.7
17
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
17.7
17
*
GD004
NOMESCO Finland
Palliative radiotherapy of trachea, bronchi and lungs
+∞
17.7
17
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
181.4
17.5
18
*
J93.8
ICD-10 Finland
Other pneumothorax
13.2
17.4
30
23
GAC00
NOMESCO Finland
Biopsy of pleura
7.1
17.4
26
37
GAA31
NOMESCO Finland
Thoracoscopy
17.1
17.4
27
16
M05BX04
ATC
denosumab; parenteral
2.7
17.2
97
376
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
5.5
17.1
33
61
SAA02
NOMESCO Finland
Basic examination of mouth
0.6
17.1
516
7145
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
17.0
302
1819
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
50.4
17.0
20
*
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
17.0
236
1320
C10AA05
ATC
atorvastatin; oral
0.7
17.0
572
7742
B01AB10
ATC
tinzaparin; parenteral
2.2
17.0
150
713
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
16.9
20
1082
8070/3-C34.8
ICD-O-3
Squamous cell carcinoma, NOS, of overlapping lesion of lung
+∞
16.7
16
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
27.7
16.5
22
8
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
4.0
16.5
46
116
L15
ICPC
Knee symptom/complaint
0.5
16.5
139
2741
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.5
16.3
218
3714
Z02.4
ICD-10 Finland
Examination for driving licence
0.6
16.2
368
5454
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.8
16.2
79
284
XG460
NOMESCO Finland
Short time oxymetry
3.1
16.2
68
225
N06DA03
ATC
rivastigmine; oral, transdermal
0.2
16.1
21
1066
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
2.5
15.9
97
391
N03AX16
ATC
[U] pregabalin
1.6
15.9
390
2561
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
15.6
15
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
15.6
15
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
15.6
15
*
YX9CD
NOMESCO Finland
Other very extensive CT eamination for dose design of radiotherapy
+∞
15.6
15
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
15.6
15
*
L01BC06
ATC
capecitabine; oral
+∞
15.6
15
*
C10AA07
ATC
rosuvastatin; oral
0.6
15.6
289
4510
R95
ICPC
Chron obstructive pulmonary disease
2.4
15.6
109
469
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.5
15.5
194
3373
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
14.9
15.3
25
17
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.3
15.2
32
1202
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.6
14.9
286
4431
N40
ICD-10 Finland
Hyperplasia of prostate
0.7
14.9
485
6660
HAC20
NOMESCO Finland
Total mastectomy
57.1
14.8
17
*
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.5
14.7
95
394
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
4.8
14.7
33
70
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
25.2
14.7
20
8
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
14.6
14
*
A04AA03
ATC
tropisetron; systemic
+∞
14.6
14
*
8070/3-C32.9
ICD-O-3
Squamous cell carcinoma, NOS, of larynx, NOS
+∞
14.6
14
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
14.6
14
*
N05AX08
ATC
risperidone; systemic
0.4
14.5
74
1779
WPA16
NOMESCO Finland
Extensive demanding palliative symptom assessment and treatment
150.9
14.5
15
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
150.9
14.5
15
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.7
14.4
519
6999
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
3.8
14.4
43
114
5188X
ICD-9 Finland
Other diseases of lung
5.6
14.3
27
49
E83.50
ICD-10 Finland
Hypercalcemia
4.5
14.2
34
76
K02.1
ICD-10 Finland
Caries of dentine
0.7
14.2
472
6474
N05CF01
ATC
zopiclone; oral
1.5
14.2
707
5393
J93.9
ICD-10 Finland
Pneumothorax, unspecified
5.7
14.1
26
46
P17
ICPC
Tobacco abuse
5.1
14.1
29
57
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
42.8
14.1
17
*
EB1VA, ,
NOMESCO Finland
0.4
14.1
57
1518
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
3.8
14.0
42
112
K03.64
ICD-10 Finland
Dental calculus supragingival
0.5
13.7
135
2536
A07AA02
ATC
nystatin; oral
2.2
13.6
116
544
L01CB01
ATC
etoposide; systemic
+∞
13.6
13
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
13.6
13
*
C32.9
ICD-10 Finland
Malignant neoplasm: Larynx, unspecified
+∞
13.6
13
*
C34.13
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma
+∞
13.6
13
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
13.6
13
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
13.6
13
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
13.6
13
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.2
13.5
120
572
H02AB07
ATC
prednisone; oral
1.7
13.4
298
1903
C10AX09
ATC
ezetimibe; oral
0.5
13.4
126
2404
R03DA04
ATC
theophylline; systemic, rectal
1.7
13.3
245
1487
SFA30
NOMESCO Finland
Three-surface restoration
0.6
13.3
315
4660
WX402
NOMESCO Finland
General anaesthesia
1.7
13.2
258
1591
J01FA06
ATC
roxithromycin; oral
1.4
13.2
731
5668
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.2
13.2
14
818
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.5
13.1
149
2679
R24
ICPC
Haemoptysis
5.0
13.1
28
57
R06.0
ICD-10 Finland
Dyspnoea
1.5
13.1
594
4437
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.5
13.1
96
1999
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
3.6
13.0
42
118
7866A
ICD-9 Finland
Symptoms involving respiratory system and other chest symptoms, Swelling, mass, or lump in chest
19.1
12.9
19
10
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
50.3
12.8
15
*
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
15.5
12.6
20
13
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
70.3
12.6
14
*
L02BA01
ATC
tamoxifen; oral
70.3
12.6
14
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.5
12
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
12.5
12
*
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
12.5
12
*
8070/3-C44.3
ICD-O-3
Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
12.5
12
*
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
12.5
12
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
12.5
12
*
GDC13
NOMESCO Finland
Extended lobectomy or bilobectomy of lung
+∞
12.5
12
*
OAA41
NOMESCO Finland
Health check based on individual needs
+∞
12.5
12
*
1629A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA EPIDERMOIDES]
+∞
12.5
12
*
C34.85
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary other non-microcellular carcinoma
+∞
12.5
12
*
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
17.4
12.5
19
11
UGC02
NOMESCO Finland
Rigid bronchoscopy
24.4
12.5
17
7
C43.31
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face originating in lentigo maligna
130.7
12.4
13
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.6
12.3
257
3921
R4110, ,
SPAT
0.4
12.2
59
1454
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.3
12.2
91
404
SCA01
NOMESCO Finland
Preventive oral health care, short
0.5
12.2
129
2373
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
16.0
12.1
19
12
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.5
12.1
138
2480
OAB42, ,
SPAT
0.4
12.0
51
1331
UDQ22
NOMESCO Finland
Microlaryngoscopy
5.3
12.0
24
46
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.6
12.0
182
3015
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
5.0
11.9
25
50
SDA03
NOMESCO Finland
Periodontal treatment
0.6
11.9
244
3745
EB4VA, ,
NOMESCO Finland
0.3
11.9
28
985
I50.9
ICD-10 Finland
Heart failure, unspecified
0.6
11.8
297
4352
I50.0
ICD-10 Finland
Congestive heart failure
0.5
11.8
129
2349
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
5.2
11.7
24
47
F01.9
ICD-10 Finland
Vascular dementia, unspecified
0.1
11.7
6
453
R4110
NOMESCO Finland
Physiotherapy
1.5
11.7
458
3314
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
30.2
11.6
15
5
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
11.6
110
538
R05CB01
ATC
acetylcysteine; inhalant, oral
2.5
11.6
69
276
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.7
11.5
426
5771
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
2.9
11.5
54
191
SPAT1109
SPAT
Analgesia with portable analgesic pump
8.7
11.5
24
28
D82
ICPC
Teeth/gum disease
0.6
11.5
220
3436
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
11.5
11
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
11.5
11
*
1624A
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA EPIDERMOIDES]
+∞
11.5
11
*
C34.95
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other non-microcellular carcinoma
+∞
11.5
11
*
YX9AW, ,
NOMESCO Finland
+∞
11.5
11
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
11.5
11
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.5
11
*
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
11.5
11
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
11.5
11
*
1625X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,EI HIST/SYTOL DG]
+∞
11.5
11
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
11.5
11
*
M05BA02
ATC
clodronic acid; systemic
120.6
11.4
12
*
SDA04
NOMESCO Finland
Demanding periodontal treatment
0.5
11.3
139
2445
P70
ICPC
Dementia
0.2
11.2
9
503
R4190
NOMESCO Finland
Nutritional therapy
3.3
11.1
40
121
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.2
11.1
89
408
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
11.2
11.0
20
18
H02
ICPC
Hearing complaint
0.5
11.0
123
2230
PJA10
NOMESCO Finland
Exploration of lymph nodes
10.1
11.0
21
21
J98.1
ICD-10 Finland
Pulmonary collapse
4.4
11.0
27
62
DHB00
NOMESCO Finland
Excision of lesion of external nose
13.9
11.0
18
13
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
15.6
10.8
17
11
C08CA01
ATC
amlodipine; oral
0.7
10.8
544
6993
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.1
10.8
45
149
N02AC04
ATC
dextropropoxyphene; oral
1.9
10.7
128
681
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
3.5
10.6
36
105
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.7
10.5
465
6117
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
10.5
127
679
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
110.5
10.4
11
*
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
10.4
10
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
10.4
10
*
C34.34
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or hunga macrocellular anaplastic carcinoma
+∞
10.4
10
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
10.4
10
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
10.4
10
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
10.4
10
*
L02BX02
ATC
degarelix; parenteral
+∞
10.4
10
*
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
1.9
10.4
142
789
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.3
10.3
74
323
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
2.1
10.2
91
435
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.5
10.1
71
1506
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.4
10.1
68
289
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
0.7
10.1
471
6147
Z01.2
ICD-10 Finland
Dental examination
0.7
10.0
317
4448
WPB10
NOMESCO Finland
Making a convalescent care decision
14.6
10.0
16
11
H13
ICPC
Plugged feeling ear
0.6
10.0
196
3052
A02BC02
ATC
pantoprazole; systemic
1.3
10.0
1217
10554
G04CB01
ATC
finasteride; oral
0.6
9.9
261
3801
D70.89
ICD-10 Finland
Neutropenic splenomegaly
5.2
9.8
20
39
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.5
9.8
122
2145
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
26.1
9.8
13
5
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
20.1
9.8
14
7
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.7
9.8
606
7565
D19
ICPC
Teeth/gum symptom/complaint
0.6
9.8
165
2669
A06AD11
ATC
lactulose; oral
1.4
9.8
423
3113
C09AA02
ATC
enalapril; systemic
0.7
9.7
309
4335
M01AH05
ATC
etoricoxib; oral
0.7
9.7
567
7143
A02BA02
ATC
ranitidine; systemic
1.4
9.7
438
3249
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
55.2
9.6
11
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
55.2
9.6
11
*
L02AE03
ATC
goserelin; implant
55.2
9.6
11
*
DFF00
NOMESCO Finland
Pure tone audiometry
0.4
9.6
64
1383
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
11.4
9.6
17
15
XX2RW, ,
NOMESCO Finland
8.4
9.5
20
24
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.5
9.5
97
1813
Z57.2
ICD-10 Finland
Occupational exposure to dust
4.8
9.5
21
44
ZY010
NOMESCO Finland
Hospital outpatient
2.6
9.5
52
200
GDA10
NOMESCO Finland
Biopsy of lung
9.1
9.5
19
21
GD6AD
NOMESCO Finland
CT of chest and neck
15.1
9.5
15
10
HA1AA
NOMESCO Finland
X-ray mammography
3.2
9.5
36
113
C32.1
ICD-10 Finland
Malignant neoplasm: Supraglottis
100.4
9.4
10
*
JN5AP
NOMESCO Finland
Total body PET (1 picture)
100.4
9.4
10
*
C39.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the respiratory system
100.4
9.4
10
*
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.3
9.4
26
837
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
0.5
9.4
70
1454
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.5
9.4
59
243
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
9.4
9
*
155
Kela drug reimbursment
Afatinib and gefitinib
+∞
9.4
9
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
9.4
9
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
9.4
9
*
L02AE04
ATC
triptorelin; parenteral
+∞
9.4
9
*
WX330
NOMESCO Finland
Paravertebral ansthesia
+∞
9.4
9
*
A06AC01
ATC
ispaghula (psylla seeds); oral
0.6
9.3
249
3623
L03
ICPC
Low back symptom/complaint
0.6
9.2
195
2988
KMAK, ,
NOMESCO Finland
0.7
9.2
403
5332
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
5.0
9.1
19
38
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.7
9.1
497
6342
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
4.6
9.1
21
46
F17.20
ICD-10 Finland
Addiction relationship caused by tobacco addiction relationship currently independent
4.6
9.1
21
46
R03AL05
ATC
formoterol and aclidinium bromide; inhalant
8.3
9.1
19
23
G04CB02
ATC
dutasteride; oral
0.5
9.0
112
1972
I87.1
ICD-10 Finland
Compression of vein
36.8
9.0
11
*
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.7
9.0
185
1156
205
Kela drug reimbursment
Chronic hypertension
0.7
8.9
530
6684
G03HA01
ATC
cyproterone; systemic
18.7
8.9
13
7
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
3.2
8.9
35
112
WZC15, ,
NOMESCO Finland
24.1
8.9
12
5
WZC00, ,
SPAT
0.5
8.9
79
1543
TDA90, ,
SPAT
0.3
8.9
29
856
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
12.6
8.9
15
12
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
8.8
179
2769
SPAT1053
SPAT
Memory test
0.6
8.8
194
2945
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.6
8.8
183
2814
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
0.5
8.8
69
1405
L13
ICPC
Hip symptom/complaint
0.6
8.7
143
2332
ZXE10
NOMESCO Finland
More than one and less than three hours
1.4
8.7
597
4736
J18.0
ICD-10 Finland
Bronchopneumonia, unspecified
2.2
8.7
70
322
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
0.6
8.7
178
2749
XX1AD
NOMESCO Finland
Other CT-examination
50.2
8.7
10
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
3.2
8.6
33
104
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
8.2
8.6
18
22
H91.1
ICD-10 Finland
Presbycusis
0.5
8.5
62
1298
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.4
8.5
434
3282
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
20.1
8.5
12
6
UGB02
NOMESCO Finland
Tracheoscopy
20.1
8.5
12
6
H81
ICPC
Excessive ear wax
0.6
8.5
188
2851
WZC30, ,
SPAT
0.4
8.4
36
936
DAX08
NOMESCO Finland
Fitting of hearing aid
0.4
8.4
37
950
M01AX05
ATC
glucosamine; oral
0.6
8.4
186
2825
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
90.4
8.4
9
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
90.4
8.4
9
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
90.4
8.4
9
*
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
1.9
8.4
101
540
M79.6
ICD-10 Finland
Pain in limb
0.7
8.4
399
5221
SDA02
NOMESCO Finland
Periodontal treatment, brief
0.7
8.4
245
3503
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
6.7
8.4
20
30
A02BC01
ATC
omeprazole; systemic
1.4
8.4
551
4341
1CD02, ,
NOMESCO Finland
+∞
8.3
8
*
8070/3-C32.0
ICD-O-3
Squamous cell carcinoma, NOS, of glottis
+∞
8.3
8
*
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
+∞
8.3
8
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
8.3
8
*
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
+∞
8.3
8
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
8.3
8
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
8.3
8
*
WB323
NOMESCO Finland
Demanding adjuvant therapy of malignancy with biomodifiers
+∞
8.3
8
*
C01
ICD-10 Finland
Malignant neoplasm of base of tongue
+∞
8.3
8
*
WE198
NOMESCO Finland
Palliative cystotatic therapy
+∞
8.3
8
*
8090/3-C44.4
ICD-O-3
Basal cell carcinoma, NOS, of skin of scalp and neck
+∞
8.3
8
*
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
+∞
8.3
8
*
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
8.3
8
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
8.3
8
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
8.3
8
*
GDB20
NOMESCO Finland
Segmental resection of lung
+∞
8.3
8
*
R81
ICPC
Pneumonia
2.0
8.3
84
422
R03BB07
ATC
umeclidinium bromide; inhalant
3.6
8.3
26
72
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
9.5
8.3
16
17
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.6
8.3
170
2624
J01DA01
ATC
[U] cefalexin
1.3
8.2
1175
10295
1440
FHL
Mediastinoscopy
14.5
8.2
13
9
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.2
8.1
31
98
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
17.2
8.1
12
7
D01AE16
ATC
amorolfine; topical
0.5
8.1
76
1455
R53
ICD-10 Finland
Malaise and fatigue
0.7
8.0
263
3683
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
0.5
8.0
62
1271
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
10.1
8.0
15
15
M25.5
ICD-10 Finland
Pain in joint
0.7
8.0
218
3167
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
0.4
8.0
31
842
WX734
NOMESCO Finland
JET-ventilation
22.1
8.0
11
5
VALMI, ,
NOMESCO Finland
0.6
8.0
118
1980
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
8.0
367
4838
C03DA01
ATC
spironolactone; oral
0.6
7.8
154
2403
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
0.7
7.7
384
5003
H61.2
ICD-10 Finland
Impacted cerumen
0.4
7.7
31
827
C44.42
ICD-10 Finland
Spinocellular carcinoma of the skin of the scalp and neck
45.1
7.7
9
*
ZX112
NOMESCO Finland
Subcutaneous
4.3
7.7
19
44
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
4.5
7.6
18
40
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
0.6
7.6
134
2150
WZA10
NOMESCO Finland
Extensive medical or dental certificate
4.0
7.6
21
53
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
18.4
7.6
11
6
GBB00
NOMESCO Finland
Tracheostomy
3.1
7.6
31
102
K05.31
ICD-10 Finland
Periodontitis pronounced
1.6
7.6
189
1240
F00.20*G30.8
ICD-10 Finland
Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms
0.2
7.5
13
544
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.8
7.5
101
561
PD3AT
NOMESCO Finland
Pelvic artery PTA
3.9
7.4
21
54
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
80.4
7.4
8
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
80.4
7.4
8
*
C44.71
ICD-10 Finland
Basocellular carcinoma of the skin of the lower extremity including the hip
80.4
7.4
8
*
C50
ICD-10 Finland
Malignant neoplasm of breast
80.4
7.4
8
*
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
13.4
7.4
12
9
GX1E5
NOMESCO Finland
Flow volume spirometry and bronchodilation test
6.0
7.4
19
32
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
7.3
7
*
C44.11
ICD-10 Finland
Basocellular carcinoma of the skin of the eyelids including the corner of the eye
+∞
7.3
7
*
C80.91
ICD-10 Finland
Malignant tumor without specified localization epidermoid carcinoma
+∞
7.3
7
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
7.3
7
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
7.3
7
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
7.3
7
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
7.3
7
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
7.3
7
*
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
+∞
7.3
7
*
1629X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,EI HIST/SYTOL DG]
+∞
7.3
7
*
DQE00
NOMESCO Finland
Implantation of prosthetic replacement for larynx
+∞
7.3
7
*
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
+∞
7.3
7
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
C34.02
ICD-10 Finland
Malignant tumor of the main bronchial adenocarcinoma
+∞
7.3
7
*
C84.0
ICD-10 Finland
Mycosis fungoides
+∞
7.3
7
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
7.3
7
*
341
Kela drug reimbursment
Afatinib and gefitinib
+∞
7.3
7
*
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
+∞
7.3
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
7.3
7
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
7.3
7
*
8090/3-C44.2
ICD-O-3
Basal cell carcinoma, NOS, of external ear
+∞
7.3
7
*
GBA22
NOMESCO Finland
Endoscopic excision of lesion of trachea
+∞
7.3
7
*
GDC11
NOMESCO Finland
Thoracoscopic bilobectomy of lung
+∞
7.3
7
*
C34.97
ICD-10 Finland
Malignant tumor in unspecified location in bronchial and pulmonary carcinoid
+∞
7.3
7
*
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
+∞
7.3
7
*
I50.1
ICD-10 Finland
Left ventricular failure
0.5
7.3
75
1396
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
2.1
7.3
64
306
Z97.4
ICD-10 Finland
Presence of external hearing-aid
0.4
7.3
41
945
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
3.5
7.3
24
69
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
0.5
7.3
52
1094
R03AC13
ATC
formoterol; inhalant
1.8
7.3
112
648
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
15.8
7.2
11
7
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
4.5
7.2
17
38
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
30.1
7.1
9
*
R05FB02
ATC
cough suppressants and expectorants; systemic
1.3
7.1
726
6060
GX1K5
NOMESCO Finland
Diffusion capacity
6.6
7.1
17
26
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
2.3
7.1
53
237
N06DA04
ATC
galantamine; oral
0.2
7.1
12
509
G20
ICD-10 Finland
Parkinson disease
0.3
7.1
23
679
SPAT1301
SPAT
No procedures
0.7
7.1
359
4667
J85.2
ICD-10 Finland
Abscess of lung without pneumonia
8.8
7.0
14
16
J43.8
ICD-10 Finland
Other emphysema
4.2
7.0
18
43
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
0.8
7.0
510
6289
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.7
7.0
291
3910
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
0.3
7.0
19
612
Z01.1
ICD-10 Finland
Examination of ears and hearing
0.6
7.0
126
2007
G04BD12
ATC
mirabegron; oral
0.6
6.9
87
1525
Z71.8
ICD-10 Finland
Other specified counselling
0.7
6.9
252
3466
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
6.9
632
5197
PH2CD
NOMESCO Finland
Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity
4.0
6.9
19
48
C09CA06
ATC
candesartan; oral
0.7
6.9
196
2826
64091
ICD-8 Finland
Medical termination of pregnancy, Weakness (medical-social reason)
2.6
6.9
39
154
Z75.5
ICD-10 Finland
Holiday relief care
0.1
6.8
*
253
AXX01, ,
SPAT
0.3
6.8
18
591
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
40.2
6.8
8
*
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.7
6.7
226
3157
G04CA01
ATC
alfuzosin; oral
0.7
6.7
205
2916
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.7
6.7
121
732
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
7.2
6.7
15
21
DQA10
NOMESCO Finland
Biopsy of larynx
7.2
6.7
15
21
N02AA03
ATC
hydromorphone; systemic, rectal
22.6
6.7
9
*
C09CA01
ATC
losartan; oral
0.7
6.7
301
3993
H25.1
ICD-10 Finland
Senile nuclear cataract
0.8
6.6
528
6445
F00.10
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.1
6.6
*
223
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
0.3
6.6
20
608
C10AA01
ATC
simvastatin; oral
0.8
6.6
795
9215
P01BA02
ATC
hydroxychloroquine; oral
1.7
6.6
109
645
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.6
6.5
90
1538
KFC10
NOMESCO Finland
Bilateral orchiectomy
70.0
6.4
7
*
N05BA04
ATC
oxazepam; oral
1.3
6.4
455
3608
SFA40
NOMESCO Finland
Restoration involving the entire crown of the tooth
0.7
6.4
175
2543
B01AA03
ATC
warfarin; systemic
0.8
6.3
429
5357
R00.1
ICD-10 Finland
Bradycardia, unspecified
0.4
6.3
24
652
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
6.3
6
*
C32.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of larynx
+∞
6.3
6
*
L01XE13
ATC
[U] afatinib
+∞
6.3
6
*
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
+∞
6.3
6
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.3
6
*
8070/3-C01.9
ICD-O-3
Squamous cell carcinoma, NOS, of base of tongue, NOS
+∞
6.3
6
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
6.3
6
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
C39.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of respiratory and intrathoracic organs
+∞
6.3
6
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
6.3
6
*
GD003
NOMESCO Finland
Adjuvant radiotherapy of trachea, bronchi and lungs
+∞
6.3
6
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
6.3
6
*
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
+∞
6.3
6
*
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
26.7
6.2
8
*
WPA13
NOMESCO Finland
Palliative consultation
7.0
6.2
14
20
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.1
6.2
57
278
RS221, ,
NOMESCO Finland
3.1
6.2
25
82
R02AD02
ATC
lidocaine; local oral
3.1
6.2
25
82
P01AB01
ATC
metronidazole; oral, rectal
1.3
6.2
564
4626
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.7
6.2
237
3235
L90
ICPC
Osteoarthrosis of knee
0.4
6.1
30
731
K78
ICPC
Atrial fibrillation/flutter
0.6
6.1
93
1545
NF1AA, ,
SPAT
0.2
6.0
*
250
F05.1
ICD-10 Finland
Delirium superimposed on dementia
0.1
6.0
*
184
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.6
6.0
118
731
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Pulmonary Disease
29 [38004472]
29 [38004472]
4.4e-01
1.7e+00
4.8e+00
6.6e+00
5.5e+00
4.1e+00
3.5e+00
cases:16.83%
controls:11.50%
cases:25.64%
controls:6.18%
cases:58.55%
controls:1.12%
cases:28.77%
controls:0.06%
cases:72.49%
controls:1.11%
cases:79.28%
controls:6.10%
cases:84.09%
controls:13.44%
382
2608
1888
20069
582
1401
1688
21276
1329
254
941
22423
653
13
1617
22664
1568
252
595
22393
1270
1350
332
20786
576
2482
109
15980
Medical Oncology
90 [38004507]
90 [38004507]
4.6e+00
4.7e+00
—
1.0e+50
—
8.4e+00
7.0e+00
cases:4.58%
controls:0.05%
cases:2.82%
controls:0.03%
—
—
cases:0.88%
controls:0.00%
—
—
cases:58.30%
controls:0.03%
cases:34.45%
controls:0.05%
104
11
2166
22666
64
6
2206
22671
—
20
0
2250
22677
—
934
7
668
22129
236
9
449
18453
Flexible bronchoscopy
UGC12 [2001303610]
UGC12 [2001303610]
9.3e-01
3.5e+00
6.1e+00
1.0e+50
6.3e+00
3.8e+00
2.8e+00
cases:1.81%
controls:0.72%
cases:6.17%
controls:0.20%
cases:13.74%
controls:0.04%
cases:10.79%
controls:0.00%
cases:11.14%
controls:0.02%
cases:10.61%
controls:0.28%
cases:10.95%
controls:0.71%
41
163
2229
22514
140
45
2130
22632
312
8
1958
22669
245
0
2025
22677
241
5
1922
22640
170
61
1432
22075
75
131
610
18331
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
R91 [45548995]
1.3e+00
3.5e+00
6.6e+00
—
5.9e+00
3.4e+00
2.0e+00
cases:3.83%
controls:1.09%
cases:12.86%
controls:0.43%
cases:28.72%
controls:0.05%
—
—
cases:20.99%
controls:0.08%
cases:13.67%
controls:0.51%
cases:9.93%
controls:1.42%
87
247
2183
22430
292
98
1978
22579
652
12
1618
22665
—
454
17
1709
22628
219
112
1383
22024
68
263
617
18199
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
1.3e+00
2.4e+00
4.0e+00
1.0e+50
5.0e+00
4.4e+00
3.3e+00
cases:1.23%
controls:0.34%
cases:1.06%
controls:0.10%
cases:1.45%
controls:0.03%
cases:15.68%
controls:0.00%
cases:3.10%
controls:0.02%
cases:6.87%
controls:0.09%
cases:7.45%
controls:0.30%
28
77
2242
22600
24
22
2246
22655
33
6
2237
22671
356
0
1914
22677
67
5
2096
22640
110
20
1492
22116
51
56
634
18406
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-1.8e-01
1.5e-01
2.4e+00
3.1e+00
4.8e+00
4.0e+00
3.6e+00
cases:21.10%
controls:24.19%
cases:8.85%
controls:7.69%
cases:9.21%
controls:0.89%
cases:0.57%
controls:0.03%
cases:6.75%
controls:0.06%
cases:21.04%
controls:0.47%
cases:29.93%
controls:1.14%
479
5485
1791
17192
201
1744
2069
20933
209
202
2061
22475
13
6
2257
22671
146
13
2017
22632
337
104
1265
22032
205
211
480
18251
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
8.6e-01
2.0e+00
5.0e+00
—
4.3e+00
2.8e+00
2.9e+00
cases:4.67%
controls:2.02%
cases:4.76%
controls:0.65%
cases:7.97%
controls:0.06%
—
—
cases:3.88%
controls:0.05%
cases:6.93%
controls:0.47%
cases:17.66%
controls:1.14%
106
459
2164
22218
108
147
2162
22530
181
13
2089
22664
—
84
12
2079
22633
111
104
1491
22032
121
211
564
18251
FEV1
20150-9 [3024653]
20150-9 [3024653]
8.6e-01
2.0e+00
5.0e+00
—
4.3e+00
2.8e+00
2.9e+00
cases:4.67%
controls:2.02%
cases:4.76%
controls:0.65%
cases:7.97%
controls:0.06%
—
—
cases:3.88%
controls:0.05%
cases:6.93%
controls:0.47%
cases:17.66%
controls:1.14%
106
459
2164
22218
108
147
2162
22530
181
13
2089
22664
—
84
12
2079
22633
111
104
1491
22032
121
211
564
18251
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
8.6e-01
2.0e+00
5.0e+00
—
4.3e+00
2.8e+00
2.9e+00
cases:4.67%
controls:2.02%
cases:4.76%
controls:0.65%
cases:7.97%
controls:0.06%
—
—
cases:3.88%
controls:0.05%
cases:6.93%
controls:0.47%
cases:17.66%
controls:1.14%
106
459
2164
22218
108
147
2162
22530
181
13
2089
22664
—
84
12
2079
22633
111
104
1491
22032
121
211
564
18251
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
8.5e-01
2.0e+00
5.2e+00
—
4.1e+00
2.8e+00
2.9e+00
cases:4.10%
controls:1.79%
cases:3.92%
controls:0.55%
cases:6.87%
controls:0.04%
—
—
cases:2.77%
controls:0.05%
cases:5.74%
controls:0.37%
cases:15.18%
controls:0.97%
93
405
2177
22272
89
124
2181
22553
156
9
2114
22668
—
60
11
2103
22634
92
83
1510
22053
104
179
581
18283
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
8.5e-01
2.0e+00
5.2e+00
—
4.1e+00
2.8e+00
2.9e+00
cases:4.10%
controls:1.79%
cases:3.92%
controls:0.55%
cases:6.87%
controls:0.04%
—
—
cases:2.77%
controls:0.05%
cases:5.74%
controls:0.37%
cases:15.18%
controls:0.97%
93
405
2177
22272
89
124
2181
22553
156
9
2114
22668
—
60
11
2103
22634
92
83
1510
22053
104
179
581
18283
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
8.5e-01
2.0e+00
5.2e+00
—
4.1e+00
2.8e+00
2.9e+00
cases:4.10%
controls:1.79%
cases:3.92%
controls:0.55%
cases:6.87%
controls:0.04%
—
—
cases:2.77%
controls:0.05%
cases:5.74%
controls:0.37%
cases:15.18%
controls:0.97%
93
405
2177
22272
89
124
2181
22553
156
9
2114
22668
—
60
11
2103
22634
92
83
1510
22053
104
179
581
18283
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
8.5e-01
2.0e+00
5.2e+00
—
4.1e+00
2.8e+00
2.9e+00
cases:4.10%
controls:1.79%
cases:3.92%
controls:0.55%
cases:6.87%
controls:0.04%
—
—
cases:2.77%
controls:0.05%
cases:5.74%
controls:0.37%
cases:15.18%
controls:0.97%
93
405
2177
22272
89
124
2181
22553
156
9
2114
22668
—
60
11
2103
22634
92
83
1510
22053
104
179
581
18283
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
8.5e-01
2.0e+00
5.2e+00
—
4.1e+00
2.8e+00
2.9e+00
cases:4.10%
controls:1.79%
cases:3.92%
controls:0.55%
cases:6.87%
controls:0.04%
—
—
cases:2.77%
controls:0.05%
cases:5.74%
controls:0.37%
cases:15.18%
controls:0.97%
93
405
2177
22272
89
124
2181
22553
156
9
2114
22668
—
60
11
2103
22634
92
83
1510
22053
104
179
581
18283
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
1.3e+00
1.7e+00
3.2e+00
4.1e+00
3.3e+00
2.2e+00
2.0e+00
cases:12.16%
controls:3.70%
cases:11.67%
controls:2.40%
cases:11.76%
controls:0.52%
cases:2.73%
controls:0.05%
cases:11.88%
controls:0.49%
cases:21.10%
controls:2.90%
cases:32.55%
controls:6.20%
276
839
1994
21838
265
545
2005
22132
267
118
2003
22559
62
11
2208
22666
257
112
1906
22533
338
642
1264
21494
223
1144
462
17318
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
OMOP4822009 [45756830]
3.1e-02
1.3e+00
4.4e+00
—
5.4e+00
4.4e+00
1.4e+00
cases:1.98%
controls:1.92%
cases:1.76%
controls:0.50%
cases:5.07%
controls:0.07%
—
—
cases:8.00%
controls:0.04%
cases:24.66%
controls:0.39%
cases:4.96%
controls:1.22%
45
436
2225
22241
40
114
2230
22563
115
15
2155
22662
—
173
9
1990
22636
395
86
1207
22050
34
226
651
18236
Thorax extensive CT-examination
GD1BD [2001303621]
GD1BD [2001303621]
1.1e+00
2.5e+00
—
—
4.0e+00
4.6e+00
4.0e+00
cases:1.50%
controls:0.50%
cases:1.37%
controls:0.11%
—
—
—
—
cases:1.25%
controls:0.02%
cases:7.62%
controls:0.09%
cases:9.93%
controls:0.19%
34
114
2236
22563
31
26
2239
22651
—
—
27
5
2136
22640
122
19
1480
22117
68
36
617
18426
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
D38.1 [45605357]
D38.1 [45605357]
1.5e+00
5.1e+00
—
1.0e+50
1.0e+50
5.3e+00
3.8e+00
cases:0.44%
controls:0.10%
cases:5.68%
controls:0.04%
—
—
cases:9.12%
controls:0.00%
cases:14.52%
controls:0.00%
cases:8.68%
controls:0.05%
cases:4.38%
controls:0.10%
10
23
2260
22654
129
8
2141
22669
—
207
0
2063
22677
314
0
1849
22645
139
10
1463
22126
30
19
655
18443
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
3.7e+00
3.9e+00
—
1.0e+50
—
3.6e+00
3.9e+00
cases:8.81%
controls:0.23%
cases:3.26%
controls:0.07%
—
—
cases:99.21%
controls:0.00%
—
—
cases:3.12%
controls:0.09%
cases:10.80%
controls:0.25%
200
52
2070
22625
74
16
2196
22661
—
2252
0
18
22677
—
50
19
1552
22117
74
47
611
18415
olodaterol and tiotropium bromide
R03AL06 [1588644]
R03AL06 [1588644]
1.6e+00
2.1e+00
2.5e+00
—
2.9e+00
2.9e+00
2.9e+00
cases:1.01%
controls:0.20%
cases:1.50%
controls:0.19%
cases:1.01%
controls:0.09%
—
—
cases:1.34%
controls:0.08%
cases:3.50%
controls:0.21%
cases:7.01%
controls:0.40%
23
45
2247
22632
34
43
2236
22634
23
20
2247
22657
—
29
17
2134
22628
56
46
1546
22090
48
73
637
18389
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 [4010399]
113016006 [4010399]
6.8e-01
1.9e+00
4.5e+00
—
3.8e+00
1.7e+00
1.9e+00
cases:3.79%
controls:1.95%
cases:4.14%
controls:0.64%
cases:6.34%
controls:0.07%
—
—
cases:1.80%
controls:0.04%
cases:4.12%
controls:0.76%
cases:13.28%
controls:2.31%
86
443
2184
22234
94
144
2176
22533
144
17
2126
22660
—
39
9
2124
22636
66
168
1536
21968
91
427
594
18035
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
3.5e-01
9.9e-01
3.0e+00
4.0e+00
2.4e+00
2.0e+00
1.4e+00
cases:10.93%
controls:7.96%
cases:12.25%
controls:4.93%
cases:15.07%
controls:0.86%
cases:1.15%
controls:0.02%
cases:8.51%
controls:0.82%
cases:27.03%
controls:4.91%
cases:36.64%
controls:12.15%
248
1804
2022
20873
278
1118
1992
21559
342
196
1928
22481
26
5
2244
22672
184
186
1979
22459
433
1087
1169
21049
251
2244
434
16218
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
3.5e-01
9.8e-01
3.0e+00
4.0e+00
2.4e+00
2.0e+00
1.4e+00
cases:10.88%
controls:7.93%
cases:12.16%
controls:4.92%
cases:15.07%
controls:0.87%
cases:1.15%
controls:0.02%
cases:8.55%
controls:0.82%
cases:26.78%
controls:4.91%
cases:36.79%
controls:12.14%
247
1798
2023
20879
276
1116
1994
21561
342
197
1928
22480
26
5
2244
22672
185
186
1978
22459
429
1087
1173
21049
252
2242
433
16220
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
3.5e-01
9.9e-01
3.0e+00
4.0e+00
2.4e+00
1.9e+00
1.4e+00
cases:10.88%
controls:7.89%
cases:12.16%
controls:4.90%
cases:15.02%
controls:0.87%
cases:1.15%
controls:0.02%
cases:8.55%
controls:0.82%
cases:26.59%
controls:4.91%
cases:36.50%
controls:12.22%
247
1789
2023
20888
276
1112
1994
21565
341
197
1929
22480
26
5
2244
22672
185
185
1978
22460
426
1086
1176
21050
250
2256
435
16206
Body CT examination
JN4AD [2001310897]
JN4AD [2001310897]
1.3e+00
1.9e+00
4.2e+00
1.0e+50
—
3.8e+00
2.8e+00
cases:0.93%
controls:0.26%
cases:1.10%
controls:0.16%
cases:2.07%
controls:0.03%
cases:0.26%
controls:0.00%
—
—
cases:8.18%
controls:0.19%
cases:13.58%
controls:0.95%
21
60
2249
22617
25
37
2245
22640
47
7
2223
22670
6
0
2264
22677
—
131
42
1471
22094
93
175
592
18287
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
3.7e-01
9.8e-01
3.0e+00
3.9e+00
2.4e+00
1.9e+00
1.4e+00
cases:11.45%
controls:8.19%
cases:12.69%
controls:5.16%
cases:15.81%
controls:0.92%
cases:1.23%
controls:0.03%
cases:8.92%
controls:0.86%
cases:27.72%
controls:5.23%
cases:39.12%
controls:13.32%
260
1858
2010
20819
288
1170
1982
21507
359
209
1911
22468
28
6
2242
22671
193
195
1970
22450
444
1157
1158
20979
268
2460
417
16002
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
2.1e-01
6.9e-01
2.8e+00
4.4e+00
2.7e+00
2.0e+00
1.3e+00
cases:9.12%
controls:7.51%
cases:8.37%
controls:4.39%
cases:9.47%
controls:0.64%
cases:2.20%
controls:0.03%
cases:9.06%
controls:0.65%
cases:26.72%
controls:4.53%
cases:35.77%
controls:13.40%
207
1702
2063
20975
190
996
2080
21681
215
146
2055
22531
50
6
2220
22671
196
147
1967
22498
428
1002
1174
21134
245
2474
440
15988
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
3.4e-01
9.7e-01
3.0e+00
3.9e+00
2.4e+00
1.9e+00
1.4e+00
cases:11.06%
controls:8.11%
cases:12.25%
controls:5.04%
cases:15.02%
controls:0.88%
cases:1.10%
controls:0.02%
cases:8.55%
controls:0.84%
cases:27.03%
controls:5.08%
cases:36.79%
controls:12.59%
251
1839
2019
20838
278
1143
1992
21534
341
200
1929
22477
25
5
2245
22672
185
190
1978
22455
433
1125
1169
21011
252
2324
433
16138
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
3.7e-01
9.9e-01
3.0e+00
3.7e+00
2.4e+00
1.9e+00
1.4e+00
cases:11.54%
controls:8.24%
cases:12.78%
controls:5.18%
cases:15.86%
controls:0.93%
cases:1.23%
controls:0.03%
cases:8.97%
controls:0.87%
cases:27.78%
controls:5.27%
cases:39.42%
controls:13.45%
262
1868
2008
20809
290
1174
1980
21503
360
212
1910
22465
28
7
2242
22670
194
196
1969
22449
445
1166
1157
20970
270
2484
415
15978
Palliative care
Z51.5 [45547323]
Z51.5 [45547323]
—
—
2.6e+00
—
4.1e+00
4.1e+00
3.0e+00
—
—
—
—
cases:0.35%
controls:0.03%
—
—
cases:1.62%
controls:0.03%
cases:8.55%
controls:0.15%
cases:9.64%
controls:0.55%
—
—
8
6
2262
22671
—
35
6
2128
22639
137
34
1465
22102
66
102
619
18360
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
3.5e-01
9.8e-01
3.0e+00
3.7e+00
2.4e+00
1.9e+00
1.4e+00
cases:11.94%
controls:8.71%
cases:13.26%
controls:5.40%
cases:16.39%
controls:0.97%
cases:1.28%
controls:0.03%
cases:9.06%
controls:0.90%
cases:27.97%
controls:5.47%
cases:39.27%
controls:13.80%
271
1975
1999
20702
301
1225
1969
21452
372
221
1898
22456
29
7
2241
22670
196
203
1967
22442
448
1210
1154
20926
269
2548
416
15914
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
2039-6 [3003785]
6.7e-01
2.3e+00
5.0e+00
1.0e+50
1.0e+50
3.3e+00
2.4e+00
cases:1.50%
controls:0.77%
cases:3.48%
controls:0.35%
cases:6.30%
controls:0.04%
cases:1.10%
controls:0.00%
cases:3.61%
controls:0.00%
cases:6.80%
controls:0.27%
cases:10.95%
controls:1.13%
34
175
2236
22502
79
80
2191
22597
143
10
2127
22667
25
0
2245
22677
78
0
2085
22645
109
59
1493
22077
75
208
610
18254
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
2.5e-01
7.9e-01
2.9e+00
3.4e+00
2.8e+00
2.1e+00
1.5e+00
cases:19.87%
controls:16.16%
cases:18.46%
controls:9.35%
cases:21.81%
controls:1.55%
cases:1.32%
controls:0.04%
cases:18.86%
controls:1.34%
cases:45.76%
controls:9.68%
cases:57.81%
controls:23.84%
451
3665
1819
19012
419
2121
1851
20556
495
351
1775
22326
30
10
2240
22667
408
304
1755
22341
733
2143
869
19993
396
4401
289
14061
dexamethasone; oral, parenteral
H02AB02 [21602730]
H02AB02 [21602730]
3.5e-01
1.0e+00
2.2e+00
—
4.5e+00
3.9e+00
2.0e+00
cases:1.76%
controls:1.25%
cases:1.10%
controls:0.40%
cases:0.44%
controls:0.05%
—
—
cases:4.90%
controls:0.06%
cases:21.04%
controls:0.52%
cases:13.72%
controls:2.05%
40
283
2230
22394
25
91
2245
22586
10
11
2260
22666
—
106
13
2057
22632
337
115
1265
22021
94
378
591
18084
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
3.6e-01
9.4e-01
3.0e+00
3.7e+00
2.4e+00
1.9e+00
1.4e+00
cases:11.94%
controls:8.63%
cases:12.82%
controls:5.42%
cases:15.90%
controls:0.97%
cases:1.23%
controls:0.03%
cases:9.06%
controls:0.90%
cases:27.78%
controls:5.49%
cases:39.42%
controls:13.88%
271
1958
1999
20719
291
1230
1979
21447
361
220
1909
22457
28
7
2242
22670
196
204
1967
22441
445
1215
1157
20921
270
2563
415
15899
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
1.5e-01
6.7e-01
2.6e+00
4.4e+00
2.7e+00
2.0e+00
1.3e+00
cases:9.60%
controls:8.36%
cases:9.21%
controls:4.96%
cases:9.74%
controls:0.78%
cases:2.11%
controls:0.03%
cases:10.12%
controls:0.76%
cases:29.21%
controls:5.47%
cases:40.58%
controls:15.72%
218
1896
2052
20781
209
1124
2061
21553
221
178
2049
22499
48
6
2222
22671
219
173
1944
22472
468
1211
1134
20925
278
2903
407
15559
vilanterol and umeclidinium bromide
R03AL03 [43534845]
R03AL03 [43534845]
1.6e+00
2.2e+00
2.3e+00
—
2.4e+00
2.2e+00
2.8e+00
cases:0.88%
controls:0.18%
cases:1.10%
controls:0.12%
cases:0.40%
controls:0.04%
—
—
cases:0.55%
controls:0.05%
cases:1.19%
controls:0.13%
cases:3.36%
controls:0.22%
20
41
2250
22636
25
27
2245
22650
9
9
2261
22668
—
12
11
2151
22634
19
28
1583
22108
23
40
662
18422
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
8.5e-01
9.2e-01
1.3e+00
—
4.7e+00
4.4e+00
2.7e+00
cases:2.82%
controls:1.23%
cases:1.23%
controls:0.49%
cases:0.22%
controls:0.06%
—
—
cases:6.56%
controls:0.07%
cases:30.40%
controls:0.51%
cases:18.10%
controls:1.44%
64
279
2206
22398
28
112
2242
22565
5
13
2265
22664
—
142
15
2021
22630
487
114
1115
22022
124
266
561
18196
Teaching
WZC30 [2001310891]
WZC30 [2001310891]
2.7e-01
1.3e+00
3.2e+00
—
4.0e+00
3.5e+00
1.6e+00
cases:1.67%
controls:1.29%
cases:1.72%
controls:0.48%
cases:1.45%
controls:0.06%
—
—
cases:2.50%
controls:0.05%
cases:13.61%
controls:0.46%
cases:8.76%
controls:1.90%
38
292
2232
22385
39
109
2231
22568
33
14
2237
22663
—
54
11
2109
22634
218
102
1384
22034
60
351
625
18111
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
3.2e-01
9.4e-01
2.9e+00
3.7e+00
2.4e+00
1.9e+00
1.4e+00
cases:10.62%
controls:7.91%
cases:11.63%
controls:4.90%
cases:14.19%
controls:0.87%
cases:1.06%
controls:0.03%
cases:8.23%
controls:0.84%
cases:25.78%
controls:4.96%
cases:36.06%
controls:12.30%
241
1794
2029
20883
264
1111
2006
21566
322
198
1948
22479
24
6
2246
22671
178
191
1985
22454
413
1099
1189
21037
247
2270
438
16192
Outpatient Hospital
22 [8756]
22 [8756]
2.5e-01
5.5e-01
3.0e+00
4.4e+00
2.9e+00
1.9e+00
4.3e-01
cases:31.94%
controls:26.77%
cases:13.44%
controls:8.26%
cases:17.18%
controls:1.01%
cases:5.20%
controls:0.07%
cases:17.15%
controls:1.08%
cases:36.58%
controls:7.71%
cases:30.22%
controls:22.01%
725
6071
1545
16606
305
1872
1965
20805
390
229
1880
22448
118
15
2152
22662
371
244
1792
22401
586
1706
1016
20430
207
4063
478
14399
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
4.2e-01
1.2e+00
3.5e+00
—
3.4e+00
2.9e+00
2.0e+00
cases:13.26%
controls:9.09%
cases:9.87%
controls:3.34%
cases:10.66%
controls:0.37%
—
—
cases:9.57%
controls:0.34%
cases:36.77%
controls:3.22%
cases:46.28%
controls:10.67%
301
2062
1969
20615
224
757
2046
21920
242
84
2028
22593
—
207
77
1956
22568
589
713
1013
21423
317
1970
368
16492
vilanterol, umeclidinium bromide and fluticasone furoate
R03AL08 [1501769]
R03AL08 [1501769]
1.6e+00
2.1e+00
2.4e+00
—
2.4e+00
2.4e+00
2.3e+00
cases:0.70%
controls:0.14%
cases:1.01%
controls:0.13%
cases:0.57%
controls:0.05%
—
—
cases:0.69%
controls:0.06%
cases:1.75%
controls:0.15%
cases:3.36%
controls:0.34%
16
32
2254
22645
23
29
2247
22648
13
12
2257
22665
—
15
14
2148
22631
28
34
1574
22102
23
62
662
18400
Microscopic observation [Identifier] in Buccal smear by Cyto stain
18501-7 [3018559]
18501-7 [3018559]
1.4e+00
3.4e+00
—
1.0e+50
1.0e+50
4.0e+00
4.0e+00
cases:0.44%
controls:0.11%
cases:1.67%
controls:0.06%
—
—
cases:9.74%
controls:0.00%
cases:1.85%
controls:0.00%
cases:1.75%
controls:0.03%
cases:4.09%
controls:0.08%
10
25
2260
22652
38
13
2232
22664
—
221
0
2049
22677
40
0
2123
22645
28
7
1574
22129
28
14
657
18448
ondansetron; oral, parenteral, rectal
A04AA01 [21600493]
A04AA01 [21600493]
1.8e+00
1.9e+00
—
—
—
5.4e+00
3.6e+00
cases:0.44%
controls:0.07%
cases:0.35%
controls:0.05%
—
—
—
—
—
—
cases:13.36%
controls:0.07%
cases:7.74%
controls:0.23%
10
16
2260
22661
8
12
2262
22665
—
—
—
214
15
1388
22121
53
43
632
18419
Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
14804-9 [3022250]
14804-9 [3022250]
4.0e-01
1.0e+00
3.2e+00
—
3.6e+00
2.9e+00
2.0e+00
cases:2.03%
controls:1.37%
cases:1.81%
controls:0.65%
cases:2.03%
controls:0.08%
—
—
cases:3.74%
controls:0.11%
cases:10.67%
controls:0.64%
cases:15.04%
controls:2.40%
46
310
2224
22367
41
148
2229
22529
46
19
2224
22658
—
81
25
2082
22620
171
142
1431
21994
103
443
582
18019
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
3.9e-02
4.1e-01
2.8e+00
4.1e+00
2.6e+00
1.8e+00
9.4e-01
cases:11.63%
controls:11.24%
cases:8.99%
controls:6.16%
cases:10.44%
controls:0.68%
cases:1.76%
controls:0.03%
cases:9.75%
controls:0.79%
cases:29.09%
controls:6.25%
cases:36.79%
controls:18.57%
264
2548
2006
20129
204
1398
2066
21279
237
154
2033
22523
40
7
2230
22670
211
179
1952
22466
466
1384
1136
20752
252
3428
433
15034
Inpatient Hospital
21 [8717]
21 [8717]
2.4e-01
5.6e-01
2.8e+00
3.8e+00
2.8e+00
1.9e+00
4.5e-01
cases:41.81%
controls:36.04%
cases:23.22%
controls:14.69%
cases:28.50%
controls:2.26%
cases:4.41%
controls:0.11%
cases:30.98%
controls:2.54%
cases:52.31%
controls:14.29%
cases:43.65%
controls:33.17%
949
8172
1321
14505
527
3331
1743
19346
647
512
1623
22165
100
24
2170
22653
670
576
1493
22069
838
3164
764
18972
299
6124
386
12338
Enolase.neuron specific [Mass/volume] in Serum or Plasma
15060-7 [3028531]
15060-7 [3028531]
1.3e+00
4.0e+00
—
1.0e+50
1.0e+50
4.6e+00
3.7e+00
cases:0.31%
controls:0.08%
cases:1.94%
controls:0.04%
—
—
cases:1.06%
controls:0.00%
cases:2.73%
controls:0.00%
cases:2.62%
controls:0.03%
cases:3.65%
controls:0.09%
7
19
2263
22658
44
8
2226
22669
—
24
0
2246
22677
59
0
2104
22645
42
6
1560
22130
25
17
660
18445
Thorax and upper abdomen combined CT examination of
GD5AD [2001303655]
GD5AD [2001303655]
—
2.9e+00
—
1.0e+50
1.0e+50
4.9e+00
4.4e+00
—
—
cases:0.48%
controls:0.03%
—
—
cases:0.22%
controls:0.00%
cases:0.23%
controls:0.00%
cases:3.43%
controls:0.03%
cases:8.03%
controls:0.11%
—
11
6
2259
22671
—
5
0
2265
22677
5
0
2158
22645
55
6
1547
22130
55
20
630
18442
Multidisciplinary treatment meeting
WZC20 [2001310890]
WZC20 [2001310890]
1.7e+00
3.2e+00
—
—
—
4.3e+00
3.0e+00
cases:0.48%
controls:0.09%
cases:0.62%
controls:0.03%
—
—
—
—
—
—
cases:2.62%
controls:0.04%
cases:3.21%
controls:0.17%
11
20
2259
22657
14
6
2256
22671
—
—
—
42
8
1560
22128
22
31
663
18431
Haemoptysis
R04.2 [45577777]
R04.2 [45577777]
6.6e-01
2.6e+00
4.9e+00
1.0e+50
—
2.5e+00
2.0e+00
cases:0.75%
controls:0.39%
cases:1.72%
controls:0.13%
cases:3.57%
controls:0.03%
cases:0.84%
controls:0.00%
—
—
cases:1.56%
controls:0.14%
cases:3.36%
controls:0.45%
17
88
2253
22589
39
30
2231
22647
81
6
2189
22671
19
0
2251
22677
—
25
30
1577
22106
23
83
662
18379
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
4.0e-01
4.9e-01
2.7e+00
3.3e+00
3.1e+00
1.9e+00
4.2e-01
cases:11.50%
controls:8.01%
cases:3.92%
controls:2.44%
cases:3.74%
controls:0.26%
cases:0.75%
controls:0.03%
cases:6.38%
controls:0.30%
cases:12.73%
controls:2.13%
cases:10.66%
controls:7.30%
261
1816
2009
20861
89
554
2181
22123
85
59
2185
22618
17
6
2253
22671
138
67
2025
22578
204
471
1398
21665
73
1347
612
17115
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
4.8e-01
7.5e-01
3.1e+00
—
3.2e+00
3.1e+00
1.4e+00
cases:4.93%
controls:3.12%
cases:1.41%
controls:0.67%
cases:1.15%
controls:0.05%
—
—
cases:1.25%
controls:0.05%
cases:8.93%
controls:0.45%
cases:5.26%
controls:1.39%
112
707
2158
21970
32
152
2238
22525
26
12
2244
22665
—
27
12
2136
22633
143
100
1459
22036
36
257
649
18205
Intravenous
ZX120 [2001311495]
ZX120 [2001311495]
3.7e-01
1.6e+00
2.2e+00
1.0e+50
2.9e+00
3.3e+00
1.8e+00
cases:1.23%
controls:0.86%
cases:1.06%
controls:0.22%
cases:0.35%
controls:0.04%
cases:0.31%
controls:0.00%
cases:1.11%
controls:0.06%
cases:7.43%
controls:0.28%
cases:4.53%
controls:0.79%
28
194
2242
22483
24
50
2246
22627
8
9
2262
22668
7
0
2263
22677
24
14
2139
22631
119
63
1483
22073
31
146
654
18316
levofloxacin; inhalant, oral, parenteral
J01MA12 [21603019]
J01MA12 [21603019]
6.1e-01
1.2e+00
2.8e+00
—
3.2e+00
2.8e+00
1.1e+00
cases:4.01%
controls:2.21%
cases:2.33%
controls:0.72%
cases:1.10%
controls:0.07%
—
—
cases:1.94%
controls:0.08%
cases:11.05%
controls:0.71%
cases:8.91%
controls:3.16%
91
502
2179
22175
53
164
2217
22513
25
16
2245
22661
—
42
18
2121
22627
177
158
1425
21978
61
583
624
17879
Treatment plan or consultation
WZC00 [2001310885]
WZC00 [2001310885]
6.9e-01
7.8e-01
2.0e+00
—
3.5e+00
3.2e+00
1.5e+00
cases:5.99%
controls:3.10%
cases:2.47%
controls:1.14%
cases:1.23%
controls:0.18%
—
—
cases:5.55%
controls:0.17%
cases:20.91%
controls:1.07%
cases:16.06%
controls:3.94%
136
702
2134
21975
56
259
2214
22418
28
40
2242
22637
—
120
39
2043
22606
335
237
1267
21899
110
727
575
17735
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
5.7e-01
6.6e-01
2.4e+00
—
3.6e+00
3.2e+00
1.9e+00
cases:2.07%
controls:1.18%
cases:1.23%
controls:0.64%
cases:1.81%
controls:0.17%
—
—
cases:6.10%
controls:0.18%
cases:18.79%
controls:0.93%
cases:17.08%
controls:3.02%
47
268
2223
22409
28
146
2242
22531
41
39
2229
22638
—
132
40
2031
22605
301
205
1301
21931
117
558
568
17904
Diffusion capacity of lung
54715006 [4182985]
54715006 [4182985]
4.3e-01
2.3e+00
4.4e+00
—
—
2.4e+00
2.4e+00
cases:0.66%
controls:0.43%
cases:1.19%
controls:0.12%
cases:1.85%
controls:0.02%
—
—
—
—
cases:1.81%
controls:0.16%
cases:3.80%
controls:0.36%
15
98
2255
22579
27
28
2243
22649
42
5
2228
22672
—
—
29
36
1573
22100
26
67
659
18395
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
6.7e-01
1.4e+00
3.3e+00
—
2.9e+00
2.1e+00
1.1e+00
cases:7.80%
controls:4.15%
cases:7.05%
controls:1.80%
cases:6.56%
controls:0.26%
—
—
cases:4.62%
controls:0.26%
cases:15.92%
controls:2.29%
cases:22.19%
controls:8.66%
177
940
2093
21737
160
408
2110
22269
149
58
2121
22619
—
100
58
2063
22587
255
508
1347
21628
152
1598
533
16864
Gas panel - Arterial blood
24336-0 [3019060]
24336-0 [3019060]
7.2e-01
1.0e+00
3.8e+00
—
3.0e+00
2.0e+00
9.1e-01
cases:2.29%
controls:1.13%
cases:1.54%
controls:0.55%
cases:1.01%
controls:0.02%
—
—
cases:1.34%
controls:0.07%
cases:4.00%
controls:0.58%
cases:4.23%
controls:1.74%
52
257
2218
22420
35
125
2235
22552
23
5
2247
22672
—
29
15
2134
22630
64
129
1538
22007
29
322
656
18140
Asthma, unspecified
J45.9 [45562456]
J45.9 [45562456]
2.6e-01
7.1e-01
2.3e+00
3.7e+00
2.3e+00
1.1e+00
1.3e+00
cases:4.10%
controls:3.18%
cases:3.13%
controls:1.57%
cases:2.33%
controls:0.24%
cases:0.93%
controls:0.02%
cases:2.45%
controls:0.26%
cases:4.99%
controls:1.68%
cases:14.31%
controls:4.48%
93
721
2177
21956
71
355
2199
22322
53
54
2217
22623
21
5
2249
22672
53
59
2110
22586
80
371
1522
21765
98
827
587
17635
Gas panel - Capillary blood
24337-8 [3022313]
24337-8 [3022313]
8.1e-01
1.0e+00
3.6e+00
—
2.8e+00
2.0e+00
1.2e+00
cases:1.59%
controls:0.71%
cases:1.06%
controls:0.38%
cases:1.32%
controls:0.04%
—
—
cases:0.97%
controls:0.06%
cases:2.81%
controls:0.40%
cases:3.94%
controls:1.21%
36
162
2234
22515
24
87
2246
22590
30
8
2240
22669
—
21
14
2142
22631
45
89
1557
22047
27
223
658
18239
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
3.4e-01
8.6e-01
2.7e+00
—
3.4e+00
2.5e+00
1.6e+00
cases:10.79%
controls:7.96%
cases:9.21%
controls:4.10%
cases:9.30%
controls:0.66%
—
—
cases:14.29%
controls:0.57%
cases:35.83%
controls:4.46%
cases:42.04%
controls:13.02%
245
1805
2025
20872
209
929
2061
21748
211
150
2059
22527
—
309
129
1854
22516
574
988
1028
21148
288
2403
397
16059
pH of Arterial blood
2744-1 [3019977]
2744-1 [3019977]
5.5e-01
8.9e-01
3.4e+00
—
2.9e+00
2.2e+00
1.3e+00
cases:2.64%
controls:1.55%
cases:2.07%
controls:0.86%
cases:1.45%
controls:0.05%
—
—
cases:1.94%
controls:0.11%
cases:8.36%
controls:0.95%
cases:10.80%
controls:3.24%
60
351
2210
22326
47
196
2223
22481
33
11
2237
22666
—
42
24
2121
22621
134
211
1468
21925
74
599
611
17863
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
2.1e-01
8.1e-01
2.4e+00
—
3.5e+00
2.9e+00
1.6e+00
cases:2.60%
controls:2.12%
cases:2.11%
controls:0.95%
cases:1.81%
controls:0.16%
—
—
cases:4.53%
controls:0.15%
cases:16.54%
controls:1.03%
cases:13.87%
controls:3.03%
59
480
2211
22197
48
216
2222
22461
41
37
2229
22640
—
98
34
2065
22611
265
228
1337
21908
95
559
590
17903
Oxygen [Partial pressure] in Arterial blood
2703-7 [3027801]
2703-7 [3027801]
5.2e-01
9.0e-01
3.4e+00
—
2.9e+00
2.2e+00
1.2e+00
cases:2.60%
controls:1.56%
cases:2.11%
controls:0.87%
cases:1.37%
controls:0.04%
—
—
cases:1.94%
controls:0.11%
cases:8.30%
controls:0.96%
cases:10.07%
controls:3.29%
59
353
2211
22324
48
197
2222
22480
31
10
2239
22667
—
42
24
2121
22621
133
213
1469
21923
69
607
616
17855
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 [3027946]
2019-8 [3027946]
5.2e-01
9.0e-01
3.4e+00
—
2.9e+00
2.2e+00
1.2e+00
cases:2.60%
controls:1.56%
cases:2.11%
controls:0.87%
cases:1.37%
controls:0.04%
—
—
cases:1.94%
controls:0.11%
cases:8.30%
controls:0.97%
cases:10.07%
controls:3.29%
59
353
2211
22324
48
197
2222
22480
31
10
2239
22667
—
42
24
2121
22621
133
214
1469
21922
69
607
616
17855
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
4.4e-01
9.4e-01
2.9e+00
—
2.9e+00
2.3e+00
1.7e+00
cases:13.52%
controls:9.17%
cases:13.88%
controls:5.93%
cases:16.96%
controls:1.09%
—
—
cases:16.00%
controls:0.99%
cases:38.33%
controls:5.85%
cases:46.86%
controls:14.38%
307
2079
1963
20598
315
1344
1955
21333
385
248
1885
22429
—
346
225
1817
22420
614
1294
988
20842
321
2655
364
15807
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
8.0e-02
6.9e-01
2.6e+00
3.0e+00
2.4e+00
1.5e+00
9.4e-01
cases:26.83%
controls:25.29%
cases:28.37%
controls:16.60%
cases:29.87%
controls:3.03%
cases:4.19%
controls:0.21%
cases:24.78%
controls:2.83%
cases:47.38%
controls:17.40%
cases:59.71%
controls:36.71%
609
5736
1661
16941
644
3764
1626
18913
678
686
1592
21991
95
48
2175
22629
536
640
1627
22005
759
3852
843
18284
409
6777
276
11685
Addiction caused by tobacco UNS
F17.29 [2000501845]
F17.29 [2000501845]
2.3e+00
2.2e+00
1.0e+50
1.0e+50
—
3.3e+00
3.3e+00
cases:1.06%
controls:0.11%
cases:0.35%
controls:0.04%
cases:0.44%
controls:0.00%
cases:0.26%
controls:0.00%
—
—
cases:1.19%
controls:0.05%
cases:2.48%
controls:0.09%
24
24
2246
22653
8
9
2262
22668
10
0
2260
22677
6
0
2264
22677
—
19
10
1583
22126
17
17
668
18445
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
5.4e-01
8.9e-01
3.3e+00
—
2.9e+00
2.3e+00
1.2e+00
cases:2.64%
controls:1.56%
cases:2.07%
controls:0.86%
cases:1.37%
controls:0.05%
—
—
cases:1.90%
controls:0.11%
cases:8.30%
controls:0.94%
cases:10.22%
controls:3.31%
60
354
2210
22323
47
195
2223
22482
31
12
2239
22665
—
41
24
2122
22621
133
209
1469
21927
70
611
615
17851
Outpatient Visit
OP [9202]
OP [9202]
2.2e-01
3.7e-01
1.8e+00
3.8e+00
2.4e+00
1.7e+00
7.7e-01
cases:71.94%
controls:67.24%
cases:58.24%
controls:49.02%
cases:38.33%
controls:9.71%
cases:15.73%
controls:0.40%
cases:52.57%
controls:9.49%
cases:84.77%
controls:50.10%
cases:88.76%
controls:78.49%
1633
15247
637
7430
1322
11117
948
11560
870
2202
1400
20475
357
90
1913
22587
1137
2150
1026
20495
1358
11091
244
11045
608
14491
77
3971
Extensive body CT
JN4BD [2001310899]
JN4BD [2001310899]
1.4e+00
2.6e+00
—
1.0e+50
—
3.9e+00
3.1e+00
cases:2.20%
controls:0.57%
cases:1.45%
controls:0.11%
—
—
cases:0.35%
controls:0.00%
—
—
cases:7.18%
controls:0.16%
cases:7.88%
controls:0.37%
50
129
2220
22548
33
25
2237
22652
—
8
0
2262
22677
—
115
35
1487
22101
54
68
631
18394
Vascular Surgery
77 [38004496]
77 [38004496]
6.3e-01
8.2e-01
2.1e+00
3.5e+00
1.6e+00
1.5e+00
9.2e-01
cases:6.65%
controls:3.66%
cases:3.61%
controls:1.62%
cases:2.16%
controls:0.28%
cases:0.70%
controls:0.02%
cases:1.76%
controls:0.36%
cases:6.68%
controls:1.60%
cases:11.68%
controls:5.02%
151
830
2119
21847
82
368
2188
22309
49
64
2221
22613
16
5
2254
22672
38
82
2125
22563
107
354
1495
21782
80
926
605
17536
Bacterial pneumonia, unspecified
J15.9 [45557621]
J15.9 [45557621]
5.7e-01
1.4e+00
3.1e+00
—
3.1e+00
1.9e+00
8.9e-01
cases:2.42%
controls:1.38%
cases:1.98%
controls:0.49%
cases:1.50%
controls:0.07%
—
—
cases:1.34%
controls:0.06%
cases:4.31%
controls:0.69%
cases:5.84%
controls:2.49%
55
314
2215
22363
45
111
2225
22566
34
15
2236
22662
—
29
14
2134
22631
69
152
1533
21984
40
460
645
18002
Interstitial pulmonary disease, unspecified
J84.9 [45543277]
J84.9 [45543277]
1.1e+00
1.6e+00
2.6e+00
1.0e+50
2.4e+00
1.7e+00
1.4e+00
cases:0.62%
controls:0.20%
cases:0.79%
controls:0.15%
cases:0.66%
controls:0.05%
cases:0.31%
controls:0.00%
cases:0.60%
controls:0.05%
cases:1.19%
controls:0.22%
cases:1.75%
controls:0.42%
14
45
2256
22632
18
35
2252
22642
15
11
2255
22666
7
0
2263
22677
13
12
2150
22633
19
49
1583
22087
12
78
673
18384
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
5.4e-01
9.1e-01
3.4e+00
1.0e+50
2.7e+00
2.2e+00
1.2e+00
cases:2.16%
controls:1.27%
cases:1.81%
controls:0.74%
cases:1.37%
controls:0.04%
cases:1.32%
controls:0.00%
cases:1.53%
controls:0.11%
cases:7.18%
controls:0.89%
cases:9.49%
controls:3.07%
49
289
2221
22388
41
167
2229
22510
31
10
2239
22667
30
0
2240
22677
33
24
2130
22621
115
196
1487
21940
65
567
620
17895
Carbon dioxide [Partial pressure] in Capillary blood
2020-6 [3023024]
2020-6 [3023024]
7.8e-01
1.1e+00
3.3e+00
1.0e+50
2.7e+00
1.8e+00
1.2e+00
cases:1.89%
controls:0.87%
cases:1.50%
controls:0.50%
cases:1.89%
controls:0.07%
cases:0.26%
controls:0.00%
cases:1.34%
controls:0.09%
cases:4.06%
controls:0.67%
cases:5.84%
controls:1.89%
43
198
2227
22479
34
113
2236
22564
43
16
2227
22661
6
0
2264
22677
29
21
2134
22624
65
148
1537
21988
40
349
645
18113
Bicarbonate [Moles/volume] standard in Capillary blood
19231-0 [3004490]
19231-0 [3004490]
8.7e-01
9.7e-01
3.3e+00
—
2.8e+00
1.9e+00
9.8e-01
cases:1.50%
controls:0.63%
cases:0.84%
controls:0.32%
cases:0.70%
controls:0.03%
—
—
cases:0.83%
controls:0.05%
cases:2.06%
controls:0.30%
cases:2.34%
controls:0.89%
34
143
2236
22534
19
72
2251
22605
16
6
2254
22671
—
18
12
2145
22633
33
67
1569
22069
16
165
669
18297
pH of Capillary blood
2745-8 [3009343]
2745-8 [3009343]
7.9e-01
1.1e+00
3.3e+00
1.0e+50
2.7e+00
1.8e+00
1.2e+00
cases:1.89%
controls:0.87%
cases:1.41%
controls:0.49%
cases:1.85%
controls:0.07%
cases:0.26%
controls:0.00%
cases:1.29%
controls:0.09%
cases:3.81%
controls:0.66%
cases:5.55%
controls:1.83%
43
197
2227
22480
32
110
2238
22567
42
16
2228
22661
6
0
2264
22677
28
20
2135
22625
61
146
1541
21990
38
337
647
18125
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
2.6e-01
1.1e+00
3.5e+00
1.0e+50
2.8e+00
2.5e+00
9.1e-01
cases:1.45%
controls:1.12%
cases:1.37%
controls:0.46%
cases:2.16%
controls:0.07%
cases:2.51%
controls:0.00%
cases:1.29%
controls:0.08%
cases:5.37%
controls:0.48%
cases:5.11%
controls:2.12%
33
255
2237
22422
31
104
2239
22573
49
15
2221
22662
57
0
2213
22677
28
18
2135
22627
86
107
1516
22029
35
391
650
18071
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
4.2e-01
8.2e-01
3.4e+00
1.0e+50
2.9e+00
2.3e+00
1.3e+00
cases:1.67%
controls:1.10%
cases:1.41%
controls:0.63%
cases:1.19%
controls:0.04%
cases:1.37%
controls:0.00%
cases:1.48%
controls:0.08%
cases:6.74%
controls:0.75%
cases:9.64%
controls:2.74%
38
250
2232
22427
32
142
2238
22535
27
9
2243
22668
31
0
2239
22677
32
19
2131
22626
108
167
1494
21969
66
506
619
17956
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
3.6e-01
1.1e+00
2.6e+00
—
3.1e+00
2.3e+00
1.2e+00
cases:7.14%
controls:5.09%
cases:5.29%
controls:1.87%
cases:3.00%
controls:0.22%
—
—
cases:4.21%
controls:0.20%
cases:13.61%
controls:1.56%
cases:14.89%
controls:5.05%
162
1155
2108
21522
120
425
2150
22252
68
51
2202
22626
—
91
46
2072
22599
218
346
1384
21790
102
932
583
17530
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
3.8e-01
1.0e+00
3.1e+00
—
2.5e+00
2.1e+00
1.6e+00
cases:7.49%
controls:5.26%
cases:8.68%
controls:3.29%
cases:11.63%
controls:0.60%
—
—
cases:6.75%
controls:0.61%
cases:21.79%
controls:3.40%
cases:30.22%
controls:8.17%
170
1193
2100
21484
197
747
2073
21930
264
135
2006
22542
—
146
139
2017
22506
349
753
1253
21383
207
1508
478
16954
Myelocytes/Leukocytes in Blood
26498-6 [3017181]
26498-6 [3017181]
7.6e-01
8.7e-01
3.0e+00
—
2.9e+00
1.9e+00
1.2e+00
cases:1.32%
controls:0.62%
cases:1.32%
controls:0.56%
cases:1.72%
controls:0.09%
—
—
cases:0.79%
controls:0.04%
cases:4.12%
controls:0.65%
cases:7.01%
controls:2.25%
30
141
2240
22536
30
126
2240
22551
39
20
2231
22657
—
17
10
2146
22635
66
143
1536
21993
48
415
637
18047
Chronic obstructive pulmonary disease, unspecified
J44.9 [45548115]
J44.9 [45548115]
9.8e-01
1.4e+00
2.9e+00
—
2.4e+00
1.7e+00
1.1e+00
cases:2.56%
controls:0.97%
cases:1.85%
controls:0.45%
cases:1.32%
controls:0.07%
—
—
cases:0.97%
controls:0.09%
cases:3.31%
controls:0.62%
cases:5.69%
controls:1.89%
58
221
2212
22456
42
101
2228
22576
30
16
2240
22661
—
21
21
2142
22624
53
138
1549
21998
39
349
646
18113
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
3.2e-01
9.7e-01
2.7e+00
1.0e+50
3.1e+00
2.4e+00
1.3e+00
cases:0.75%
controls:0.55%
cases:0.84%
controls:0.32%
cases:0.40%
controls:0.03%
cases:1.10%
controls:0.00%
cases:1.11%
controls:0.05%
cases:4.81%
controls:0.46%
cases:5.40%
controls:1.48%
17
124
2253
22553
19
72
2251
22605
9
6
2261
22671
25
0
2245
22677
24
11
2139
22634
77
101
1525
22035
37
274
648
18188
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
1.3e-02
6.9e-01
3.6e+00
—
3.0e+00
2.1e+00
1.1e+00
cases:4.23%
controls:4.18%
cases:4.41%
controls:2.25%
cases:10.62%
controls:0.32%
—
—
cases:5.18%
controls:0.27%
cases:13.42%
controls:1.92%
cases:16.06%
controls:5.80%
96
947
2174
21730
100
510
2170
22167
241
72
2029
22605
—
112
61
2051
22584
215
426
1387
21710
110
1071
575
17391
Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
72720-6 [43055554]
72720-6 [43055554]
8.3e-01
1.1e+00
3.2e+00
1.0e+50
2.6e+00
1.8e+00
1.0e+00
cases:1.89%
controls:0.83%
cases:1.37%
controls:0.47%
cases:1.45%
controls:0.06%
cases:0.22%
controls:0.00%
cases:1.11%
controls:0.08%
cases:3.31%
controls:0.57%
cases:4.38%
controls:1.60%
43
189
2227
22488
31
106
2239
22571
33
14
2237
22663
5
0
2265
22677
24
19
2139
22626
53
127
1549
22009
30
295
655
18167
Spirometry
127783003 [4133840]
127783003 [4133840]
9.0e-01
1.6e+00
—
1.0e+50
3.4e+00
2.4e+00
2.2e+00
cases:1.32%
controls:0.54%
cases:1.06%
controls:0.22%
—
—
cases:0.35%
controls:0.00%
cases:0.88%
controls:0.03%
cases:2.00%
controls:0.18%
cases:3.36%
controls:0.38%
30
123
2240
22554
24
49
2246
22628
—
8
0
2262
22677
19
7
2144
22638
32
39
1570
22097
23
71
662
18391
Chronic asthma and similar chronic obstructive pulmonary diseases
203 [2001600201]
203 [2001600201]
6.5e-01
9.1e-01
2.8e+00
—
2.6e+00
2.2e+00
1.4e+00
cases:4.05%
controls:2.15%
cases:1.23%
controls:0.50%
cases:0.35%
controls:0.02%
—
—
cases:0.51%
controls:0.04%
cases:3.43%
controls:0.41%
cases:7.15%
controls:1.83%
92
487
2178
22190
28
113
2242
22564
8
5
2262
22672
—
11
9
2152
22636
55
91
1547
22045
49
338
636
18124
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
6.3e-02
6.1e-01
2.6e+00
2.8e+00
2.1e+00
1.3e+00
1.1e+00
cases:6.87%
controls:6.48%
cases:9.52%
controls:5.40%
cases:12.60%
controls:1.11%
cases:1.10%
controls:0.07%
cases:7.63%
controls:1.03%
cases:19.98%
controls:6.36%
cases:31.39%
controls:13.73%
156
1469
2114
21208
216
1225
2054
21452
286
252
1984
22425
25
15
2245
22662
165
234
1998
22411
320
1408
1282
20728
215
2535
470
15927
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
1.5e-01
5.1e-01
2.4e+00
3.5e+00
1.6e+00
1.6e+00
8.2e-01
cases:12.69%
controls:11.14%
cases:11.28%
controls:7.09%
cases:23.00%
controls:2.70%
cases:4.27%
controls:0.13%
cases:11.93%
controls:2.70%
cases:27.03%
controls:7.02%
cases:30.36%
controls:16.09%
288
2527
1982
20150
256
1607
2014
21070
522
612
1748
22065
97
30
2173
22647
258
611
1905
22034
433
1553
1169
20583
208
2970
477
15492
Cathetrisation of artery
TPH07 [2001309747]
TPH07 [2001309747]
7.2e-01
4.5e-02
3.1e+00
1.0e+50
2.9e+00
2.6e+00
1.1e+00
cases:1.98%
controls:0.97%
cases:0.40%
controls:0.38%
cases:0.57%
controls:0.03%
cases:1.23%
controls:0.00%
cases:0.92%
controls:0.05%
cases:4.49%
controls:0.35%
cases:4.53%
controls:1.61%
45
221
2225
22456
9
86
2261
22591
13
6
2257
22671
28
0
2242
22677
20
12
2143
22633
72
77
1530
22059
31
298
654
18164
Hematology
82 [38004501]
82 [38004501]
9.5e-01
1.4e+00
2.6e+00
—
2.4e+00
1.8e+00
1.1e+00
cases:1.32%
controls:0.52%
cases:0.97%
controls:0.23%
cases:0.66%
controls:0.05%
—
—
cases:0.51%
controls:0.05%
cases:1.25%
controls:0.20%
cases:2.04%
controls:0.67%
30
117
2240
22560
22
53
2248
22624
15
11
2255
22666
—
11
11
2152
22634
20
45
1582
22091
14
123
671
18339
Bicarbonate [Moles/volume] in Capillary blood
1961-2 [3015235]
1961-2 [3015235]
5.1e-01
1.4e+00
3.3e+00
1.0e+50
2.7e+00
1.7e+00
1.2e+00
cases:0.40%
controls:0.24%
cases:0.66%
controls:0.17%
cases:1.19%
controls:0.04%
cases:0.22%
controls:0.00%
cases:0.51%
controls:0.04%
cases:1.94%
controls:0.35%
cases:3.50%
controls:1.03%
9
54
2261
22623
15
39
2255
22638
27
10
2243
22667
5
0
2265
22677
11
8
2152
22637
31
77
1571
22059
24
191
661
18271
Other chronic obstructive pulmonary disease
J44 [45543268]
J44 [45543268]
1.4e+00
1.5e+00
2.0e+00
—
2.7e+00
1.6e+00
1.1e+00
cases:2.60%
controls:0.65%
cases:1.10%
controls:0.24%
cases:0.26%
controls:0.04%
—
—
cases:0.51%
controls:0.04%
cases:1.19%
controls:0.25%
cases:2.63%
controls:0.87%
59
148
2211
22529
25
55
2245
22622
6
8
2264
22669
—
11
8
2152
22637
19
56
1583
22080
18
161
667
18301
Chronic obstructive pulmonary disease with acute lower respiratory infection
J44.0 [45601131]
J44.0 [45601131]
1.3e+00
1.4e+00
2.7e+00
—
2.1e+00
1.3e+00
1.5e+00
cases:3.00%
controls:0.87%
cases:1.98%
controls:0.51%
cases:1.19%
controls:0.08%
—
—
cases:0.79%
controls:0.10%
cases:2.18%
controls:0.60%
cases:7.45%
controls:1.72%
68
197
2202
22480
45
116
2225
22561
27
18
2243
22659
—
17
22
2146
22623
35
132
1567
22004
51
318
634
18144
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 [21602863]
J01CR02 [21602863]
4.4e-01
1.2e+00
2.8e+00
—
2.6e+00
1.9e+00
1.3e+00
cases:8.46%
controls:5.60%
cases:5.33%
controls:1.60%
cases:2.73%
controls:0.17%
—
—
cases:2.08%
controls:0.15%
cases:10.49%
controls:1.79%
cases:18.83%
controls:5.82%
192
1269
2078
21408
121
363
2149
22314
62
39
2208
22638
—
45
35
2118
22610
168
396
1434
21740
129
1075
556
17387
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
4.7e-01
9.3e-01
1.7e+00
2.1e+00
1.9e+00
1.9e+00
1.3e+00
cases:16.56%
controls:11.06%
cases:13.35%
controls:5.75%
cases:5.64%
controls:1.11%
cases:0.40%
controls:0.05%
cases:7.40%
controls:1.13%
cases:28.09%
controls:5.69%
cases:34.89%
controls:13.17%
376
2507
1894
20170
303
1305
1967
21372
128
251
2142
22426
9
11
2261
22666
160
256
2003
22389
450
1259
1152
20877
239
2432
446
16030
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
4.7e-01
9.2e-01
1.7e+00
2.1e+00
1.9e+00
1.9e+00
1.3e+00
cases:16.65%
controls:11.11%
cases:13.35%
controls:5.76%
cases:5.64%
controls:1.11%
cases:0.40%
controls:0.05%
cases:7.40%
controls:1.13%
cases:28.15%
controls:5.70%
cases:34.89%
controls:13.22%
378
2519
1892
20158
303
1306
1967
21371
128
251
2142
22426
9
11
2261
22666
160
256
2003
22389
451
1261
1151
20875
239
2441
446
16021
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
1.1e-01
4.2e-01
2.5e+00
3.3e+00
2.1e+00
1.3e+00
5.9e-01
cases:8.77%
controls:7.90%
cases:6.21%
controls:4.15%
cases:5.07%
controls:0.45%
cases:0.57%
controls:0.02%
cases:4.21%
controls:0.56%
cases:14.04%
controls:4.15%
cases:21.17%
controls:12.99%
199
1791
2071
20886
141
942
2129
21735
115
102
2155
22575
13
5
2257
22672
91
126
2072
22519
225
919
1377
21217
145
2398
540
16064
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2885-2 [3020630]
4.1e-01
1.1e+00
3.2e+00
—
3.3e+00
1.7e+00
7.6e-01
cases:1.81%
controls:1.21%
cases:1.45%
controls:0.50%
cases:1.72%
controls:0.07%
—
—
cases:0.83%
controls:0.03%
cases:3.25%
controls:0.60%
cases:4.23%
controls:2.03%
41
274
2229
22403
33
113
2237
22564
39
16
2231
22661
—
18
7
2145
22638
52
133
1550
22003
29
374
656
18088
Calcium [Moles/volume] in Serum or Plasma
2000-8 [3015377]
2000-8 [3015377]
7.6e-02
5.3e-01
3.2e+00
—
3.0e+00
2.1e+00
1.3e+00
cases:5.33%
controls:4.96%
cases:3.88%
controls:2.32%
cases:5.07%
controls:0.22%
—
—
cases:4.72%
controls:0.24%
cases:16.48%
controls:2.45%
cases:23.65%
controls:7.84%
121
1125
2149
21552
88
527
2182
22150
115
51
2155
22626
—
102
55
2061
22590
264
543
1338
21593
162
1448
523
17014
Bicarbonate [Moles/volume] in Arterial blood
1960-4 [3008152]
1960-4 [3008152]
4.9e-01
9.0e-01
3.0e+00
1.0e+50
3.1e+00
1.9e+00
1.1e+00
cases:1.63%
controls:1.01%
cases:1.23%
controls:0.51%
cases:1.01%
controls:0.05%
cases:1.06%
controls:0.00%
cases:1.25%
controls:0.06%
cases:3.75%
controls:0.57%
cases:5.55%
controls:1.99%
37
229
2233
22448
28
115
2242
22562
23
11
2247
22666
24
0
2246
22677
27
13
2136
22632
60
126
1542
22010
38
367
647
18095
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
3.2e-01
3.9e-01
3.4e+00
1.0e+50
3.0e+00
2.8e+00
7.8e-01
cases:3.26%
controls:2.39%
cases:1.15%
controls:0.78%
cases:2.29%
controls:0.08%
cases:1.76%
controls:0.00%
cases:1.90%
controls:0.09%
cases:10.99%
controls:0.76%
cases:6.42%
controls:3.04%
74
543
2196
22134
26
176
2244
22501
52
18
2218
22659
40
0
2230
22677
41
21
2122
22624
176
168
1426
21968
44
561
641
17901
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
3.7e-01
8.4e-01
2.7e+00
1.0e+50
3.0e+00
2.1e+00
1.4e+00
cases:2.33%
controls:1.63%
cases:2.38%
controls:1.04%
cases:2.16%
controls:0.15%
cases:0.26%
controls:0.00%
cases:2.03%
controls:0.11%
cases:9.49%
controls:1.23%
cases:17.52%
controls:5.15%
53
369
2217
22308
54
236
2216
22441
49
35
2221
22642
6
0
2264
22677
44
24
2119
22621
152
272
1450
21864
120
950
565
17512
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 [3013707]
4537-7 [3013707]
9.2e-02
7.8e-01
2.7e+00
3.0e+00
1.7e+00
1.0e+00
8.0e-01
cases:17.75%
controls:16.44%
cases:17.14%
controls:8.65%
cases:15.55%
controls:1.19%
cases:0.84%
controls:0.04%
cases:5.13%
controls:1.01%
cases:20.85%
controls:8.84%
cases:39.85%
controls:22.87%
403
3729
1867
18948
389
1961
1881
20716
353
269
1917
22408
19
10
2251
22667
111
228
2052
22417
334
1957
1268
20179
273
4222
412
14240
Pleural effusion, not elsewhere classified
J90 [45605897]
J90 [45605897]
2.1e-01
1.5e+00
4.0e+00
1.0e+50
—
2.9e+00
1.6e+00
cases:0.40%
controls:0.32%
cases:0.66%
controls:0.14%
cases:1.63%
controls:0.03%
cases:0.35%
controls:0.00%
—
—
cases:3.18%
controls:0.19%
cases:2.34%
controls:0.50%
9
73
2261
22604
15
32
2255
22645
37
7
2233
22670
8
0
2262
22677
—
51
42
1551
22094
16
93
669
18369
Short blood count panel - Blood
55429-5 [40758558]
55429-5 [40758558]
3.3e-01
8.1e-01
2.9e+00
—
2.8e+00
2.1e+00
1.2e+00
cases:5.11%
controls:3.72%
cases:4.36%
controls:1.98%
cases:5.20%
controls:0.29%
—
—
cases:4.90%
controls:0.30%
cases:13.23%
controls:1.88%
cases:18.54%
controls:6.16%
116
843
2154
21834
99
450
2171
22227
118
65
2152
22612
—
106
68
2057
22577
212
417
1390
21719
127
1138
558
17324
Emergency Room Visit
ER [9203]
ER [9203]
1.2e-01
5.0e-01
2.4e+00
3.2e+00
1.9e+00
1.4e+00
5.0e-01
cases:35.55%
controls:32.76%
cases:19.38%
controls:12.76%
cases:16.12%
controls:1.65%
cases:1.28%
controls:0.05%
cases:10.45%
controls:1.80%
cases:37.20%
controls:12.47%
cases:46.13%
controls:34.08%
807
7429
1463
15248
440
2893
1830
19784
366
374
1904
22303
29
12
2241
22665
226
407
1937
22238
596
2761
1006
19375
316
6291
369
12171
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
3.9e-01
6.1e-01
2.0e+00
—
3.4e+00
2.5e+00
8.1e-01
cases:6.26%
controls:4.33%
cases:2.25%
controls:1.23%
cases:1.63%
controls:0.22%
—
—
cases:4.11%
controls:0.14%
cases:12.48%
controls:1.10%
cases:8.61%
controls:4.02%
142
983
2128
21694
51
279
2219
22398
37
49
2233
22628
—
89
31
2074
22614
200
244
1402
21892
59
743
626
17719
Metamyelocytes/Leukocytes in Blood
28541-1 [3002179]
28541-1 [3002179]
6.9e-01
8.1e-01
2.9e+00
—
3.0e+00
1.9e+00
1.3e+00
cases:1.06%
controls:0.53%
cases:1.10%
controls:0.49%
cases:1.63%
controls:0.09%
—
—
cases:0.69%
controls:0.04%
cases:3.87%
controls:0.63%
cases:6.86%
controls:2.06%
24
121
2246
22556
25
112
2245
22565
37
20
2233
22657
—
15
8
2148
22637
62
139
1540
21997
47
380
638
18082
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
29265-6 [3020059]
-1.1e-01
5.0e-01
3.0e+00
—
3.3e+00
2.1e+00
1.4e+00
cases:2.64%
controls:2.95%
cases:2.29%
controls:1.40%
cases:2.86%
controls:0.15%
—
—
cases:3.74%
controls:0.14%
cases:11.67%
controls:1.56%
cases:17.23%
controls:5.11%
60
669
2210
22008
52
317
2218
22360
65
33
2205
22644
—
81
31
2082
22614
187
345
1415
21791
118
944
567
17518
aPTT in Platelet poor plasma by Coagulation assay
14979-9 [3018677]
14979-9 [3018677]
-1.9e-02
4.2e-01
3.9e+00
—
3.1e+00
2.2e+00
6.8e-01
cases:2.56%
controls:2.60%
cases:1.59%
controls:1.05%
cases:5.59%
controls:0.12%
—
—
cases:2.59%
controls:0.12%
cases:7.30%
controls:0.90%
cases:7.01%
controls:3.66%
58
590
2212
22087
36
237
2234
22440
127
27
2143
22650
—
56
28
2107
22617
117
199
1485
21937
48
676
637
17786
Granulocytes [#/volume] in Blood
30394-1 [3035715]
30394-1 [3035715]
8.9e-01
1.4e+00
—
—
2.5e+00
2.8e+00
2.1e+00
cases:0.79%
controls:0.33%
cases:0.44%
controls:0.11%
—
—
—
—
cases:0.28%
controls:0.02%
cases:1.06%
controls:0.06%
cases:1.46%
controls:0.18%
18
74
2252
22603
10
24
2260
22653
—
—
6
5
2157
22640
17
14
1585
22122
10
33
675
18429
Pathology report gross observation
24419-4 [3002256]
24419-4 [3002256]
5.7e-01
1.4e+00
1.8e+00
1.0e+50
3.6e+00
3.3e+00
1.5e+00
cases:1.81%
controls:1.03%
cases:1.32%
controls:0.34%
cases:0.22%
controls:0.04%
cases:1.50%
controls:0.00%
cases:1.25%
controls:0.04%
cases:6.99%
controls:0.28%
cases:5.55%
controls:1.29%
41
233
2229
22444
30
76
2240
22601
5
8
2265
22669
34
0
2236
22677
27
8
2136
22637
112
61
1490
22075
38
238
647
18224
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
4.4e-01
6.0e-01
2.6e+00
—
2.7e+00
2.2e+00
1.2e+00
cases:6.12%
controls:4.04%
cases:4.14%
controls:2.31%
cases:4.23%
controls:0.32%
—
—
cases:4.21%
controls:0.30%
cases:18.04%
controls:2.38%
cases:23.36%
controls:8.37%
139
917
2131
21760
94
523
2176
22154
96
73
2174
22604
—
91
68
2072
22577
289
527
1313
21609
160
1546
525
16916
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
14675-3 [3036481]
2.3e-01
4.1e-01
1.4e+00
—
3.9e+00
3.5e+00
2.4e+00
cases:1.32%
controls:1.05%
cases:0.66%
controls:0.44%
cases:0.31%
controls:0.08%
—
—
cases:3.24%
controls:0.07%
cases:10.17%
controls:0.36%
cases:14.45%
controls:1.58%
30
238
2240
22439
15
100
2255
22577
7
18
2263
22659
—
70
15
2093
22630
163
79
1439
22057
99
291
586
18171
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 [3020427]
3216-9 [3020427]
3.1e-01
1.5e-01
2.6e+00
1.0e+50
3.0e+00
2.7e+00
1.3e+00
cases:0.70%
controls:0.52%
cases:0.22%
controls:0.19%
cases:0.31%
controls:0.02%
cases:0.26%
controls:0.00%
cases:0.65%
controls:0.03%
cases:2.87%
controls:0.19%
cases:2.34%
controls:0.65%
16
117
2254
22560
5
43
2265
22634
7
5
2263
22672
6
0
2264
22677
14
7
2149
22638
46
42
1556
22094
16
120
669
18342
tinzaparin; parenteral
B01AB10 [21600981]
B01AB10 [21600981]
4.5e-01
2.0e-01
2.9e+00
—
2.7e+00
2.9e+00
1.3e+00
cases:0.66%
controls:0.42%
cases:0.26%
controls:0.22%
cases:0.62%
controls:0.04%
—
—
cases:1.06%
controls:0.07%
cases:4.37%
controls:0.26%
cases:3.80%
controls:1.10%
15
96
2255
22581
6
49
2264
22628
14
8
2256
22669
—
23
16
2140
22629
70
58
1532
22078
26
204
659
18258
moxifloxacin; oral, parenteral
J01MA14 [21603021]
J01MA14 [21603021]
5.8e-01
1.8e+00
3.0e+00
—
—
3.0e+00
1.9e+00
cases:1.72%
controls:0.97%
cases:1.67%
controls:0.27%
cases:0.88%
controls:0.04%
—
—
—
—
cases:4.43%
controls:0.24%
cases:5.11%
controls:0.81%
39
220
2231
22457
38
62
2232
22615
20
10
2250
22667
—
—
71
53
1531
22083
35
150
650
18312
fenoterol and ipratropium bromide
R03AL01 [43534843]
R03AL01 [43534843]
9.9e-01
1.3e+00
1.8e+00
—
2.2e+00
1.7e+00
1.6e+00
cases:4.63%
controls:1.77%
cases:4.05%
controls:1.14%
cases:1.54%
controls:0.26%
—
—
cases:2.73%
controls:0.30%
cases:6.49%
controls:1.21%
cases:11.82%
controls:2.66%
105
401
2165
22276
92
259
2178
22418
35
60
2235
22617
—
59
67
2104
22578
104
267
1498
21869
81
492
604
17970
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
2.2e-01
5.3e-01
3.0e+00
—
2.7e+00
2.5e+00
9.2e-01
cases:4.27%
controls:3.46%
cases:2.33%
controls:1.38%
cases:3.04%
controls:0.16%
—
—
cases:2.50%
controls:0.18%
cases:14.48%
controls:1.33%
cases:10.80%
controls:4.61%
97
785
2173
21892
53
314
2217
22363
69
36
2201
22641
—
54
40
2109
22605
232
295
1370
21841
74
852
611
17610
Promyelocytes/Leukocytes in Blood
26524-9 [3021440]
26524-9 [3021440]
6.5e-01
8.3e-01
3.0e+00
—
2.9e+00
1.8e+00
1.1e+00
cases:1.15%
controls:0.60%
cases:1.23%
controls:0.54%
cases:1.67%
controls:0.09%
—
—
cases:0.79%
controls:0.04%
cases:3.75%
controls:0.62%
cases:6.42%
controls:2.23%
26
136
2244
22541
28
123
2242
22554
38
20
2232
22657
—
17
10
2146
22635
60
137
1542
21999
44
411
641
18051
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
9.7e-02
8.0e-01
2.8e+00
—
2.6e+00
2.0e+00
1.4e+00
cases:4.80%
controls:4.38%
cases:5.59%
controls:2.60%
cases:7.00%
controls:0.45%
—
—
cases:5.09%
controls:0.40%
cases:17.60%
controls:2.78%
cases:26.57%
controls:8.48%
109
993
2161
21684
127
589
2143
22088
159
102
2111
22575
—
110
90
2053
22555
282
615
1320
21521
182
1566
503
16896
Thoracal epidural anesthesia
WX302 [2001310795]
WX302 [2001310795]
1.8e+00
1.9e+00
—
1.0e+50
1.0e+50
5.6e+00
2.2e+00
cases:0.66%
controls:0.11%
cases:0.26%
controls:0.04%
—
—
cases:0.79%
controls:0.00%
cases:0.65%
controls:0.00%
cases:6.68%
controls:0.03%
cases:1.17%
controls:0.13%
15
25
2255
22652
6
9
2264
22668
—
18
0
2252
22677
14
0
2149
22645
107
6
1495
22130
8
24
677
18438
Bacteria identified in Sputum by Culture
6460-0 [3023419]
6460-0 [3023419]
1.1e+00
2.2e+00
—
1.0e+50
2.7e+00
2.3e+00
2.4e+00
cases:0.48%
controls:0.16%
cases:0.70%
controls:0.08%
—
—
cases:0.79%
controls:0.00%
cases:0.32%
controls:0.02%
cases:0.94%
controls:0.09%
cases:2.77%
controls:0.27%
11
36
2259
22641
16
18
2254
22659
—
18
0
2252
22677
7
5
2156
22640
15
20
1587
22116
19
50
666
18412
erdosteine; oral
R05CB15 [21603394]
R05CB15 [21603394]
7.1e-01
1.4e+00
2.2e+00
—
1.8e+00
1.8e+00
1.6e+00
cases:4.98%
controls:2.51%
cases:4.14%
controls:1.02%
cases:1.28%
controls:0.14%
—
—
cases:0.97%
controls:0.16%
cases:6.43%
controls:1.16%
cases:17.37%
controls:3.97%
113
570
2157
22107
94
231
2176
22446
29
32
2241
22645
—
21
37
2142
22608
103
257
1499
21879
119
733
566
17729
Inpatient Visit
IP [9201]
IP [9201]
1.8e-01
5.1e-01
2.7e+00
—
3.2e+00
2.2e+00
9.9e-01
cases:10.44%
controls:8.84%
cases:5.15%
controls:3.18%
cases:5.77%
controls:0.40%
—
—
cases:7.95%
controls:0.37%
cases:20.72%
controls:2.95%
cases:22.77%
controls:9.87%
237
2005
2033
20672
117
720
2153
21957
131
91
2139
22586
—
172
83
1991
22562
332
652
1270
21484
156
1823
529
16639
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
2.3e-01
8.3e-01
2.5e+00
—
2.8e+00
2.0e+00
1.4e+00
cases:1.32%
controls:1.05%
cases:1.59%
controls:0.70%
cases:1.45%
controls:0.12%
—
—
cases:1.20%
controls:0.08%
cases:6.37%
controls:0.90%
cases:13.87%
controls:3.98%
30
239
2240
22438
36
158
2234
22519
33
27
2237
22650
—
26
17
2137
22628
102
199
1500
21937
95
735
590
17727
varenicline; oral
N07BA03 [21604819]
N07BA03 [21604819]
2.0e+00
2.4e+00
—
—
—
2.9e+00
2.2e+00
cases:3.39%
controls:0.47%
cases:1.28%
controls:0.12%
—
—
—
—
—
—
cases:1.56%
controls:0.09%
cases:2.48%
controls:0.27%
77
106
2193
22571
29
27
2241
22650
—
—
—
25
20
1577
22116
17
50
668
18412
Clinic/Center
261Q00000X [38004207]
261Q00000X [38004207]
3.1e-01
1.6e+00
—
—
3.2e+00
3.1e+00
1.6e+00
cases:0.84%
controls:0.62%
cases:0.66%
controls:0.14%
—
—
—
—
cases:0.97%
controls:0.04%
cases:3.93%
controls:0.19%
cases:3.07%
controls:0.64%
19
140
2251
22537
15
31
2255
22646
—
—
21
9
2142
22636
63
41
1539
22095
21
119
664
18343
formoterol, glycopyrronium bromide and beclometasone
R03AL09 [1502099]
R03AL09 [1502099]
9.7e-01
1.5e+00
2.2e+00
—
1.9e+00
2.0e+00
1.8e+00
cases:0.44%
controls:0.17%
cases:0.97%
controls:0.22%
cases:0.88%
controls:0.10%
—
—
cases:0.83%
controls:0.13%
cases:2.37%
controls:0.32%
cases:4.53%
controls:0.74%
10
38
2260
22639
22
49
2248
22628
20
23
2250
22654
—
18
29
2145
22616
38
70
1564
22066
31
137
654
18325
Pulmonary embolism without mention of acute cor pulmonale
I26.9 [45552785]
I26.9 [45552785]
-3.5e-01
6.6e-01
2.8e+00
—
3.1e+00
2.1e+00
1.4e+00
cases:0.35%
controls:0.50%
cases:0.26%
controls:0.14%
cases:0.57%
controls:0.04%
—
—
cases:0.69%
controls:0.03%
cases:1.69%
controls:0.21%
cases:2.92%
controls:0.73%
8
113
2262
22564
6
31
2264
22646
13
8
2257
22669
—
15
7
2148
22638
27
46
1575
22090
20
134
665
18328
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
1.3e-01
3.9e-01
3.1e+00
—
2.5e+00
2.5e+00
1.3e+00
cases:0.70%
controls:0.62%
cases:0.62%
controls:0.42%
cases:0.88%
controls:0.04%
—
—
cases:0.83%
controls:0.07%
cases:5.06%
controls:0.45%
cases:5.26%
controls:1.47%
16
140
2254
22537
14
95
2256
22582
20
9
2250
22668
—
18
16
2145
22629
81
100
1521
22036
36
271
649
18191
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
3.4e-01
8.0e-01
2.5e+00
—
2.7e+00
1.9e+00
1.3e+00
cases:1.54%
controls:1.10%
cases:1.54%
controls:0.70%
cases:1.37%
controls:0.11%
—
—
cases:1.06%
controls:0.07%
cases:5.74%
controls:0.86%
cases:12.85%
controls:3.79%
35
250
2235
22427
35
158
2235
22519
31
26
2239
22651
—
23
16
2140
22629
92
191
1510
21945
88
700
597
17762
Monitored bed care
WX892 [2001310850]
WX892 [2001310850]
4.3e-01
6.1e-01
3.1e+00
—
2.4e+00
2.1e+00
1.6e+00
cases:1.37%
controls:0.90%
cases:0.62%
controls:0.34%
cases:0.88%
controls:0.04%
—
—
cases:0.55%
controls:0.05%
cases:2.31%
controls:0.29%
cases:3.94%
controls:0.81%
31
203
2239
22474
14
76
2256
22601
20
9
2250
22668
—
12
11
2151
22634
37
64
1565
22072
27
149
658
18313
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
JN1AE [2001305517]
8.4e-01
6.1e-01
2.5e+00
—
2.7e+00
1.9e+00
1.3e+00
cases:1.37%
controls:0.60%
cases:0.40%
controls:0.22%
cases:0.26%
controls:0.02%
—
—
cases:0.32%
controls:0.02%
cases:1.25%
controls:0.19%
cases:2.04%
controls:0.57%
31
135
2239
22542
9
49
2261
22628
6
5
2264
22672
—
7
5
2156
22640
20
42
1582
22094
14
106
671
18356
tiotropium bromide; inhalant
R03BB04 [21603296]
R03BB04 [21603296]
1.3e+00
1.3e+00
1.6e+00
-1.0e+50
1.8e+00
1.6e+00
1.6e+00
cases:11.01%
controls:3.27%
cases:9.91%
controls:2.84%
cases:4.85%
controls:1.01%
cases:0.00%
controls:0.03%
cases:5.09%
controls:0.92%
cases:13.61%
controls:3.00%
cases:19.42%
controls:4.79%
250
741
2020
21936
225
643
2045
22034
110
229
2160
22448
0
7
2270
22670
110
208
2053
22437
218
665
1384
21471
133
884
552
17578
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
4.6e-01
7.0e-01
2.7e+00
1.0e+50
2.3e+00
2.0e+00
1.0e+00
cases:3.52%
controls:2.26%
cases:1.94%
controls:0.97%
cases:1.72%
controls:0.12%
cases:1.28%
controls:0.00%
cases:1.06%
controls:0.11%
cases:5.87%
controls:0.83%
cases:7.88%
controls:3.07%
80
513
2190
22164
44
220
2226
22457
39
27
2231
22650
29
0
2241
22677
23
24
2140
22621
94
184
1508
21952
54
566
631
17896
Blasts/Leukocytes in Blood
26446-5 [3025159]
26446-5 [3025159]
6.5e-01
7.6e-01
2.9e+00
—
2.7e+00
1.6e+00
1.2e+00
cases:1.01%
controls:0.53%
cases:1.10%
controls:0.52%
cases:1.59%
controls:0.09%
—
—
cases:0.69%
controls:0.05%
cases:3.43%
controls:0.68%
cases:7.01%
controls:2.27%
23
120
2247
22557
25
117
2245
22560
36
20
2234
22657
—
15
11
2148
22634
55
151
1547
21985
48
420
637
18042
Gas panel - Central venous blood
97535-9 [1616796]
97535-9 [1616796]
4.5e-01
6.5e-01
3.2e+00
—
2.7e+00
1.9e+00
1.3e+00
cases:0.44%
controls:0.28%
cases:0.35%
controls:0.19%
cases:0.66%
controls:0.03%
—
—
cases:0.46%
controls:0.03%
cases:1.56%
controls:0.23%
cases:2.04%
controls:0.56%
10
64
2260
22613
8
42
2262
22635
15
6
2255
22671
—
10
7
2153
22638
25
52
1577
22084
14
104
671
18358
Thorax CT examination
GD1AD [2001303618]
GD1AD [2001303618]
6.8e-01
2.1e+00
—
—
—
3.8e+00
3.2e+00
cases:0.75%
controls:0.38%
cases:1.37%
controls:0.17%
—
—
—
—
—
—
cases:8.86%
controls:0.21%
cases:15.62%
controls:0.77%
17
86
2253
22591
31
38
2239
22639
—
—
—
142
47
1460
22089
107
142
578
18320
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
6.1e-02
3.2e-01
2.1e+00
3.4e+00
1.9e+00
8.5e-01
4.5e-01
cases:30.13%
controls:28.86%
cases:25.81%
controls:20.21%
cases:24.19%
controls:3.80%
cases:4.98%
controls:0.17%
cases:19.65%
controls:3.42%
cases:37.89%
controls:20.70%
cases:48.91%
controls:37.98%
684
6544
1586
16133
586
4584
1684
18093
549
862
1721
21815
113
38
2157
22639
425
775
1738
21870
607
4582
995
17554
335
7011
350
11451
codeine; oral
R05DA04 [21603399]
R05DA04 [21603399]
1.4e-01
9.5e-01
2.6e+00
—
2.4e+00
2.0e+00
1.1e+00
cases:3.13%
controls:2.73%
cases:1.50%
controls:0.58%
cases:0.70%
controls:0.05%
—
—
cases:0.69%
controls:0.07%
cases:3.93%
controls:0.54%
cases:3.65%
controls:1.21%
71
619
2199
22058
34
132
2236
22545
16
12
2254
22665
—
15
15
2148
22630
63
119
1539
22017
25
223
660
18239
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
2.0e-01
4.8e-01
2.8e+00
—
2.5e+00
2.4e+00
8.8e-01
cases:5.95%
controls:4.93%
cases:3.17%
controls:1.99%
cases:3.92%
controls:0.26%
—
—
cases:3.14%
controls:0.26%
cases:17.04%
controls:1.84%
cases:13.87%
controls:6.26%
135
1117
2135
21560
72
452
2198
22225
89
58
2181
22619
—
68
58
2095
22587
273
407
1329
21729
95
1155
590
17307
Procalcitonin [Mass/volume] in Serum or Plasma
33959-8 [3046279]
33959-8 [3046279]
8.5e-01
1.0e+00
3.3e+00
—
—
2.6e+00
1.2e+00
cases:0.93%
controls:0.40%
cases:0.62%
controls:0.22%
cases:0.75%
controls:0.03%
—
—
—
—
cases:3.93%
controls:0.30%
cases:3.50%
controls:1.06%
21
90
2249
22587
14
50
2256
22627
17
6
2253
22671
—
—
63
67
1539
22069
24
196
661
18266
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
2.8e-02
3.0e-01
2.2e+00
3.4e+00
2.0e+00
7.6e-01
4.6e-01
cases:34.89%
controls:34.25%
cases:36.04%
controls:29.42%
cases:37.62%
controls:6.25%
cases:7.93%
controls:0.30%
cases:30.24%
controls:5.71%
cases:49.75%
controls:31.54%
cases:60.73%
controls:49.32%
792
7766
1478
14911
818
6671
1452
16006
854
1417
1416
21260
180
68
2090
22609
654
1294
1509
21351
797
6982
805
15154
416
9105
269
9357
HIV 1 and 2 tests - Meaningful Use set
75622-1 [46235355]
75622-1 [46235355]
4.5e-01
8.3e-01
3.0e+00
—
2.4e+00
1.9e+00
9.9e-01
cases:1.54%
controls:0.99%
cases:1.15%
controls:0.50%
cases:0.79%
controls:0.04%
—
—
cases:0.55%
controls:0.05%
cases:2.06%
controls:0.33%
cases:3.94%
controls:1.50%
35
224
2235
22453
26
114
2244
22563
18
9
2252
22668
—
12
12
2151
22633
33
72
1569
22064
27
277
658
18185
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
5.2e-02
3.2e-01
2.2e+00
3.2e+00
1.9e+00
8.0e-01
6.0e-01
cases:20.53%
controls:19.69%
cases:22.07%
controls:17.06%
cases:25.90%
controls:3.67%
cases:4.45%
controls:0.19%
cases:19.19%
controls:3.38%
cases:34.14%
controls:18.87%
cases:47.15%
controls:32.89%
466
4465
1804
18212
501
3868
1769
18809
588
832
1682
21845
101
44
2169
22633
415
765
1748
21880
547
4176
1055
17960
323
6073
362
12389
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
2.9e-02
3.0e-01
2.2e+00
3.3e+00
2.0e+00
7.7e-01
4.6e-01
cases:34.85%
controls:34.19%
cases:35.95%
controls:29.33%
cases:37.62%
controls:6.22%
cases:7.58%
controls:0.30%
cases:30.24%
controls:5.69%
cases:49.75%
controls:31.47%
cases:60.73%
controls:49.29%
791
7754
1479
14923
816
6652
1454
16025
854
1410
1416
21267
172
68
2098
22609
654
1289
1509
21356
797
6966
805
15170
416
9099
269
9363
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
3.0e-02
3.1e-01
2.2e+00
3.3e+00
2.0e+00
7.7e-01
4.6e-01
cases:34.93%
controls:34.26%
cases:36.21%
controls:29.42%
cases:37.62%
controls:6.24%
cases:7.58%
controls:0.30%
cases:30.28%
controls:5.70%
cases:49.81%
controls:31.56%
cases:60.73%
controls:49.37%
793
7769
1477
14908
822
6672
1448
16005
854
1415
1416
21262
172
68
2098
22609
655
1291
1508
21354
798
6987
804
15149
416
9114
269
9348
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
3.0e-02
3.0e-01
2.2e+00
3.3e+00
2.0e+00
7.7e-01
4.6e-01
cases:34.89%
controls:34.22%
cases:35.99%
controls:29.36%
cases:37.62%
controls:6.23%
cases:7.58%
controls:0.30%
cases:30.24%
controls:5.70%
cases:49.75%
controls:31.49%
cases:60.73%
controls:49.30%
792
7759
1478
14918
817
6659
1453
16018
854
1412
1416
21265
172
68
2098
22609
654
1290
1509
21355
797
6970
805
15166
416
9102
269
9360
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
2.7e-02
3.0e-01
2.2e+00
3.3e+00
2.0e+00
7.6e-01
4.6e-01
cases:34.89%
controls:34.29%
cases:36.08%
controls:29.40%
cases:37.67%
controls:6.24%
cases:7.71%
controls:0.30%
cases:30.33%
controls:5.72%
cases:49.75%
controls:31.55%
cases:60.73%
controls:49.34%
792
7775
1478
14902
819
6668
1451
16009
855
1416
1415
21261
175
69
2095
22608
656
1296
1507
21349
797
6983
805
15153
416
9110
269
9352
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
2.9e-02
3.0e-01
2.2e+00
3.3e+00
2.0e+00
7.7e-01
4.6e-01
cases:34.89%
controls:34.23%
cases:36.04%
controls:29.39%
cases:37.62%
controls:6.23%
cases:7.58%
controls:0.30%
cases:30.24%
controls:5.70%
cases:49.75%
controls:31.51%
cases:60.73%
controls:49.32%
792
7762
1478
14915
818
6665
1452
16012
854
1413
1416
21264
172
68
2098
22609
654
1291
1509
21354
797
6976
805
15160
416
9105
269
9357
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
2.9e-02
3.0e-01
2.2e+00
3.3e+00
2.0e+00
7.7e-01
4.6e-01
cases:34.89%
controls:34.23%
cases:36.04%
controls:29.39%
cases:37.62%
controls:6.23%
cases:7.58%
controls:0.30%
cases:30.24%
controls:5.70%
cases:49.75%
controls:31.53%
cases:60.73%
controls:49.32%
792
7763
1478
14914
818
6665
1452
16012
854
1412
1416
21265
172
68
2098
22609
654
1291
1509
21354
797
6979
805
15157
416
9106
269
9356
Nonallergic asthma
J45.1 [45557625]
J45.1 [45557625]
2.6e-01
9.7e-01
2.7e+00
—
2.7e+00
1.5e+00
1.1e+00
cases:1.15%
controls:0.88%
cases:1.01%
controls:0.39%
cases:0.88%
controls:0.06%
—
—
cases:1.16%
controls:0.08%
cases:1.56%
controls:0.34%
cases:3.36%
controls:1.14%
26
200
2244
22477
23
88
2247
22589
20
14
2250
22663
—
25
18
2138
22627
25
75
1577
22061
23
211
662
18251
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
2.4e-01
5.8e-01
2.7e+00
—
2.8e+00
1.9e+00
9.6e-01
cases:6.30%
controls:5.02%
cases:3.92%
controls:2.24%
cases:4.19%
controls:0.29%
—
—
cases:5.04%
controls:0.33%
cases:15.17%
controls:2.57%
cases:17.23%
controls:7.36%
143
1139
2127
21538
89
507
2181
22170
95
66
2175
22611
—
109
75
2054
22570
243
568
1359
21568
118
1359
567
17103
Myoglobin [Mass/volume] in Serum or Plasma
2639-3 [3005895]
2639-3 [3005895]
-2.5e-01
1.4e-01
2.0e+00
—
2.9e+00
2.4e+00
1.6e+00
cases:0.44%
controls:0.56%
cases:0.26%
controls:0.23%
cases:0.35%
controls:0.05%
—
—
cases:1.06%
controls:0.06%
cases:2.50%
controls:0.23%
cases:4.53%
controls:0.93%
10
128
2260
22549
6
52
2264
22625
8
11
2262
22666
—
23
14
2140
22631
40
51
1562
22085
31
171
654
18291
Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
95941-1 [36031861]
95941-1 [36031861]
6.0e-01
8.3e-01
2.5e+00
—
3.1e+00
2.1e+00
1.2e+00
cases:0.44%
controls:0.24%
cases:0.57%
controls:0.25%
cases:0.57%
controls:0.05%
—
—
cases:0.79%
controls:0.04%
cases:2.81%
controls:0.37%
cases:6.86%
controls:2.13%
10
55
2260
22622
13
57
2257
22620
13
11
2257
22666
—
17
8
2146
22637
45
82
1557
22054
47
394
638
18068
Pleural plaque with presence of asbestos
J92.0 [45567277]
J92.0 [45567277]
6.6e-01
1.0e+00
2.8e+00
—
3.0e+00
2.0e+00
2.6e-01
cases:1.06%
controls:0.55%
cases:0.79%
controls:0.28%
cases:0.97%
controls:0.06%
—
—
cases:1.43%
controls:0.07%
cases:2.06%
controls:0.30%
cases:0.88%
controls:0.68%
24
125
2246
22552
18
64
2252
22613
22
13
2248
22664
—
31
16
2132
22629
33
66
1569
22070
6
125
679
18337
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
4.2e-01
8.6e-01
3.0e+00
—
2.6e+00
1.2e+00
6.7e-01
cases:6.04%
controls:4.03%
cases:2.78%
controls:1.20%
cases:2.38%
controls:0.12%
—
—
cases:1.90%
controls:0.15%
cases:3.43%
controls:1.03%
cases:4.82%
controls:2.52%
137
915
2133
21762
63
271
2207
22406
54
28
2216
22649
—
41
33
2122
22612
55
227
1547
21909
33
465
652
17997
Lactate [Moles/volume] in Blood
32693-4 [3047181]
32693-4 [3047181]
3.8e-01
6.4e-01
2.7e+00
—
3.2e+00
1.8e+00
1.0e+00
cases:0.57%
controls:0.39%
cases:0.44%
controls:0.23%
cases:0.40%
controls:0.03%
—
—
cases:0.79%
controls:0.03%
cases:1.69%
controls:0.29%
cases:2.04%
controls:0.76%
13
89
2257
22588
10
53
2260
22624
9
6
2261
22671
—
17
7
2146
22638
27
64
1575
22072
14
141
671
18321
Emergency Medicine
93 [38004510]
93 [38004510]
4.5e-02
4.3e-01
2.3e+00
2.7e+00
1.5e+00
1.1e+00
7.2e-01
cases:12.25%
controls:11.77%
cases:9.82%
controls:6.63%
cases:8.02%
controls:0.90%
cases:0.40%
controls:0.03%
cases:4.25%
controls:0.96%
cases:19.48%
controls:7.66%
cases:36.50%
controls:21.83%
278
2670
1992
20007
223
1503
2047
21174
182
205
2088
22472
9
6
2261
22671
92
217
2071
22428
312
1696
1290
20440
250
4030
435
14432
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
3.4e-02
2.9e-01
2.1e+00
3.0e+00
1.9e+00
8.8e-01
4.9e-01
cases:32.69%
controls:31.95%
cases:32.07%
controls:26.07%
cases:29.82%
controls:4.94%
cases:5.33%
controls:0.29%
cases:24.92%
controls:4.51%
cases:48.50%
controls:28.09%
cases:59.27%
controls:47.18%
742
7245
1528
15432
728
5911
1542
16766
677
1121
1593
21556
121
65
2149
22612
539
1022
1624
21623
777
6219
825
15917
406
8710
279
9752
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
1.4e-01
4.9e-01
2.4e+00
—
2.8e+00
1.9e+00
1.1e+00
cases:8.59%
controls:7.57%
cases:6.92%
controls:4.33%
cases:6.70%
controls:0.63%
—
—
cases:8.74%
controls:0.60%
cases:23.66%
controls:4.52%
cases:30.66%
controls:12.89%
195
1716
2075
20961
157
983
2113
21694
152
142
2118
22535
—
189
135
1974
22510
379
1000
1223
21136
210
2379
475
16083
SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
94759-8 [586526]
94759-8 [586526]
1.6e-02
8.7e-01
3.0e+00
—
2.4e+00
2.0e+00
1.3e+00
cases:0.53%
controls:0.52%
cases:0.62%
controls:0.26%
cases:0.62%
controls:0.03%
—
—
cases:0.46%
controls:0.04%
cases:2.68%
controls:0.36%
cases:5.11%
controls:1.48%
12
118
2258
22559
14
59
2256
22618
14
7
2256
22670
—
10
10
2153
22635
43
79
1559
22057
35
273
650
18189
Cytology report of Tissue fine needle aspirate Cyto stain
33718-8 [3043109]
33718-8 [3043109]
4.0e-01
2.3e+00
—
1.0e+50
1.0e+50
3.6e+00
2.8e+00
cases:0.31%
controls:0.21%
cases:0.70%
controls:0.07%
—
—
cases:3.22%
controls:0.00%
cases:1.11%
controls:0.00%
cases:1.56%
controls:0.05%
cases:2.19%
controls:0.14%
7
47
2263
22630
16
16
2254
22661
—
73
0
2197
22677
24
0
2139
22645
25
10
1577
22126
15
25
670
18437
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
2.4e-02
2.3e-01
1.7e+00
4.2e+00
1.6e+00
5.6e-01
3.9e-01
cases:37.49%
controls:36.92%
cases:39.69%
controls:34.36%
cases:40.62%
controls:10.95%
cases:30.48%
controls:0.65%
cases:36.15%
controls:10.62%
cases:50.69%
controls:36.94%
cases:61.17%
controls:51.58%
851
8372
1419
14305
901
7791
1369
14886
922
2483
1348
20194
692
148
1578
22529
782
2404
1381
20241
812
8178
790
13958
419
9523
266
8939
Internal Medicine
11 [38004456]
11 [38004456]
1.5e-01
4.5e-01
2.0e+00
2.7e+00
1.6e+00
1.3e+00
5.3e-01
cases:30.70%
controls:27.70%
cases:17.14%
controls:11.66%
cases:13.39%
controls:1.99%
cases:0.93%
controls:0.06%
cases:9.20%
controls:1.95%
cases:31.90%
controls:11.72%
cases:40.88%
controls:28.95%
697
6282
1573
16395
389
2645
1881
20032
304
451
1966
22226
21
14
2249
22663
199
442
1964
22203
511
2595
1091
19541
280
5344
405
13118
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
2.1e-01
7.2e-01
2.3e+00
—
2.3e+00
2.3e+00
9.5e-01
cases:3.22%
controls:2.61%
cases:2.03%
controls:1.00%
cases:1.32%
controls:0.13%
—
—
cases:1.16%
controls:0.11%
cases:8.55%
controls:0.96%
cases:8.47%
controls:3.44%
73
593
2197
22084
46
227
2224
22450
30
29
2240
22648
—
25
26
2138
22619
137
213
1465
21923
58
635
627
17827
ethylmorphine; oral
R05DA01 [21603397]
R05DA01 [21603397]
3.3e-01
1.1e+00
2.4e+00
—
2.4e+00
2.0e+00
7.3e-01
cases:3.04%
controls:2.20%
cases:1.76%
controls:0.60%
cases:0.88%
controls:0.08%
—
—
cases:0.92%
controls:0.08%
cases:4.24%
controls:0.62%
cases:4.82%
controls:2.38%
69
498
2201
22179
40
137
2230
22540
20
18
2250
22659
—
20
19
2143
22626
68
137
1534
21999
33
440
652
18022
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
3.8e-02
2.8e-01
2.1e+00
3.0e+00
1.9e+00
8.6e-01
4.7e-01
cases:32.95%
controls:32.11%
cases:32.25%
controls:26.44%
cases:29.74%
controls:5.08%
cases:5.24%
controls:0.29%
cases:25.01%
controls:4.61%
cases:48.56%
controls:28.52%
cases:59.12%
controls:47.38%
748
7282
1522
15395
732
5995
1538
16682
675
1152
1595
21525
119
65
2151
22612
541
1044
1622
21601
778
6313
824
15823
405
8747
280
9715
CBC W Ordered Manual Differential panel - Blood
57782-5 [40760892]
57782-5 [40760892]
2.7e-01
8.3e-01
3.0e+00
—
2.3e+00
1.5e+00
9.7e-01
cases:3.61%
controls:2.77%
cases:3.74%
controls:1.67%
cases:5.07%
controls:0.27%
—
—
cases:2.13%
controls:0.23%
cases:7.80%
controls:1.78%
cases:11.97%
controls:4.92%
82
629
2188
22048
85
378
2185
22299
115
62
2155
22615
—
46
51
2117
22594
125
394
1477
21742
82
908
603
17554
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 [3005702]
543-9 [3005702]
4.7e-01
2.8e+00
—
1.0e+50
—
3.1e+00
2.6e+00
cases:0.40%
controls:0.25%
cases:1.67%
controls:0.10%
—
—
cases:6.52%
controls:0.00%
—
—
cases:1.94%
controls:0.09%
cases:4.09%
controls:0.31%
9
56
2261
22621
38
23
2232
22654
—
148
0
2122
22677
—
31
19
1571
22117
28
58
657
18404
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
1.5e-01
6.0e-01
3.0e+00
—
2.4e+00
2.1e+00
1.1e+00
cases:1.89%
controls:1.64%
cases:1.63%
controls:0.90%
cases:1.37%
controls:0.07%
—
—
cases:1.48%
controls:0.13%
cases:7.87%
controls:1.08%
cases:11.24%
controls:4.17%
43
372
2227
22305
37
205
2233
22472
31
16
2239
22661
—
32
30
2131
22615
126
239
1476
21897
77
770
608
17692
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
1.1e-01
3.8e-01
2.1e+00
2.5e+00
2.0e+00
9.5e-01
6.5e-01
cases:23.17%
controls:21.33%
cases:25.68%
controls:19.04%
cases:25.02%
controls:3.96%
cases:2.60%
controls:0.22%
cases:20.90%
controls:3.55%
cases:41.26%
controls:21.44%
cases:54.31%
controls:38.20%
526
4838
1744
17839
583
4318
1687
18359
568
897
1702
21780
59
51
2211
22626
452
805
1711
21840
661
4746
941
17390
372
7053
313
11409
Granulocytes/Leukocytes in Blood
30395-8 [3035933]
30395-8 [3035933]
8.4e-01
1.4e+00
—
—
2.5e+00
2.6e+00
1.9e+00
cases:0.84%
controls:0.36%
cases:0.44%
controls:0.11%
—
—
—
—
cases:0.28%
controls:0.02%
cases:1.06%
controls:0.08%
cases:1.46%
controls:0.22%
19
82
2251
22595
10
25
2260
22652
—
—
6
5
2157
22640
17
17
1585
22119
10
40
675
18422
High resolution CT examination of lungs
GD1DD [2001303632]
GD1DD [2001303632]
1.0e+00
1.3e+00
—
—
2.5e+00
2.0e+00
1.7e+00
cases:1.15%
controls:0.41%
cases:0.57%
controls:0.16%
—
—
—
—
cases:0.28%
controls:0.02%
cases:1.12%
controls:0.16%
cases:2.77%
controls:0.53%
26
93
2244
22584
13
37
2257
22640
—
—
6
5
2157
22640
18
35
1584
22101
19
98
666
18364
Pleura Pathology biopsy report
66123-1 [40768806]
66123-1 [40768806]
—
2.2e+00
—
1.0e+50
1.0e+50
4.0e+00
2.2e+00
—
—
cases:0.53%
controls:0.06%
—
—
cases:0.48%
controls:0.00%
cases:0.92%
controls:0.00%
cases:1.94%
controls:0.04%
cases:2.04%
controls:0.22%
—
12
13
2258
22664
—
11
0
2259
22677
20
0
2143
22645
31
8
1571
22128
14
41
671
18421
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
2.7e-02
2.9e-01
2.1e+00
2.7e+00
2.0e+00
8.0e-01
4.8e-01
cases:34.19%
controls:33.57%
cases:34.85%
controls:28.61%
cases:34.80%
controls:5.89%
cases:4.76%
controls:0.32%
cases:29.36%
controls:5.38%
cases:49.63%
controls:30.78%
cases:60.58%
controls:48.85%
776
7613
1494
15064
791
6487
1479
16190
790
1336
1480
21341
108
73
2162
22604
635
1218
1528
21427
795
6813
807
15323
415
9019
270
9443
formoterol and beclometasone
R03AK08 [43534839]
R03AK08 [43534839]
4.3e-01
1.2e+00
1.9e+00
—
1.9e+00
1.8e+00
1.7e+00
cases:0.70%
controls:0.46%
cases:1.59%
controls:0.48%
cases:1.23%
controls:0.19%
—
—
cases:1.43%
controls:0.23%
cases:3.81%
controls:0.67%
cases:6.42%
controls:1.29%
16
104
2254
22573
36
108
2234
22569
28
42
2242
22635
—
31
51
2132
22594
61
148
1541
21988
44
238
641
18224
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
9.3e-02
3.8e-01
2.7e+00
—
2.3e+00
2.4e+00
9.9e-01
cases:4.54%
controls:4.15%
cases:2.11%
controls:1.46%
cases:2.60%
controls:0.18%
—
—
cases:1.62%
controls:0.17%
cases:13.36%
controls:1.39%
cases:10.95%
controls:4.39%
103
941
2167
21736
48
331
2222
22346
59
40
2211
22637
—
35
38
2128
22607
214
307
1388
21829
75
810
610
17652
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
5.8e-02
3.2e-01
2.1e+00
2.5e+00
1.9e+00
9.8e-01
5.6e-01
cases:32.03%
controls:30.78%
cases:29.91%
controls:23.65%
cases:24.54%
controls:4.00%
cases:1.59%
controls:0.13%
cases:19.88%
controls:3.50%
cases:47.57%
controls:25.43%
cases:59.42%
controls:45.53%
727
6980
1543
15697
679
5362
1591
17315
557
906
1713
21771
36
30
2234
22647
430
793
1733
21852
762
5629
840
16507
407
8406
278
10056
pH of Blood
11558-4 [3010421]
11558-4 [3010421]
5.2e-01
5.0e-01
3.1e+00
—
2.5e+00
1.7e+00
1.1e+00
cases:0.66%
controls:0.39%
cases:0.44%
controls:0.27%
cases:0.75%
controls:0.04%
—
—
cases:0.46%
controls:0.04%
cases:1.37%
controls:0.25%
cases:2.04%
controls:0.69%
15
89
2255
22588
10
61
2260
22616
17
8
2253
22669
—
10
9
2153
22636
22
55
1580
22081
14
128
671
18334
Other interstitial pulmonary diseases with fibrosis
J84.1 [45557630]
J84.1 [45557630]
1.2e+00
1.3e+00
2.4e+00
—
2.3e+00
1.2e+00
9.5e-01
cases:1.10%
controls:0.33%
cases:0.97%
controls:0.28%
cases:0.88%
controls:0.08%
—
—
cases:0.74%
controls:0.08%
cases:1.06%
controls:0.33%
cases:1.31%
controls:0.51%
25
74
2245
22603
22
63
2248
22614
20
19
2250
22658
—
16
17
2147
22628
17
72
1585
22064
9
95
676
18367
Fever, unspecified
R50.9 [45582716]
R50.9 [45582716]
1.4e-01
1.0e+00
2.1e+00
—
2.3e+00
2.0e+00
9.7e-01
cases:1.45%
controls:1.27%
cases:1.19%
controls:0.44%
cases:0.44%
controls:0.05%
—
—
cases:0.51%
controls:0.05%
cases:3.93%
controls:0.57%
cases:5.40%
controls:2.13%
33
288
2237
22389
27
100
2243
22577
10
12
2260
22665
—
11
12
2152
22633
63
127
1539
22009
37
393
648
18069
Dyspnoea
R06.0 [45558449]
R06.0 [45558449]
2.1e-01
1.0e+00
2.7e+00
—
1.9e+00
1.7e+00
9.4e-01
cases:4.80%
controls:3.91%
cases:4.49%
controls:1.62%
cases:2.95%
controls:0.20%
—
—
cases:1.62%
controls:0.24%
cases:7.37%
controls:1.45%
cases:13.58%
controls:5.78%
109
887
2161
21790
102
368
2168
22309
67
46
2203
22631
—
35
54
2128
22591
118
321
1484
21815
93
1067
592
17395
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
1.5e-02
3.1e-01
2.3e+00
2.5e+00
1.8e+00
8.7e-01
4.4e-01
cases:17.93%
controls:17.71%
cases:13.26%
controls:10.09%
cases:11.50%
controls:1.24%
cases:0.70%
controls:0.06%
cases:6.98%
controls:1.22%
cases:21.35%
controls:10.18%
cases:34.74%
controls:25.46%
407
4015
1863
18662
301
2289
1969
20388
261
282
2009
22395
16
13
2254
22664
151
276
2012
22369
342
2254
1260
19882
238
4700
447
13762
formoterol and aclidinium bromide
R03AL05 [45893459]
R03AL05 [45893459]
2.7e+00
2.8e+00
—
—
—
2.8e+00
—
cases:0.44%
controls:0.03%
cases:0.35%
controls:0.02%
—
—
—
—
—
—
cases:0.37%
controls:0.02%
—
—
10
7
2260
22670
8
5
2262
22672
—
—
—
6
5
1596
22131
—
Tobacco use
Z72.0 [45581063]
Z72.0 [45581063]
1.9e+00
1.8e+00
—
—
—
2.7e+00
1.8e+00
cases:1.37%
controls:0.20%
cases:0.35%
controls:0.06%
—
—
—
—
—
—
cases:0.81%
controls:0.05%
cases:0.88%
controls:0.15%
31
46
2239
22631
8
13
2262
22664
—
—
—
13
12
1589
22124
6
27
679
18435
nystatin; oral
A07AA02 [21600604]
A07AA02 [21600604]
7.2e-01
1.2e+00
—
—
2.2e+00
2.5e+00
1.6e+00
cases:1.28%
controls:0.63%
cases:0.70%
controls:0.21%
—
—
—
—
cases:0.37%
controls:0.04%
cases:2.31%
controls:0.20%
cases:3.21%
controls:0.67%
29
142
2241
22535
16
47
2254
22630
—
—
8
9
2155
22636
37
45
1565
22091
22
124
663
18338
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
8.1e-03
2.2e-01
2.0e+00
3.3e+00
1.8e+00
5.7e-01
2.7e-01
cases:25.07%
controls:24.92%
cases:24.10%
controls:20.25%
cases:25.29%
controls:4.19%
cases:4.93%
controls:0.20%
cases:20.25%
controls:3.86%
cases:32.40%
controls:21.40%
cases:41.90%
controls:35.54%
569
5650
1701
17027
547
4593
1723
18084
574
950
1696
21727
112
45
2158
22632
438
874
1725
21771
519
4737
1083
17399
287
6562
398
11900
Bacterial infection, unspecified
A49.9 [45590816]
A49.9 [45590816]
5.1e-01
3.7e-01
2.2e+00
—
2.6e+00
2.2e+00
1.1e+00
cases:1.81%
controls:1.09%
cases:0.75%
controls:0.52%
cases:0.66%
controls:0.07%
—
—
cases:0.74%
controls:0.05%
cases:4.99%
controls:0.56%
cases:5.69%
controls:2.06%
41
247
2229
22430
17
117
2253
22560
15
16
2255
22661
—
16
12
2147
22633
80
123
1522
22013
39
380
646
18082
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
1.3e-01
4.2e-01
2.8e+00
1.0e+50
2.3e+00
2.0e+00
1.1e+00
cases:1.15%
controls:1.01%
cases:0.88%
controls:0.58%
cases:0.88%
controls:0.05%
cases:0.57%
controls:0.00%
cases:0.83%
controls:0.09%
cases:4.81%
controls:0.70%
cases:7.74%
controls:2.62%
26
229
2244
22448
20
132
2250
22545
20
12
2250
22665
13
0
2257
22677
18
20
2145
22625
77
156
1525
21980
53
483
632
17979
vilanterol and fluticasone furoate
R03AK10 [43534841]
R03AK10 [43534841]
8.4e-01
1.2e+00
1.6e+00
—
1.6e+00
1.4e+00
1.5e+00
cases:1.37%
controls:0.60%
cases:1.59%
controls:0.51%
cases:0.93%
controls:0.19%
—
—
cases:0.92%
controls:0.18%
cases:2.37%
controls:0.58%
cases:4.82%
controls:1.07%
31
135
2239
22542
36
115
2234
22562
21
44
2249
22633
—
20
41
2143
22604
38
129
1564
22007
33
197
652
18265
Flexible laryngoscopy
UDQ12 [2001301827]
UDQ12 [2001301827]
1.9e-01
7.8e-01
2.6e+00
—
2.1e+00
1.9e+00
1.5e+00
cases:0.57%
controls:0.47%
cases:0.31%
controls:0.14%
cases:0.31%
controls:0.02%
—
—
cases:0.32%
controls:0.04%
cases:1.06%
controls:0.15%
cases:2.34%
controls:0.54%
13
107
2257
22570
7
32
2263
22645
7
5
2263
22672
—
7
9
2156
22636
17
34
1585
22102
16
100
669
18362
roxithromycin; oral
J01FA06 [21602974]
J01FA06 [21602974]
4.2e-01
1.1e+00
2.4e+00
—
2.2e+00
1.3e+00
7.1e-01
cases:5.73%
controls:3.85%
cases:3.04%
controls:0.98%
cases:1.10%
controls:0.10%
—
—
cases:0.69%
controls:0.08%
cases:3.50%
controls:0.96%
cases:6.72%
controls:3.41%
130
874
2140
21803
69
223
2201
22454
25
23
2245
22654
—
15
18
2148
22627
56
213
1546
21923
46
630
639
17832
Cell count panel - Pleural fluid
34561-1 [3045788]
34561-1 [3045788]
—
2.0e+00
—
—
—
4.1e+00
2.0e+00
—
—
cases:0.35%
controls:0.05%
—
—
—
—
—
—
cases:1.37%
controls:0.02%
cases:1.75%
controls:0.23%
—
8
11
2262
22666
—
—
—
22
5
1580
22131
12
43
673
18419
Atherosclerosis of arteries of extremities
I70.2 [45538421]
I70.2 [45538421]
7.8e-01
9.3e-01
1.4e+00
2.2e+00
1.3e+00
7.4e-01
8.0e-01
cases:6.78%
controls:3.23%
cases:4.27%
controls:1.74%
cases:1.50%
controls:0.38%
cases:0.40%
controls:0.04%
cases:1.71%
controls:0.47%
cases:3.87%
controls:1.88%
cases:10.07%
controls:4.78%
154
733
2116
21944
97
394
2173
22283
34
87
2236
22590
9
10
2261
22667
37
107
2126
22538
62
416
1540
21720
69
883
616
17579
Neck ultrasound examination
EP1AE [2001302284]
EP1AE [2001302284]
1.4e+00
2.5e+00
—
—
—
2.3e+00
1.9e+00
cases:0.88%
controls:0.22%
cases:0.66%
controls:0.06%
—
—
—
—
—
—
cases:0.75%
controls:0.07%
cases:1.90%
controls:0.29%
20
51
2250
22626
15
13
2255
22664
—
—
—
12
16
1590
22120
13
53
672
18409
Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection
6521-9 [3009595]
6521-9 [3009595]
—
2.3e+00
—
—
—
3.5e+00
2.2e+00
—
—
cases:0.26%
controls:0.03%
—
—
—
—
—
—
cases:0.94%
controls:0.03%
cases:1.02%
controls:0.11%
—
6
6
2264
22671
—
—
—
15
6
1587
22130
7
21
678
18441
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
1.3e-01
3.0e-01
2.8e+00
—
2.4e+00
2.1e+00
7.6e-01
cases:7.58%
controls:6.73%
cases:3.92%
controls:2.94%
cases:5.68%
controls:0.37%
—
—
cases:3.98%
controls:0.38%
cases:18.73%
controls:2.76%
cases:18.98%
controls:9.86%
172
1527
2098
21150
89
666
2181
22011
129
83
2141
22594
—
86
85
2077
22560
300
610
1302
21526
130
1821
555
16641
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
77147-7 [46236952]
3.4e-01
8.4e-01
2.9e+00
—
2.9e+00
1.5e+00
7.0e-01
cases:1.67%
controls:1.20%
cases:1.06%
controls:0.46%
cases:1.45%
controls:0.08%
—
—
cases:1.16%
controls:0.07%
cases:2.37%
controls:0.56%
cases:3.36%
controls:1.70%
38
271
2232
22406
24
104
2246
22573
33
19
2237
22658
—
25
15
2138
22630
38
124
1564
22012
23
313
662
18149
Oxygen saturation in Capillary blood
2709-4 [3021901]
2709-4 [3021901]
6.2e-01
1.6e+00
3.3e+00
—
—
1.7e+00
1.4e+00
cases:0.35%
controls:0.19%
cases:0.53%
controls:0.11%
cases:0.75%
controls:0.03%
—
—
—
—
cases:1.31%
controls:0.23%
cases:2.48%
controls:0.64%
8
43
2262
22634
12
25
2258
22652
17
6
2253
22671
—
—
21
51
1581
22085
17
119
668
18343
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
2.4e-01
5.4e-01
2.6e+00
—
2.4e+00
1.5e+00
9.8e-01
cases:4.41%
controls:3.49%
cases:4.10%
controls:2.43%
cases:5.37%
controls:0.41%
—
—
cases:3.88%
controls:0.38%
cases:13.48%
controls:3.31%
cases:26.42%
controls:11.83%
100
791
2170
21886
93
552
2177
22125
122
93
2148
22584
—
84
86
2079
22559
216
733
1386
21403
181
2184
504
16278
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
2.8e-01
4.1e-01
2.3e+00
1.0e+50
2.8e+00
2.0e+00
5.6e-01
cases:8.15%
controls:6.28%
cases:2.38%
controls:1.59%
cases:1.37%
controls:0.13%
cases:0.75%
controls:0.00%
cases:2.08%
controls:0.13%
cases:9.43%
controls:1.36%
cases:7.01%
controls:4.14%
185
1423
2085
21254
54
360
2216
22317
31
30
2239
22647
17
0
2253
22677
45
29
2118
22616
151
301
1451
21835
48
764
637
17698
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
6.2e-01
1.2e+00
1.8e+00
1.6e+00
1.5e+00
1.5e+00
1.4e+00
cases:19.82%
controls:11.73%
cases:19.16%
controls:6.54%
cases:7.93%
controls:1.43%
cases:0.31%
controls:0.06%
cases:5.50%
controls:1.26%
cases:23.85%
controls:6.76%
cases:39.71%
controls:13.90%
450
2660
1820
20017
435
1482
1835
21195
180
325
2090
22352
7
14
2263
22663
119
285
2044
22360
382
1497
1220
20639
272
2566
413
15896
Erythrocytes [#/volume] in Pleural fluid
26456-4 [3028308]
26456-4 [3028308]
—
1.9e+00
—
—
—
3.8e+00
2.3e+00
—
—
cases:0.40%
controls:0.06%
—
—
—
—
—
—
cases:1.81%
controls:0.04%
cases:2.04%
controls:0.21%
—
9
14
2261
22663
—
—
—
29
9
1573
22127
14
38
671
18424
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
2.3e-01
3.9e-01
2.2e+00
—
2.7e+00
1.9e+00
1.2e+00
cases:6.17%
controls:4.97%
cases:3.22%
controls:2.20%
cases:2.42%
controls:0.26%
—
—
cases:3.42%
controls:0.24%
cases:13.73%
controls:2.36%
cases:21.02%
controls:7.63%
140
1126
2130
21551
73
500
2197
22177
55
60
2215
22617
—
74
54
2089
22591
220
522
1382
21614
144
1409
541
17053
Neutrophils [#/volume] in Blood
26499-4 [3017732]
26499-4 [3017732]
5.9e-01
1.1e+00
2.4e+00
—
2.5e+00
1.2e+00
8.2e-01
cases:1.37%
controls:0.76%
cases:1.32%
controls:0.45%
cases:0.66%
controls:0.06%
—
—
cases:0.42%
controls:0.04%
cases:2.31%
controls:0.70%
cases:5.84%
controls:2.66%
31
173
2239
22504
30
102
2240
22575
15
14
2255
22663
—
9
8
2154
22637
37
156
1565
21980
40
491
645
17971
Oxygen [Partial pressure] in Capillary blood
2704-5 [3028626]
2704-5 [3028626]
4.3e-01
1.7e+00
3.2e+00
—
—
1.7e+00
1.3e+00
cases:0.35%
controls:0.23%
cases:0.70%
controls:0.12%
cases:0.88%
controls:0.04%
—
—
—
—
cases:1.37%
controls:0.27%
cases:2.63%
controls:0.71%
8
52
2262
22625
16
28
2254
22649
20
8
2250
22669
—
—
22
59
1580
22077
18
132
667
18330
fentanyl; nasal, sublingual, transdermal
N02AB03 [21604272]
N02AB03 [21604272]
8.4e-01
—
—
—
2.5e+00
3.4e+00
2.1e+00
cases:0.40%
controls:0.17%
—
—
—
—
—
—
cases:0.92%
controls:0.08%
cases:4.74%
controls:0.17%
cases:3.50%
controls:0.44%
9
39
2261
22638
—
—
—
20
18
2143
22627
76
38
1526
22098
24
82
661
18380
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
-3.5e-02
7.7e-01
1.9e+00
—
2.6e+00
1.8e+00
8.4e-01
cases:1.28%
controls:1.32%
cases:1.28%
controls:0.60%
cases:0.35%
controls:0.05%
—
—
cases:0.42%
controls:0.03%
cases:3.00%
controls:0.51%
cases:4.23%
controls:1.88%
29
300
2241
22377
29
135
2241
22542
8
12
2262
22665
—
9
7
2154
22638
48
113
1554
22023
29
347
656
18115
Differential panel - Pleural fluid
29583-2 [3012441]
29583-2 [3012441]
—
2.2e+00
1.0e+50
—
—
3.6e+00
2.1e+00
—
—
cases:0.53%
controls:0.06%
cases:0.93%
controls:0.00%
—
—
—
—
cases:1.50%
controls:0.04%
cases:1.46%
controls:0.19%
—
12
13
2258
22664
21
0
2249
22677
—
—
24
9
1578
22127
10
35
675
18427
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
1.4e-01
3.4e-01
2.4e+00
1.0e+50
2.1e+00
2.6e+00
8.7e-01
cases:1.23%
controls:1.07%
cases:0.93%
controls:0.66%
cases:0.70%
controls:0.07%
cases:1.54%
controls:0.00%
cases:0.65%
controls:0.08%
cases:7.24%
controls:0.61%
cases:6.13%
controls:2.67%
28
243
2242
22434
21
149
2249
22528
16
15
2254
22662
35
0
2235
22677
14
18
2149
22627
116
134
1486
22002
42
493
643
17969
Emphysema, unspecified
J43.9 [45567264]
J43.9 [45567264]
1.8e+00
2.2e+00
—
—
—
2.5e+00
1.4e+00
cases:0.84%
controls:0.15%
cases:0.70%
controls:0.07%
—
—
—
—
—
—
cases:1.56%
controls:0.13%
cases:1.31%
controls:0.34%
19
33
2251
22644
16
17
2254
22660
—
—
—
25
29
1577
22107
9
62
676
18400
Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
35704-6 [3036428]
35704-6 [3036428]
—
2.2e+00
—
—
1.0e+50
4.0e+00
1.7e+00
—
—
cases:0.31%
controls:0.04%
—
—
—
—
cases:0.28%
controls:0.00%
cases:1.19%
controls:0.02%
cases:1.02%
controls:0.18%
—
7
8
2263
22669
—
—
6
0
2157
22645
19
5
1583
22131
7
34
678
18428
Carbon dioxide [Partial pressure] in Blood
11557-6 [3013290]
11557-6 [3013290]
4.7e-01
3.7e-01
3.3e+00
—
2.7e+00
1.9e+00
1.3e+00
cases:0.57%
controls:0.36%
cases:0.35%
controls:0.24%
cases:0.70%
controls:0.03%
—
—
cases:0.46%
controls:0.03%
cases:1.37%
controls:0.22%
cases:1.31%
controls:0.38%
13
81
2257
22596
8
55
2262
22622
16
6
2254
22671
—
10
7
2153
22638
22
48
1580
22088
9
70
676
18392
Base excess in Blood by calculation
11555-0 [3012501]
11555-0 [3012501]
4.7e-01
3.7e-01
3.3e+00
—
2.7e+00
1.9e+00
1.3e+00
cases:0.57%
controls:0.36%
cases:0.35%
controls:0.24%
cases:0.70%
controls:0.03%
—
—
cases:0.46%
controls:0.03%
cases:1.37%
controls:0.22%
cases:1.31%
controls:0.38%
13
81
2257
22596
8
55
2262
22622
16
6
2254
22671
—
10
7
2153
22638
22
48
1580
22088
9
70
676
18392
Oxygen [Partial pressure] in Blood
11556-8 [3027315]
11556-8 [3027315]
5.2e-01
3.7e-01
3.3e+00
—
2.7e+00
1.9e+00
1.3e+00
cases:0.62%
controls:0.37%
cases:0.35%
controls:0.24%
cases:0.70%
controls:0.03%
—
—
cases:0.46%
controls:0.03%
cases:1.37%
controls:0.22%
cases:1.31%
controls:0.38%
14
83
2256
22594
8
55
2262
22622
16
6
2254
22671
—
10
7
2153
22638
22
48
1580
22088
9
70
676
18392
Pneumonia
R81 [2002000949]
R81 [2002000949]
8.3e-01
2.3e+00
2.3e+00
—
—
1.7e+00
1.6e+00
cases:0.79%
controls:0.35%
cases:0.93%
controls:0.10%
cases:0.31%
controls:0.03%
—
—
—
—
cases:0.62%
controls:0.12%
cases:2.34%
controls:0.49%
18
79
2252
22598
21
22
2249
22655
7
7
2263
22670
—
—
10
26
1592
22110
16
90
669
18372
Pyothorax without fistula
J86.9 [45586683]
J86.9 [45586683]
—
2.3e+00
—
—
1.0e+50
3.6e+00
1.9e+00
—
—
cases:0.26%
controls:0.03%
—
—
—
—
cases:0.32%
controls:0.00%
cases:1.31%
controls:0.04%
cases:0.88%
controls:0.14%
—
6
6
2264
22671
—
—
7
0
2156
22645
21
8
1581
22128
6
25
679
18437
Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
60022-1 [40763082]
60022-1 [40763082]
—
2.5e+00
1.0e+50
—
1.0e+50
3.6e+00
1.7e+00
—
—
cases:0.44%
controls:0.04%
cases:1.06%
controls:0.00%
—
—
cases:0.51%
controls:0.00%
cases:1.25%
controls:0.04%
cases:1.31%
controls:0.25%
—
10
8
2260
22669
24
0
2246
22677
—
11
0
2152
22645
20
8
1582
22128
9
46
676
18416
doxycycline; oral, parenteral
J01AA02 [21602800]
J01AA02 [21602800]
4.1e-01
1.2e+00
2.2e+00
—
1.8e+00
1.1e+00
1.0e+00
cases:22.33%
controls:15.98%
cases:14.41%
controls:4.98%
cases:4.98%
controls:0.56%
—
—
cases:3.01%
controls:0.51%
cases:13.30%
controls:4.73%
cases:31.09%
controls:14.08%
507
3624
1763
19053
327
1129
1943
21548
113
128
2157
22549
—
65
116
2098
22529
213
1047
1389
21089
213
2599
472
15863
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
Z03.9 [45552062]
-8.6e-03
8.8e-01
3.0e+00
—
2.6e+00
1.3e+00
2.2e-01
cases:2.38%
controls:2.40%
cases:1.94%
controls:0.82%
cases:1.59%
controls:0.08%
—
—
cases:1.02%
controls:0.08%
cases:2.87%
controls:0.81%
cases:3.36%
controls:2.72%
54
544
2216
22133
44
185
2226
22492
36
19
2234
22658
—
22
17
2141
22628
46
179
1556
21957
23
503
662
17959
Protein [Mass/volume] in Pleural fluid
2882-9 [3003434]
2882-9 [3003434]
—
2.3e+00
—
—
—
3.5e+00
1.9e+00
—
—
cases:0.62%
controls:0.06%
—
—
—
—
—
—
cases:1.94%
controls:0.06%
cases:2.34%
controls:0.35%
—
14
14
2256
22663
—
—
—
31
13
1571
22123
16
65
669
18397
Thorax and upper abdomen combined extensive CT examination of
GD5BD [2001303656]
GD5BD [2001303656]
1.3e+00
3.2e+00
—
1.0e+50
1.0e+50
—
4.5e+00
cases:0.44%
controls:0.11%
cases:0.93%
controls:0.04%
—
—
cases:0.48%
controls:0.00%
cases:1.25%
controls:0.00%
—
—
cases:7.45%
controls:0.09%
10
26
2260
22651
21
9
2249
22668
—
11
0
2259
22677
27
0
2136
22645
—
51
16
634
18446
Spirometry study
18759-1 [3000492]
18759-1 [3000492]
6.4e-01
1.1e+00
3.1e+00
—
2.1e+00
7.1e-01
8.3e-01
cases:3.04%
controls:1.63%
cases:1.67%
controls:0.56%
cases:0.93%
controls:0.04%
—
—
cases:0.42%
controls:0.05%
cases:0.94%
controls:0.46%
cases:3.07%
controls:1.36%
69
369
2201
22308
38
128
2232
22549
21
10
2249
22667
—
9
12
2154
22633
15
102
1587
22034
21
252
664
18210
General Practice
1 [38004446]
1 [38004446]
1.1e-01
3.3e-01
1.6e+00
2.0e+00
1.9e+00
1.2e+00
5.6e-01
cases:17.67%
controls:16.17%
cases:10.53%
controls:7.82%
cases:5.81%
controls:1.20%
cases:0.26%
controls:0.04%
cases:7.91%
controls:1.26%
cases:24.97%
controls:8.76%
cases:36.64%
controls:24.92%
401
3668
1869
19009
239
1774
2031
20903
132
272
2138
22405
6
8
2264
22669
171
286
1992
22359
400
1939
1202
20197
251
4600
434
13862
Excision of other lesion extending through all layers of skin in head or neck
QAE10 [2001309784]
QAE10 [2001309784]
1.9e+00
1.9e+00
—
—
—
2.0e+00
1.8e+00
cases:1.76%
controls:0.27%
cases:0.53%
controls:0.08%
—
—
—
—
—
—
cases:0.37%
controls:0.05%
cases:1.31%
controls:0.22%
40
62
2230
22615
12
18
2258
22659
—
—
—
6
11
1596
22125
9
40
676
18422
famotidine; oral, parenteral
A02BA03 [21600084]
A02BA03 [21600084]
3.2e-01
1.5e-01
—
—
2.5e+00
2.9e+00
2.2e+00
cases:0.62%
controls:0.45%
cases:0.22%
controls:0.19%
—
—
—
—
cases:0.60%
controls:0.05%
cases:2.81%
controls:0.16%
cases:2.92%
controls:0.34%
14
102
2256
22575
5
43
2265
22634
—
—
13
11
2150
22634
45
35
1557
22101
20
62
665
18400
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
2.8e-01
3.6e-01
2.2e+00
—
2.4e+00
1.8e+00
8.5e-01
cases:7.80%
controls:5.98%
cases:2.29%
controls:1.61%
cases:1.10%
controls:0.12%
—
—
cases:1.43%
controls:0.14%
cases:6.80%
controls:1.15%
cases:8.91%
controls:4.01%
177
1357
2093
21320
52
364
2218
22313
25
27
2245
22650
—
31
31
2132
22614
109
254
1493
21882
61
740
624
17722
Abdominal aortic aneurysm, without mention of rupture
I71.4 [45572130]
I71.4 [45572130]
6.8e-01
9.2e-01
1.8e+00
—
1.7e+00
1.4e+00
1.1e+00
cases:1.45%
controls:0.74%
cases:1.10%
controls:0.44%
cases:0.53%
controls:0.09%
—
—
cases:0.51%
controls:0.10%
cases:2.18%
controls:0.52%
cases:3.50%
controls:1.24%
33
168
2237
22509
25
100
2245
22577
12
20
2258
22657
—
11
22
2152
22623
35
116
1567
22020
24
229
661
18233
Leukocytes [#/volume] in Pleural fluid
26467-1 [3023199]
26467-1 [3023199]
—
1.8e+00
—
—
—
3.7e+00
2.1e+00
—
—
cases:0.40%
controls:0.07%
—
—
—
—
—
—
cases:1.81%
controls:0.05%
cases:2.04%
controls:0.27%
—
9
15
2261
22662
—
—
—
29
10
1573
22126
14
49
671
18413
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
1.5e-01
5.0e-01
1.5e+00
—
2.3e+00
2.2e+00
1.1e+00
cases:8.55%
controls:7.47%
cases:4.45%
controls:2.73%
cases:2.56%
controls:0.56%
—
—
cases:4.85%
controls:0.53%
cases:19.98%
controls:2.72%
cases:17.23%
controls:6.74%
194
1695
2076
20982
101
620
2169
22057
58
128
2212
22549
—
105
121
2058
22524
320
602
1282
21534
118
1245
567
17217
pH of Specimen
17433-4 [3019225]
17433-4 [3019225]
3.6e-01
5.1e-01
2.2e+00
1.0e+50
2.9e+00
1.6e+00
8.8e-01
cases:2.64%
controls:1.85%
cases:1.76%
controls:1.07%
cases:1.23%
controls:0.14%
cases:0.31%
controls:0.00%
cases:2.03%
controls:0.12%
cases:4.87%
controls:1.05%
cases:5.69%
controls:2.44%
60
420
2210
22257
40
242
2230
22435
28
32
2242
22645
7
0
2263
22677
44
27
2119
22618
78
233
1524
21903
39
450
646
18012
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
1.0e-01
2.4e-01
1.5e+00
3.4e+00
1.7e+00
7.4e-01
1.0e-01
cases:8.46%
controls:7.69%
cases:4.76%
controls:3.77%
cases:2.82%
controls:0.63%
cases:1.37%
controls:0.04%
cases:3.51%
controls:0.64%
cases:8.30%
controls:4.13%
cases:11.68%
controls:10.67%
192
1744
2078
20933
108
856
2162
21821
64
143
2206
22534
31
10
2239
22667
76
146
2087
22499
133
915
1469
21221
80
1970
605
16492
Glucose [Moles/volume] in Pleural fluid
14747-0 [3036782]
14747-0 [3036782]
—
2.3e+00
—
—
1.0e+50
3.4e+00
1.7e+00
—
—
cases:0.40%
controls:0.04%
—
—
—
—
cases:0.32%
controls:0.00%
cases:1.25%
controls:0.04%
cases:1.46%
controls:0.28%
—
9
9
2261
22668
—
—
7
0
2156
22645
20
9
1582
22127
10
51
675
18411
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 [3014162]
13956-8 [3014162]
5.5e-01
2.5e+00
—
1.0e+50
—
2.7e+00
2.2e+00
cases:0.93%
controls:0.53%
cases:2.51%
controls:0.21%
—
—
cases:5.55%
controls:0.00%
—
—
cases:3.00%
controls:0.20%
cases:5.84%
controls:0.70%
21
121
2249
22556
57
47
2213
22630
—
126
0
2144
22677
—
48
45
1554
22091
40
129
645
18333
Mycobacterium sp identified in Specimen
40699-1 [3042631]
40699-1 [3042631]
7.8e-01
2.2e+00
—
1.0e+50
—
3.0e+00
2.1e+00
cases:0.44%
controls:0.20%
cases:0.88%
controls:0.10%
—
—
cases:3.39%
controls:0.00%
—
—
cases:1.37%
controls:0.07%
cases:1.90%
controls:0.23%
10
46
2260
22631
20
22
2250
22655
—
77
0
2193
22677
—
22
15
1580
22121
13
42
672
18420
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 [3048816]
47598-8 [3048816]
2.7e-01
6.2e-01
2.0e+00
—
2.5e+00
1.8e+00
1.1e+00
cases:1.41%
controls:1.08%
cases:1.06%
controls:0.57%
cases:0.93%
controls:0.13%
—
—
cases:1.20%
controls:0.10%
cases:4.18%
controls:0.73%
cases:6.13%
controls:2.11%
32
245
2238
22432
24
130
2246
22547
21
29
2249
22648
—
26
23
2137
22622
67
161
1535
21975
42
389
643
18073
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
4.9e-01
2.8e-01
2.6e+00
—
2.2e+00
1.6e+00
1.0e+00
cases:2.38%
controls:1.46%
cases:1.15%
controls:0.86%
cases:1.67%
controls:0.13%
—
—
cases:1.06%
controls:0.12%
cases:3.87%
controls:0.82%
cases:6.28%
controls:2.39%
54
332
2216
22345
26
196
2244
22481
38
29
2232
22648
—
23
28
2140
22617
62
182
1540
21954
43
442
642
18020
More than three and less than five hours
ZXE20 [2001311408]
ZXE20 [2001311408]
3.2e-01
8.5e-01
—
1.0e+50
3.2e+00
3.3e+00
6.9e-01
cases:2.33%
controls:1.71%
cases:0.88%
controls:0.38%
—
—
cases:0.75%
controls:0.00%
cases:0.83%
controls:0.04%
cases:7.12%
controls:0.28%
cases:1.90%
controls:0.96%
53
388
2217
22289
20
86
2250
22591
—
17
0
2253
22677
18
8
2145
22637
114
62
1488
22074
13
178
672
18284
Other seropositive rheumatoid arthritis
M05.8 [45538634]
M05.8 [45538634]
1.1e+00
1.0e+00
1.4e+00
—
1.6e+00
1.2e+00
9.7e-01
cases:3.22%
controls:1.14%
cases:2.38%
controls:0.86%
cases:1.10%
controls:0.27%
—
—
cases:1.20%
controls:0.23%
cases:2.81%
controls:0.87%
cases:3.50%
controls:1.36%
73
259
2197
22418
54
195
2216
22482
25
61
2245
22616
—
26
53
2137
22592
45
192
1557
21944
24
251
661
18211
buprenorphine; implant, parenteral, sublingual
N07BC01 [21604826]
N07BC01 [21604826]
5.8e-01
—
—
—
2.5e+00
3.0e+00
1.8e+00
cases:0.35%
controls:0.20%
—
—
—
—
—
—
cases:0.37%
controls:0.03%
cases:1.44%
controls:0.07%
cases:1.31%
controls:0.22%
8
45
2262
22632
—
—
—
8
7
2155
22638
23
16
1579
22120
9
40
676
18422
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
4.1e-01
8.4e-01
—
1.0e+50
2.8e+00
2.4e+00
1.2e+00
cases:1.06%
controls:0.71%
cases:0.93%
controls:0.40%
—
—
cases:0.62%
controls:0.00%
cases:0.79%
controls:0.05%
cases:4.74%
controls:0.43%
cases:5.69%
controls:1.78%
24
160
2246
22517
21
91
2249
22586
—
14
0
2256
22677
17
11
2146
22634
76
96
1526
22040
39
328
646
18134
acetylcysteine; inhalant, oral
R05CB01 [21603380]
R05CB01 [21603380]
4.3e-01
1.2e+00
2.6e+00
—
—
2.8e+00
1.9e+00
cases:0.62%
controls:0.40%
cases:0.48%
controls:0.15%
cases:0.31%
controls:0.02%
—
—
—
—
cases:2.25%
controls:0.14%
cases:4.09%
controls:0.66%
14
91
2256
22586
11
34
2259
22643
7
5
2263
22672
—
—
36
32
1566
22104
28
121
657
18341
acetylcysteine
V03AB23 [21605248]
V03AB23 [21605248]
4.3e-01
1.2e+00
2.6e+00
—
—
2.8e+00
1.9e+00
cases:0.62%
controls:0.40%
cases:0.48%
controls:0.15%
cases:0.31%
controls:0.02%
—
—
—
—
cases:2.25%
controls:0.14%
cases:4.09%
controls:0.66%
14
91
2256
22586
11
34
2259
22643
7
5
2263
22672
—
—
36
32
1566
22104
28
121
657
18341
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
-1.6e-02
2.0e-01
1.5e+00
3.6e+00
1.7e+00
5.5e-01
1.2e-01
cases:22.16%
controls:22.43%
cases:12.82%
controls:10.79%
cases:7.44%
controls:1.79%
cases:3.30%
controls:0.10%
cases:8.69%
controls:1.77%
cases:18.73%
controls:11.77%
cases:32.85%
controls:30.19%
503
5086
1767
17591
291
2446
1979
20231
169
407
2101
22270
75
22
2195
22655
188
401
1975
22244
300
2606
1302
19530
225
5573
460
12889
Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32785-8 [3043405]
32785-8 [3043405]
—
2.3e+00
1.0e+50
1.0e+50
1.0e+50
2.8e+00
2.2e+00
—
—
cases:0.26%
controls:0.03%
cases:0.79%
controls:0.00%
cases:0.79%
controls:0.00%
cases:0.37%
controls:0.00%
cases:0.44%
controls:0.03%
cases:1.02%
controls:0.12%
—
6
6
2264
22671
18
0
2252
22677
18
0
2252
22677
8
0
2155
22645
7
6
1595
22130
7
22
678
18440
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
6.4e-01
1.0e+00
—
—
2.5e+00
2.5e+00
1.2e+00
cases:1.06%
controls:0.56%
cases:0.93%
controls:0.34%
—
—
—
—
cases:0.69%
controls:0.06%
cases:4.74%
controls:0.41%
cases:4.96%
controls:1.50%
24
127
2246
22550
21
77
2249
22600
—
—
15
13
2148
22632
76
91
1526
22045
34
277
651
18185
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
-2.0e-01
4.4e-01
2.6e+00
—
1.9e+00
1.8e+00
9.3e-01
cases:2.20%
controls:2.68%
cases:1.50%
controls:0.97%
cases:1.23%
controls:0.10%
—
—
cases:0.74%
controls:0.11%
cases:5.37%
controls:0.93%
cases:7.01%
controls:2.88%
50
607
2220
22070
34
219
2236
22458
28
22
2242
22655
—
16
25
2147
22620
86
205
1516
21931
48
531
637
17931
Shortness of breath/dyspnoea
R02 [2002000883]
R02 [2002000883]
5.9e-01
1.2e+00
3.4e+00
—
1.5e+00
1.1e+00
9.2e-01
cases:2.95%
controls:1.65%
cases:1.81%
controls:0.58%
cases:1.15%
controls:0.04%
—
—
cases:0.32%
controls:0.08%
cases:1.81%
controls:0.59%
cases:5.69%
controls:2.35%
67
375
2203
22302
41
131
2229
22546
26
9
2244
22668
—
7
17
2156
22628
29
130
1573
22006
39
434
646
18028
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
2.3e-01
9.0e-01
2.5e+00
—
—
2.5e+00
1.2e+00
cases:2.51%
controls:2.00%
cases:1.19%
controls:0.49%
cases:0.62%
controls:0.05%
—
—
—
—
cases:4.00%
controls:0.33%
cases:2.19%
controls:0.68%
57
453
2213
22224
27
110
2243
22567
14
11
2256
22666
—
—
64
73
1538
22063
15
125
670
18337
General Surgery
2 [38004447]
2 [38004447]
1.8e-01
2.4e-01
1.6e+00
2.3e+00
2.0e+00
1.1e+00
1.6e-02
cases:23.96%
controls:20.78%
cases:8.24%
controls:6.62%
cases:4.14%
controls:0.87%
cases:0.40%
controls:0.04%
cases:6.15%
controls:0.91%
cases:17.48%
controls:6.63%
cases:19.85%
controls:19.60%
544
4712
1726
17965
187
1502
2083
21175
94
197
2176
22480
9
9
2261
22668
133
206
2030
22439
280
1468
1322
20668
136
3618
549
14844
Very extensive CT of head and brain
AA1CD [2001300114]
AA1CD [2001300114]
—
—
—
—
1.0e+50
4.0e+00
3.2e+00
—
—
—
—
—
—
—
—
cases:0.42%
controls:0.00%
cases:1.19%
controls:0.02%
cases:1.02%
controls:0.04%
—
—
—
—
9
0
2154
22645
19
5
1583
22131
7
8
678
18454
clindamycin; oral, parenteral
J01FF01 [21602985]
J01FF01 [21602985]
1.7e-01
7.5e-01
2.4e+00
—
2.0e+00
1.3e+00
6.8e-01
cases:3.66%
controls:3.10%
cases:1.54%
controls:0.73%
cases:0.70%
controls:0.07%
—
—
cases:0.65%
controls:0.09%
cases:3.12%
controls:0.87%
cases:5.55%
controls:2.89%
83
703
2187
21974
35
166
2235
22511
16
15
2254
22662
—
14
20
2149
22625
50
192
1552
21944
38
533
647
17929
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
2.3e-01
2.3e-01
2.2e+00
—
2.7e+00
2.2e+00
4.5e-01
cases:6.43%
controls:5.17%
cases:1.59%
controls:1.27%
cases:0.93%
controls:0.10%
—
—
cases:1.90%
controls:0.13%
cases:8.61%
controls:1.05%
cases:5.55%
controls:3.60%
146
1173
2124
21504
36
287
2234
22390
21
23
2249
22654
—
41
30
2122
22615
138
232
1464
21904
38
664
647
17798
ipratropium bromide; inhalant
R03BB01 [21603293]
R03BB01 [21603293]
7.4e-01
1.1e+00
1.4e+00
—
1.3e+00
1.2e+00
1.4e+00
cases:2.64%
controls:1.27%
cases:2.33%
controls:0.80%
cases:0.93%
controls:0.24%
—
—
cases:0.97%
controls:0.26%
cases:2.68%
controls:0.84%
cases:6.57%
controls:1.74%
60
289
2210
22388
53
182
2217
22495
21
54
2249
22623
—
21
59
2142
22586
43
186
1559
21950
45
321
640
18141
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
1.2e-01
5.1e-01
2.6e+00
—
1.6e+00
1.9e+00
9.9e-01
cases:1.15%
controls:1.02%
cases:1.10%
controls:0.67%
cases:0.93%
controls:0.07%
—
—
cases:0.60%
controls:0.13%
cases:4.49%
controls:0.67%
cases:6.42%
controls:2.49%
26
231
2244
22446
25
151
2245
22526
21
16
2249
22661
—
13
29
2150
22616
72
148
1530
21988
44
459
641
18003
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
-4.8e-02
2.2e-01
2.6e+00
—
2.9e+00
1.5e+00
2.6e-01
cases:3.13%
controls:3.28%
cases:1.32%
controls:1.07%
cases:1.54%
controls:0.11%
—
—
cases:1.53%
controls:0.08%
cases:4.74%
controls:1.09%
cases:5.40%
controls:4.22%
71
743
2199
21934
30
242
2240
22435
35
26
2235
22651
—
33
19
2130
22626
76
241
1526
21895
37
780
648
17682
formoterol and budesonide
R03AK07 [21603281]
R03AK07 [21603281]
1.0e-01
8.6e-01
1.9e+00
—
1.6e+00
1.4e+00
1.4e+00
cases:1.32%
controls:1.20%
cases:1.63%
controls:0.70%
cases:1.15%
controls:0.18%
—
—
cases:0.79%
controls:0.17%
cases:2.56%
controls:0.67%
cases:5.84%
controls:1.53%
30
271
2240
22406
37
158
2233
22519
26
41
2244
22636
—
17
38
2146
22607
41
149
1561
21987
40
282
645
18180
Predominantly allergic asthma
J45.0 [45557624]
J45.0 [45557624]
2.6e-01
1.0e+00
1.9e+00
—
2.6e+00
1.4e+00
7.9e-01
cases:0.84%
controls:0.65%
cases:0.66%
controls:0.24%
cases:0.31%
controls:0.04%
—
—
cases:0.42%
controls:0.03%
cases:1.00%
controls:0.25%
cases:1.61%
controls:0.74%
19
147
2251
22530
15
54
2255
22623
7
10
2263
22667
—
9
7
2154
22638
16
55
1586
22081
11
136
674
18326
Extensive CT of head and brain
AA1BD [2001300110]
AA1BD [2001300110]
5.4e-01
—
1.0e+50
—
—
4.4e+00
2.5e+00
cases:0.22%
controls:0.13%
—
—
cases:0.48%
controls:0.00%
—
—
—
—
cases:2.25%
controls:0.03%
cases:1.17%
controls:0.10%
5
29
2265
22648
—
11
0
2259
22677
—
—
36
6
1566
22130
8
18
677
18444
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
-9.2e-02
8.0e-01
2.4e+00
—
2.0e+00
1.1e+00
6.8e-01
cases:2.38%
controls:2.60%
cases:1.94%
controls:0.88%
cases:0.97%
controls:0.09%
—
—
cases:0.51%
controls:0.07%
cases:2.31%
controls:0.81%
cases:5.99%
controls:3.11%
54
590
2216
22087
44
199
2226
22478
22
20
2248
22657
—
11
16
2152
22629
37
180
1565
21956
41
575
644
17887
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
4.0e-01
6.0e-01
1.8e+00
—
2.2e+00
1.9e+00
1.1e+00
cases:1.28%
controls:0.86%
cases:0.70%
controls:0.39%
cases:0.31%
controls:0.05%
—
—
cases:0.46%
controls:0.05%
cases:2.06%
controls:0.32%
cases:3.50%
controls:1.20%
29
195
2241
22482
16
88
2254
22589
7
12
2263
22665
—
10
12
2153
22633
33
71
1569
22065
24
222
661
18240
Pneumoconiosis due to asbestos and other mineral fibres
J61 [45581861]
J61 [45581861]
1.0e+00
1.9e+00
3.2e+00
—
—
1.8e+00
—
cases:0.44%
controls:0.16%
cases:0.57%
controls:0.09%
cases:0.53%
controls:0.02%
—
—
—
—
cases:0.81%
controls:0.13%
—
—
10
37
2260
22640
13
20
2257
22657
12
5
2258
22672
—
—
13
29
1589
22107
—
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
-1.6e-01
4.1e-01
2.0e+00
—
2.4e+00
1.6e+00
9.3e-01
cases:3.22%
controls:3.76%
cases:3.04%
controls:2.04%
cases:2.03%
controls:0.28%
—
—
cases:2.54%
controls:0.24%
cases:9.24%
controls:2.09%
cases:14.45%
controls:6.26%
73
852
2197
21825
69
463
2201
22214
46
63
2224
22614
—
55
54
2108
22591
148
462
1454
21674
99
1156
586
17306
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
3.3e-01
3.3e-01
2.5e+00
1.0e+50
2.2e+00
2.2e+00
5.8e-01
cases:2.82%
controls:2.05%
cases:0.70%
controls:0.51%
cases:0.70%
controls:0.06%
cases:0.22%
controls:0.00%
cases:0.42%
controls:0.05%
cases:3.81%
controls:0.45%
cases:2.77%
controls:1.58%
64
465
2206
22212
16
115
2254
22562
16
13
2254
22664
5
0
2265
22677
9
11
2154
22634
61
99
1541
22037
19
291
666
18171
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
-1.0e-03
6.0e-01
2.7e+00
1.0e+50
2.6e+00
1.6e+00
6.3e-01
cases:2.33%
controls:2.34%
cases:1.23%
controls:0.68%
cases:1.28%
controls:0.09%
cases:1.45%
controls:0.00%
cases:1.11%
controls:0.08%
cases:2.81%
controls:0.60%
cases:3.94%
controls:2.14%
53
530
2217
22147
28
154
2242
22523
29
20
2241
22657
33
0
2237
22677
24
19
2139
22626
45
133
1557
22003
27
396
658
18066
morphine; oral, parenteral, rectal
N02AA01 [21604256]
N02AA01 [21604256]
—
—
—
—
—
4.2e+00
2.6e+00
—
—
—
—
—
—
—
—
—
—
cases:3.06%
controls:0.05%
cases:3.21%
controls:0.25%
—
—
—
—
—
49
10
1553
22126
22
46
663
18416
Ultrasound examination of thorax
GA1AE [2001303415]
GA1AE [2001303415]
7.2e-01
1.5e+00
1.0e+50
—
1.0e+50
4.2e+00
2.7e+00
cases:0.31%
controls:0.15%
cases:0.22%
controls:0.05%
cases:0.70%
controls:0.00%
—
—
cases:0.46%
controls:0.00%
cases:2.25%
controls:0.04%
cases:1.90%
controls:0.14%
7
34
2263
22643
5
11
2265
22666
16
0
2254
22677
—
10
0
2153
22645
36
8
1566
22128
13
25
672
18437
Atherosclerotic heart disease
I25.1 [45596196]
I25.1 [45596196]
-5.3e-02
-7.0e-02
1.2e+00
3.7e+00
1.4e+00
4.5e-01
-9.0e-02
cases:8.19%
controls:8.60%
cases:4.01%
controls:4.29%
cases:2.95%
controls:0.89%
cases:1.10%
controls:0.03%
cases:3.42%
controls:0.87%
cases:7.55%
controls:4.94%
cases:12.26%
controls:13.27%
186
1950
2084
20727
91
972
2179
21705
67
202
2203
22475
25
6
2245
22671
74
197
2089
22448
121
1094
1481
21042
84
2449
601
16013
Thoracocentesis
TGA30 [2001303535]
TGA30 [2001303535]
—
—
1.0e+50
1.0e+50
1.0e+50
4.0e+00
2.8e+00
—
—
—
—
cases:0.35%
controls:0.00%
cases:0.22%
controls:0.00%
cases:0.23%
controls:0.00%
cases:1.19%
controls:0.02%
cases:0.73%
controls:0.04%
—
—
8
0
2262
22677
5
0
2265
22677
5
0
2158
22645
19
5
1583
22131
5
8
680
18454
salmeterol and fluticasone
R03AK06 [21603280]
R03AK06 [21603280]
7.6e-01
1.0e+00
1.4e+00
—
1.4e+00
1.3e+00
9.5e-01
cases:7.58%
controls:3.68%
cases:7.84%
controls:2.93%
cases:3.66%
controls:0.97%
—
—
cases:3.56%
controls:0.94%
cases:10.24%
controls:2.95%
cases:11.39%
controls:4.73%
172
835
2098
21842
178
664
2092
22013
83
219
2187
22458
—
77
212
2086
22433
164
652
1438
21484
78
874
607
17588
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
1.3e-01
6.7e-01
1.9e+00
—
1.8e+00
1.4e+00
9.0e-01
cases:4.89%
controls:4.30%
cases:4.41%
controls:2.30%
cases:2.42%
controls:0.35%
—
—
cases:1.76%
controls:0.31%
cases:9.30%
controls:2.37%
cases:16.93%
controls:7.63%
111
975
2159
21702
100
521
2170
22156
55
80
2215
22597
—
38
70
2125
22575
149
525
1453
21611
116
1408
569
17054
Intercostal insertion of pleural drainage tube
GAA10 [2001303430]
GAA10 [2001303430]
—
2.1e+00
—
1.0e+50
1.0e+50
4.1e+00
2.6e+00
—
—
cases:0.22%
controls:0.03%
—
—
cases:0.44%
controls:0.00%
cases:0.69%
controls:0.00%
cases:1.87%
controls:0.03%
cases:1.31%
controls:0.10%
—
5
6
2265
22671
—
10
0
2260
22677
15
0
2148
22645
30
7
1572
22129
9
18
676
18444
Dentistry
C5 [903277]
C5 [903277]
3.4e-01
7.1e-01
1.9e+00
—
3.1e+00
1.7e+00
5.1e-01
cases:1.89%
controls:1.36%
cases:0.93%
controls:0.46%
cases:0.48%
controls:0.07%
—
—
cases:1.48%
controls:0.07%
cases:2.43%
controls:0.45%
cases:2.34%
controls:1.42%
43
308
2227
22369
21
104
2249
22573
11
17
2259
22660
—
32
15
2131
22630
39
99
1563
22037
16
262
669
18200
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
3.2e-01
7.6e-01
—
1.0e+50
2.9e+00
2.5e+00
1.3e+00
cases:0.97%
controls:0.71%
cases:0.88%
controls:0.41%
—
—
cases:0.57%
controls:0.00%
cases:0.79%
controls:0.04%
cases:4.87%
controls:0.43%
cases:6.42%
controls:1.75%
22
160
2248
22517
20
94
2250
22583
—
13
0
2257
22677
17
10
2146
22635
78
96
1524
22040
44
323
641
18139
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
1.8e-01
6.5e-01
1.9e+00
—
1.8e+00
1.4e+00
8.7e-01
cases:5.42%
controls:4.55%
cases:4.67%
controls:2.48%
cases:2.47%
controls:0.38%
—
—
cases:1.94%
controls:0.33%
cases:10.11%
controls:2.64%
cases:17.81%
controls:8.33%
123
1032
2147
21645
106
563
2164
22114
56
86
2214
22591
—
42
75
2121
22570
162
585
1440
21551
122
1537
563
16925
Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]
WX602 [2001310813]
1.0e+00
1.3e+00
—
1.0e+50
1.0e+50
3.9e+00
1.7e+00
cases:0.66%
controls:0.23%
cases:0.22%
controls:0.06%
—
—
cases:0.44%
controls:0.00%
cases:0.60%
controls:0.00%
cases:4.12%
controls:0.09%
cases:1.31%
controls:0.24%
15
53
2255
22624
5
14
2265
22663
—
10
0
2260
22677
13
0
2150
22645
66
20
1536
22116
9
44
676
18418
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
6.0e-01
9.2e-01
2.3e+00
—
—
2.0e+00
8.2e-01
cases:2.20%
controls:1.22%
cases:0.88%
controls:0.35%
cases:0.48%
controls:0.05%
—
—
—
—
cases:1.81%
controls:0.26%
cases:2.77%
controls:1.23%
50
276
2220
22401
20
80
2250
22597
11
11
2259
22666
—
—
29
57
1573
22079
19
228
666
18234
Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
76080-1 [46235759]
76080-1 [46235759]
4.6e-01
7.0e-01
2.9e+00
—
—
2.4e+00
1.2e+00
cases:0.75%
controls:0.48%
cases:0.57%
controls:0.29%
cases:0.57%
controls:0.03%
—
—
—
—
cases:3.00%
controls:0.27%
cases:3.21%
controls:0.96%
17
108
2253
22569
13
65
2257
22612
13
7
2257
22670
—
—
48
59
1554
22077
22
177
663
18285
Periodontitis pronounced
K05.31 [2000502729]
K05.31 [2000502729]
8.5e-01
1.1e+00
1.5e+00
—
2.7e+00
1.1e+00
8.5e-01
cases:3.17%
controls:1.38%
cases:1.41%
controls:0.49%
cases:0.26%
controls:0.06%
—
—
cases:0.79%
controls:0.05%
cases:1.94%
controls:0.63%
cases:4.23%
controls:1.86%
72
312
2198
22365
32
112
2238
22565
6
13
2264
22664
—
17
12
2146
22633
31
140
1571
21996
29
344
656
18118
Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
40988-8 [3044254]
40988-8 [3044254]
6.7e-01
4.1e-01
2.9e+00
—
—
2.5e+00
1.2e+00
cases:0.75%
controls:0.38%
cases:0.40%
controls:0.26%
cases:0.57%
controls:0.03%
—
—
—
—
cases:2.62%
controls:0.23%
cases:2.92%
controls:0.91%
17
87
2253
22590
9
60
2261
22617
13
7
2257
22670
—
—
42
51
1560
22085
20
168
665
18294
Paralysis of vocal cords and larynx
J38.0 [45543265]
J38.0 [45543265]
—
—
—
—
1.0e+50
3.7e+00
2.9e+00
—
—
—
—
—
—
—
—
cases:0.28%
controls:0.00%
cases:1.56%
controls:0.04%
cases:1.75%
controls:0.10%
—
—
—
—
6
0
2157
22645
25
9
1577
22127
12
18
673
18444
Mycobacterium sp identified in Sputum by Organism specific culture
539-7 [3027544]
539-7 [3027544]
6.9e-01
2.5e+00
—
1.0e+50
—
2.4e+00
1.7e+00
cases:0.31%
controls:0.15%
cases:0.75%
controls:0.06%
—
—
cases:0.22%
controls:0.00%
—
—
cases:0.69%
controls:0.06%
cases:1.02%
controls:0.19%
7
35
2263
22642
17
14
2253
22663
—
5
0
2265
22677
—
11
14
1591
22122
7
36
678
18426
Microorganisms panel - Urine sediment
58435-9 [40761536]
58435-9 [40761536]
3.2e-01
4.7e-01
1.9e+00
—
2.1e+00
1.6e+00
9.5e-01
cases:2.03%
controls:1.48%
cases:1.23%
controls:0.77%
cases:0.79%
controls:0.12%
—
—
cases:0.55%
controls:0.07%
cases:2.87%
controls:0.61%
cases:4.53%
controls:1.80%
46
335
2224
22342
28
175
2242
22502
18
27
2252
22650
—
12
15
2151
22630
46
135
1556
22001
31
333
654
18129
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
3.1e-01
8.1e-01
—
1.0e+50
2.8e+00
2.4e+00
1.3e+00
cases:0.97%
controls:0.71%
cases:0.93%
controls:0.41%
—
—
cases:0.62%
controls:0.00%
cases:0.83%
controls:0.05%
cases:4.87%
controls:0.45%
cases:6.28%
controls:1.85%
22
161
2248
22516
21
94
2249
22583
—
14
0
2256
22677
18
11
2145
22634
78
99
1524
22037
43
342
642
18120
Atrial fibrillation and flutter
I48 [45596206]
I48 [45596206]
-5.9e-02
1.7e-01
1.3e+00
2.9e+00
1.5e+00
8.3e-01
6.0e-02
cases:8.99%
controls:9.49%
cases:6.65%
controls:5.65%
cases:4.45%
controls:1.28%
cases:0.79%
controls:0.04%
cases:4.90%
controls:1.09%
cases:11.92%
controls:5.58%
cases:14.01%
controls:13.30%
204
2151
2066
20526
151
1282
2119
21395
101
291
2169
22386
18
10
2252
22667
106
246
2057
22399
191
1236
1411
20900
96
2456
589
16006
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 [3005785]
13969-1 [3005785]
6.4e-02
3.3e-02
2.4e+00
—
2.2e+00
1.3e+00
6.6e-01
cases:2.20%
controls:2.07%
cases:0.93%
controls:0.90%
cases:0.79%
controls:0.07%
—
—
cases:0.65%
controls:0.08%
cases:2.75%
controls:0.75%
cases:4.67%
controls:2.48%
50
469
2220
22208
21
203
2249
22474
18
17
2252
22660
—
14
17
2149
22628
44
165
1558
21971
32
458
653
18004
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46082-4 [3046524]
46082-4 [3046524]
-1.7e-01
—
2.6e+00
—
—
2.3e+00
1.5e+00
cases:0.40%
controls:0.47%
—
—
cases:0.31%
controls:0.02%
—
—
—
—
cases:1.12%
controls:0.11%
cases:1.61%
controls:0.36%
9
107
2261
22570
—
7
5
2263
22672
—
—
18
25
1584
22111
11
66
674
18396
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46083-2 [3043362]
46083-2 [3043362]
-1.7e-01
—
2.6e+00
—
—
2.3e+00
1.5e+00
cases:0.40%
controls:0.47%
—
—
cases:0.31%
controls:0.02%
—
—
—
—
cases:1.12%
controls:0.11%
cases:1.61%
controls:0.36%
9
107
2261
22570
—
7
5
2263
22672
—
—
18
25
1584
22111
11
66
674
18396
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
6.5e-01
8.8e-01
1.3e+00
—
2.4e+00
1.6e+00
1.0e+00
cases:1.94%
controls:1.02%
cases:1.06%
controls:0.44%
cases:0.35%
controls:0.09%
—
—
cases:0.60%
controls:0.06%
cases:2.37%
controls:0.51%
cases:4.53%
controls:1.70%
44
231
2226
22446
24
100
2246
22577
8
21
2262
22656
—
13
13
2150
22632
38
113
1564
22023
31
313
654
18149
amoxicillin; oral, parenteral
J01CA04 [21602823]
J01CA04 [21602823]
2.6e-01
8.8e-01
2.1e+00
—
1.5e+00
9.4e-01
7.0e-01
cases:20.13%
controls:16.21%
cases:11.28%
controls:5.02%
cases:4.89%
controls:0.60%
—
—
cases:2.64%
controls:0.60%
cases:12.42%
controls:5.25%
cases:29.34%
controls:17.11%
457
3677
1813
19000
256
1138
2014
21539
111
135
2159
22542
—
57
135
2106
22510
199
1162
1403
20974
201
3159
484
15303
Epithelial cells [#/volume] in Urine
30383-4 [3000850]
30383-4 [3000850]
1.9e-01
7.1e-01
2.1e+00
—
1.5e+00
1.4e+00
6.5e-01
cases:4.41%
controls:3.66%
cases:3.35%
controls:1.68%
cases:1.85%
controls:0.23%
—
—
cases:1.02%
controls:0.23%
cases:6.68%
controls:1.65%
cases:9.64%
controls:5.25%
100
829
2170
21848
76
381
2194
22296
42
52
2228
22625
—
22
51
2141
22594
107
366
1495
21770
66
970
619
17492
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
2.3e-01
6.7e-01
1.9e+00
—
1.8e+00
1.3e+00
7.3e-01
cases:6.43%
controls:5.19%
cases:5.51%
controls:2.90%
cases:2.82%
controls:0.43%
—
—
cases:2.27%
controls:0.40%
cases:10.92%
controls:3.13%
cases:18.83%
controls:10.03%
146
1178
2124
21499
125
658
2145
22019
64
98
2206
22579
—
49
90
2114
22555
175
693
1427
21443
129
1852
556
16610
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
393
175
26.95
307.65
1.2
1.1
—
—
—
0
0
319
348
10.50
270.77
1.3
1.5
—
—
—
0
0
447
841
6.37
235.01
2.7
1.3
39.98
2.87
ug/l
0.60
413
641
356
622
6.60
200.30
2.2
2.8
—
—
—
0
0
167
148
12.10
162.09
1.2
1.2
—
—
—
0
0
361
1144
3.56
94.37
6.5
1.7
428.01
373.95
nmol/l
4.34
348
1023
460
1800
2.95
83.89
4.4
2.0
222.86
237.36
u/l
2.49
449
1651
544
2447
2.61
74.97
3.9
2.4
0.77
0.83
mmol/l
20.77
531
2250
69
69
10.28
61.26
1.3
1.2
—
—
—
0
0
108
190
5.92
59.01
1.3
1.3
15.38
8.17
u/l
4.86
94
152
130
288
4.73
54.82
1.4
1.4
36.05
27.26
g/l
13.15
123
257
950
13304
0.51
52.47
6.9
7.7
41.69
41.19
mmol/mol
0.91
844
12122
108
216
5.20
51.33
1.4
1.5
30496.78
74661.17
e6/l
0.69
64
125
114
240
4.95
51.07
1.4
1.5
8860.25
2308.98
e6/l
0.44
85
169
233
5441
0.36
49.03
1.8
1.9
1.38
1.26
mmol/l
2.26
198
4434
950
13100
0.53
46.90
4.4
5.5
1.32
1.37
mmol/l
3.28
829
11794
968
13240
0.53
46.03
4.3
5.6
4.23
4.22
mmol/l
0.04
856
12035
1010
13604
0.54
45.08
4.9
6.5
2.44
2.40
mmol/l
0.57
885
12318
925
12597
0.55
40.32
3.9
4.7
1.34
1.25
mmol/l
3.81
795
11220
267
1165
2.46
37.38
1.4
1.4
—
—
—
0
0
70
127
5.66
36.99
1.4
1.3
11.56
15.23
u/l
3.98
70
120
1062
7592
1.75
36.28
15.7
5.6
5.25
4.63
e9/l
8.57
955
6417
1042
13532
0.58
35.72
6.0
5.8
6.23
6.19
mmol/l
0.41
930
12032
205
805
2.70
35.62
2.1
1.7
1.14
2.06
ug/l
1.15
184
690
30
0
+∞
31.32
1.0
0.0
—
—
—
0
0
1198
14808
0.60
31.25
47.8
26.3
8.40
7.02
e9/l
34.65
1168
14234
1198
14805
0.60
31.19
48.2
26.5
125.24
134.18
g/l
65.11
1179
14471
1198
14804
0.60
31.16
47.8
26.3
4.23
4.41
e12/l
26.79
1165
14224
1198
14803
0.60
31.14
48.8
26.8
38.30
39.95
%
25.15
1178
14456
1198
14803
0.60
31.14
47.7
26.3
91.61
92.12
fl
2.87
1180
14468
1198
14803
0.60
31.14
47.9
26.4
275.99
229.65
e9/l
58.44
1168
14304
1031
7534
1.67
30.78
10.9
3.8
9.29
13.18
umol/l
22.21
1014
7072
1201
14767
0.60
29.70
41.4
24.0
81.18
90.56
umol/l
20.64
1178
14433
607
8797
0.58
28.58
4.7
4.4
2.36
2.34
ug/l
0.03
522
7807
996
12709
0.61
27.56
6.6
4.8
2.00
2.08
mu/l
0.71
912
11346
1197
14628
0.62
27.48
35.8
23.0
4.04
4.04
mmol/l
0.65
1177
14205
1197
14611
0.62
27.12
36.0
22.8
138.47
139.75
mmol/l
43.83
1177
14207
522
3267
1.78
26.76
2.1
1.9
—
—
—
0
0
113
377
3.10
26.39
1.3
1.3
—
—
—
0
0
79
210
3.86
26.22
3.1
3.8
—
—
—
0
0
1176
14356
0.62
25.93
20.4
10.7
22.33
25.16
u/l
4.37
1162
13637
468
7114
0.57
25.38
4.2
4.1
21.46
24.66
%
4.80
233
3624
110
375
3.03
24.76
1.3
1.3
—
—
—
0
0
546
7852
0.60
23.29
2.0
2.3
86.52
91.79
pmol/l
1.84
320
4241
41
70
5.95
23.09
1.2
1.2
20.29
26.90
iu/l
0.58
31
57
387
6070
0.56
22.94
3.3
3.5
7.44
7.48
mmol/l
0.05
314
5031
1056
13017
0.65
22.33
32.0
17.7
76.84
70.21
ml/min/173m2
25.05
1006
12071
517
3393
1.68
21.75
2.7
2.2
—
—
—
0
0
301
4966
0.55
20.96
3.1
3.0
0.83
0.76
ug/l
0.31
213
3516
408
6193
0.58
20.94
4.2
4.3
12.30
8.66
mg/mmol
0.81
271
4035
81
258
3.22
20.47
1.2
1.4
—
—
—
0
0
373
2281
1.76
20.15
7.5
6.4
1.88
1.07
mmol/l
4.08
320
1814
372
2293
1.74
19.50
7.5
6.4
10.59
11.07
kpa
1.58
359
2182
372
2294
1.74
19.47
7.5
6.5
5.45
5.04
kpa
8.14
359
2186
340
2058
1.77
18.95
7.7
6.5
94.43
94.53
%
0.09
330
1982
945
7322
1.50
18.74
8.4
5.8
1.22
1.20
mmol/l
10.32
908
6591
207
1078
2.01
18.39
7.3
7.9
25.98
24.79
mmol/l
4.70
207
1065
386
2461
1.68
17.76
2.0
1.8
—
—
—
0
0
305
1833
1.77
17.34
8.1
7.2
120.73
121.62
g/l
0.33
298
1800
403
2625
1.65
17.02
2.0
1.8
29.70
30.08
s
0.75
397
2557
675
4957
1.51
16.94
5.5
2.1
2.38
2.34
mmol/l
9.41
639
4272
871
10847
0.68
16.89
43.5
23.5
327.27
331.88
g/l
42.07
863
10741
468
3175
1.60
16.72
5.8
2.2
2.54
2.45
mmol/l
29.61
439
2755
359
2293
1.67
16.31
2.0
1.9
—
—
—
0
0
1015
8129
1.45
16.24
9.0
6.1
1.22
1.21
mmol/l
7.06
899
6904
47
122
3.91
16.20
1.1
1.3
—
—
—
0
0
235
1341
1.84
15.83
4.3
3.8
5.39
5.18
kpa
2.30
230
1268
64
208
3.14
15.70
1.3
1.4
—
—
—
0
0
459
6417
0.64
15.47
1.9
2.3
75.49
78.32
nmol/l
1.16
394
5511
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
134
632
2.19
15.45
2.2
2.6
0.27
0.35
iu/ml
2.86
73
359
186
992
1.95
15.41
8.5
9.1
16.04
15.91
%
0.29
180
964
83
320
2.65
14.95
1.4
1.3
—
—
—
0
0
41
103
4.04
14.79
3.3
3.7
—
—
—
0
0
47
131
3.64
14.67
1.1
1.3
—
—
—
0
0
1033
8416
1.42
14.46
14.5
22.1
1.23
1.45
inr
30.50
876
7138
58
190
3.11
14.07
1.3
1.4
—
—
—
0
0
495
3523
1.52
14.01
5.3
3.8
87.13
78.46
%
12.65
489
3442
1194
13826
0.71
13.81
35.7
18.0
42.30
28.89
mg/l
31.40
1164
11630
73
276
2.70
13.68
1.3
1.3
—
—
—
0
0
574
4260
1.46
13.09
4.6
2.6
29.20
37.60
u/l
2.77
557
3970
871
6977
1.40
13.02
6.3
3.9
32.10
34.62
g/l
27.52
836
6377
200
1160
1.79
12.73
3.7
3.6
2.46
2.03
mmol/l
0.89
165
812
377
5305
0.65
12.54
1.7
1.8
18.03
19.16
nmol/l
0.82
320
4425
891
10724
0.72
12.39
40.3
21.5
14.75
13.86
%
55.36
879
10503
179
1012
1.83
12.39
1.5
1.6
—
—
—
0
0
201
1188
1.76
12.00
1.7
1.8
—
—
—
0
0
41
120
3.46
11.95
1.2
1.2
—
—
—
0
0
41
120
3.46
11.95
1.2
1.2
—
—
—
0
0
41
120
3.46
11.95
1.2
1.2
—
—
—
0
0
37
102
3.67
11.78
1.2
1.5
—
—
—
0
0
140
745
1.94
11.68
1.9
2.0
177.31
847.12
ug/l
1.76
130
706
71
287
2.52
11.68
1.4
1.3
—
—
—
0
0
63
240
2.67
11.68
1.3
1.2
—
—
—
0
0
263
1694
1.62
11.37
6.6
6.4
1.23
1.48
mmol/l
4.56
257
1644
62
238
2.65
11.33
1.6
1.9
3.19
28.24
iu/l
0.51
16
94
622
4791
1.41
11.32
5.2
2.3
56.01
62.45
u/l
2.35
596
4421
140
760
1.90
11.02
3.7
3.0
25.86
24.67
mmol/l
2.92
140
748
632
7896
0.72
10.46
4.1
3.9
18.52
3.90
estimate
0.57
149
1652
637
7945
0.72
10.42
4.1
4.0
0.00
0.01
estimate
2.23
134
1513
852
10165
0.74
10.41
5.4
3.7
15.39
15.12
pmol/l
2.14
785
9010
624
7777
0.73
10.05
4.1
3.9
0.00
0.00
estimate
0.50
144
1608
450
5894
0.71
9.76
4.4
4.0
0.02
0.01
estimate
0.05
123
1306
21
46
4.60
9.06
3.2
1.6
2.07
1.36
%
0.50
21
46
100
520
1.97
8.98
3.1
3.0
7.45
7.70
kpa
1.15
100
506
130
745
1.79
8.65
2.1
1.8
—
—
—
0
0
766
6310
1.32
8.63
3.1
2.5
—
—
estimate
—
0
0
279
3886
0.68
8.32
1.8
1.8
423.27
26750975.65
pmol/l
2.62
237
3099
121
688
1.80
8.28
2.1
1.7
—
—
—
0
0
42
158
2.69
8.07
1.3
1.9
275.05
287.04
mu/l
0.13
42
144
29
88
3.33
8.07
1.5
1.3
—
—
—
0
0
90
470
1.95
8.02
1.4
1.7
—
—
—
0
0
353
4658
0.71
7.69
4.3
4.0
0.02
0.00
estimate
0.41
118
1410
161
2459
0.63
7.44
1.2
1.3
1.58
1.83
u/ml
0.13
42
626
47
195
2.44
7.43
2.4
4.5
223.86
622.70
iu/ml
—
7
23
29
93
3.15
7.41
1.5
1.3
—
—
—
0
0
31
104
3.01
7.35
1.5
1.3
—
—
—
0
0
273
3726
0.70
7.19
4.6
4.2
1.02
1.02
kg/l
0.45
191
2463
13
13
10.05
7.03
1.1
1.1
—
—
—
0
0
505
6232
0.76
6.95
2.8
3.1
233.23
155.29
ug/l
5.47
465
5656
73
377
1.97
6.76
5.4
5.2
5.19
5.08
kpa
0.44
73
364
89
492
1.84
6.72
2.3
2.2
122.29
131.30
g/l
2.70
59
391
36
139
2.62
6.63
1.3
2.2
—
293.20
u/ml
—
0
15
21
60
3.52
6.44
1.3
1.1
—
—
—
0
0
21
60
3.52
6.44
1.3
1.1
—
—
—
0
0
21
60
3.52
6.44
1.3
1.1
—
—
—
0
0
21
60
3.52
6.44
1.3
1.1
—
—
—
0
0
60
297
2.05
6.28
2.0
1.8
26.90
443.13
u/ml
0.51
49
236
36
144
2.52
6.20
1.4
1.4
—
—
—
0
0
109
669
1.66
5.77
4.5
4.2
25.56
24.68
mmol/l
2.07
101
599
216
1556
1.43
5.51
1.8
1.6
65.48
66.18
g/l
0.60
201
1374
303
3900
0.74
5.42
3.8
3.6
0.02
0.01
estimate
0.19
109
1223
178
1253
1.46
5.15
1.8
1.9
0.20
0.19
g/l
1.08
161
1122
69
389
1.80
4.98
3.3
2.6
14.74
16.33
%
3.93
69
381
340
4244
0.77
4.83
2.7
2.7
361.67
375.51
umol/l
1.49
279
3555
179
1293
1.42
4.53
9.7
6.2
25.76
24.38
mmol/l
4.42
172
1249
37
177
2.11
4.33
1.1
1.2
—
—
—
0
0
37
178
2.10
4.27
1.1
1.2
—
—
—
0
0
166
1200
1.41
4.20
1.6
1.6
—
—
—
0
0
35
166
2.13
4.19
1.1
1.3
—
—
—
0
0
37
180
2.07
4.16
1.1
1.3
—
—
—
0
0
35
167
2.11
4.14
1.1
1.3
—
—
—
0
0
153
2100
0.71
4.09
13.4
8.1
—
—
—
0
0
35
168
2.10
4.08
1.1
1.3
—
—
—
0
0
14
42
3.35
4.04
1.4
2.7
—
—
—
0
0
14
42
3.35
4.04
1.0
1.2
—
—
—
0
0
310
3814
0.78
3.87
1.8
1.8
1030.28
1149.16
nmol/l
1.62
241
2865
87
564
1.56
3.79
5.3
3.1
4.39
4.31
pmol/l
0.32
81
484
13
33
3.96
3.79
1.2
1.2
—
—
—
0
0
222
1719
1.32
3.67
3.8
6.2
9.24
12.40
mmol/l
7.27
210
1611
71
450
1.60
3.44
1.3
1.4
—
—
—
0
0
71
450
1.60
3.44
1.3
1.4
—
—
—
0
0
13
37
3.53
3.40
1.2
1.1
—
—
—
0
0
57
343
1.68
3.38
8.5
6.3
104.46
105.19
mmol/l
0.40
52
313
13
38
3.43
3.31
1.2
1.1
—
—
—
0
0
13
38
3.43
3.31
1.2
1.1
—
—
—
0
0
19
77
2.48
3.29
1.5
2.5
—
—
—
0
0
149
1975
0.74
3.23
4.2
5.5
32.99
33.57
%
0.27
99
1233
1025
9402
1.16
3.20
7.6
5.0
6.89
7.01
mmol/l
1.01
1008
8967
167
1274
1.34
3.09
4.2
3.3
1.24
1.22
mmol/l
3.42
157
1067
9
247
0.36
3.04
1.0
1.1
—
20.59
—
0
12
39
220
1.79
2.94
4.5
2.3
1.48
0.12
mmol/l
1.19
39
212
21
95
2.22
2.90
1.1
1.4
—
—
—
0
0
11
32
3.45
2.90
1.1
1.1
1.30
0.97
mmol/l
0.82
11
17
273
2250
1.24
2.79
4.7
5.4
0.98
1.04
mmol/l
2.66
258
2041
16
65
2.47
2.79
1.1
1.3
—
—
—
0
0
16
65
2.47
2.79
1.1
1.3
—
—
—
0
0
46
278
1.67
2.74
7.6
34.0
7.32
7.68
mmol/l
0.31
38
227
21
98
2.15
2.71
1.1
1.4
—
—
—
0
0
514
4539
1.17
2.52
3.3
3.3
0.79
0.52
e6/l
1.45
402
3428
25
458
0.54
2.49
1.2
1.1
—
—
—
0
0
350
3001
1.20
2.42
1.5
1.6
1.29
1.41
mg/l
0.43
297
2367
304
2573
1.21
2.42
3.2
3.2
3.05
1.42
e6/l
1.19
158
1346
81
576
1.42
2.37
6.8
4.0
4.00
3.96
mmol/l
0.42
81
568
8
22
3.65
2.36
1.1
1.1
0.70
0.66
mmol/l
—
8
9
167
2082
0.79
2.35
1.4
1.3
2.99
2.97
g/l
0.05
97
1152
45
283
1.60
2.34
2.2
2.0
1.61
1.84
mmol/l
1.13
45
276
15
65
2.32
2.31
2.3
2.6
8.81
9.72
kpa
1.21
15
65
15
65
2.32
2.31
2.3
2.6
4.89
5.02
kpa
0.16
15
65
156
1234
1.28
2.29
2.9
2.3
36.21
41.43
u/l
0.38
136
992
409
3575
1.18
2.27
5.5
4.6
402.09
474.47
ng/l
0.13
369
3193
738
8047
0.88
2.25
4.9
3.2
62.55
54.11
u/l
0.91
695
7275
27
466
0.57
2.21
1.3
1.5
0.18
0.34
mg/l
2.30
18
198
50
332
1.52
2.09
1.4
1.6
—
—
—
0
0
58
400
1.46
2.03
2.8
2.5
1.43
1.93
mg/l
4.88
52
339
100
1298
0.76
1.96
1.8
2.1
263.60
195.06
ug/g
0.40
82
1019
5
11
4.55
1.94
1.4
1.4
—
—
—
0
0
55
381
1.45
1.90
1.5
1.5
2.74
16.78
iu/ml
0.66
11
85
74
542
1.38
1.89
1.3
1.2
96.29
97.18
u/ml
0.01
18
205
319
2778
1.17
1.87
3.2
3.0
1.11
1.11
e6/l
0.00
173
1552
6
18
3.34
1.74
1.2
1.1
32.33
29.50
u/l
—
6
8
1008
10670
0.90
1.72
6.4
4.3
25.64
13.94
mm/h
42.91
966
9780
42
286
1.48
1.62
1.5
2.0
88.76
87.20
%
0.15
42
281
20
338
0.59
1.59
1.5
1.2
552.00
626.18
mg/l
0.29
20
313
26
160
1.63
1.56
1.4
1.4
273.85
274.26
mosm/kgh2o
0.03
20
108
0
43
0.00
1.52
0.0
1.1
—
1609.05
—
0
43
0
45
0.00
1.49
0.0
1.3
—
—
—
0
0
424
4675
0.89
1.48
2.2
2.4
3.21
2.90
mg/l
1.40
374
3931
169
1995
0.83
1.48
1.2
1.3
33.79
13.85
u/ml
1.07
42
706
1157
11049
1.10
1.41
15.4
5.6
85.58
79.05
u/l
4.64
1137
10224
948
9992
0.91
1.39
4.7
4.8
127.00
2197.32
e6/l
2.48
22
214
74
574
1.30
1.36
1.2
1.2
—
—
—
0
0
145
1216
1.21
1.36
5.4
2.5
65.03
59.49
ml/min/173m2
1.13
64
500
663
7081
0.91
1.27
5.2
4.6
45.63
105.18
ng/l
1.57
575
5720
18
292
0.61
1.27
1.4
1.2
3.84
3.98
mmol/l
0.50
18
268
17
100
1.71
1.23
1.0
1.1
—
—
—
0
0
51
672
0.75
1.21
1.5
1.4
—
—
—
0
0
5
20
2.50
1.15
1.2
1.2
—
—
—
0
0
0
35
0.00
1.15
0.0
8.5
—
10.19
—
0
35
50
379
1.33
1.12
1.3
1.3
—
—
—
0
0
22
143
1.54
1.11
1.7
1.5
6.42
8.18
mmol/l
3.67
22
143
5
21
2.38
1.09
1.2
1.1
—
—
—
0
0
32
441
0.72
1.05
1.7
1.5
26.78
28.49
u/ml
—
6
82
29
403
0.72
1.00
1.1
1.4
227.22
288.39
ug/g
1.19
18
257
12
68
1.77
1.00
1.2
1.6
—
—
—
0
0
130
1119
1.17
0.97
1.3
1.3
—
—
—
0
0
0
32
0.00
0.95
0.0
1.1
—
—
—
0
0
574
5401
1.08
0.93
3.5
3.3
90.65
93.82
e6/l
0.03
464
4231
5
104
0.48
0.89
1.0
1.9
65.60
102.69
umol/l
—
5
104
190
2124
0.88
0.88
1.2
1.3
52.90
41.35
iu/ml
0.34
49
633
13
79
1.65
0.88
1.2
1.7
—
—
—
0
0
6
31
1.94
0.84
1.0
1.0
—
—
—
0
0
93
1084
0.85
0.79
2.2
2.2
10.48
15.14
nmol/l
6.12
81
953
20
282
0.71
0.79
1.2
1.3
—
—
—
0
0
41
518
0.79
0.78
4.5
3.1
1.75
1.70
mmol/l
0.08
41
505
7
122
0.57
0.78
1.0
1.5
—
1853.33
—
0
6
77
908
0.84
0.76
4.1
3.5
1.02
1.02
ratio
0.15
71
833
21
151
1.39
0.71
2.5
2.6
—
—
—
0
0
36
455
0.79
0.71
1.3
1.2
—
—
—
0
0
168
1513
1.12
0.71
2.0
2.1
6.78
8.64
umol/l
0.76
150
1327
592
6212
0.94
0.70
2.6
2.2
—
—
—
0
0
9
144
0.62
0.69
1.7
1.5
—
—
—
0
0
24
315
0.76
0.64
1.6
1.4
—
—
—
0
0
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
22
288
0.76
0.59
1.6
1.4
—
—
—
0
0
10
64
1.56
0.58
1.6
1.2
—
—
—
0
0
54
460
1.18
0.53
4.4
3.9
2.16
1.47
index
0.70
38
225
6
96
0.62
0.52
1.0
1.0
381.33
283.11
mg/l
—
6
85
6
96
0.62
0.52
1.2
1.1
—
—
—
0
0
26
326
0.80
0.52
1.6
1.6
—
—
—
0
0
403
3837
1.06
0.50
2.7
2.6
5.60
4.03
e6/l
1.46
371
3474
22
171
1.29
0.49
1.4
1.3
410737.73
177089.14
e6/l
0.31
15
125
10
68
1.47
0.47
1.4
1.5
—
—
—
0
0
14
188
0.74
0.47
1.6
1.6
—
—
—
0
0
7
48
1.46
0.46
1.0
1.1
—
—
—
0
0
31
375
0.82
0.46
1.2
1.1
—
—
—
0
0
60
524
1.15
0.46
1.2
1.8
35.34
37.48
u/l
0.38
50
425
116
1272
0.91
0.45
2.6
3.9
66.13
99.14
ng/l
6.52
97
1061
31
372
0.83
0.43
1.2
1.1
—
—
—
0
0
38
447
0.85
0.43
4.4
3.2
6.98
7.77
mmol/l
2.15
38
435
8
56
1.43
0.42
1.0
1.1
—
—
—
0
0
6
92
0.65
0.42
1.2
1.4
—
—
—
0
0
6
94
0.64
0.42
1.0
1.0
—
—
—
0
0
13
173
0.75
0.42
1.0
1.3
336.38
256.57
pmol/l
—
8
142
5
33
1.52
0.41
1.2
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
217
2042
1.07
0.41
3.3
3.4
6.09
5.86
kpa
2.10
212
1967
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
7
101
0.69
0.39
1.1
1.1
—
—
—
0
0
35
297
1.18
0.39
1.3
1.2
13.67
6.07
u/ml
—
6
23
7
106
0.66
0.39
1.0
1.1
—
—
—
0
0
46
526
0.87
0.38
2.2
2.3
87.57
108.66
ug/min
0.24
22
305
9
68
1.32
0.37
1.0
1.2
186.56
381.52
u/l
—
9
61
212
2001
1.07
0.37
3.3
3.4
2.58
1.86
mmol/l
1.82
189
1688
39
336
1.16
0.37
1.4
1.2
1.67
3.60
u/ml
—
6
33
87
955
0.91
0.37
1.6
1.6
1.95
1.51
g/l
3.62
72
808
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
5
77
0.65
0.35
1.0
1.0
—
—
—
0
0
6
42
1.43
0.35
1.0
1.3
1.17
1.18
mmol/l
—
6
42
39
338
1.16
0.35
1.4
1.2
3.55
3.40
u/ml
0.08
11
52
6
46
1.31
0.33
1.0
1.1
—
—
—
0
0
45
507
0.89
0.32
1.4
1.3
—
—
—
0
0
22
260
0.84
0.29
1.2
1.4
—
—
—
0
0
40
354
1.13
0.29
1.4
1.2
21.00
32.01
u/ml
—
5
17
8
108
0.74
0.29
1.3
1.0
—
—
—
0
0
16
195
0.82
0.28
1.3
1.9
4.12
4.44
mmol/24h
0.16
16
170
27
312
0.86
0.28
1.1
1.3
1.27
0.85
nmol/l
0.39
20
254
8
62
1.29
0.28
1.3
1.8
11.75
14.15
nmol/l
—
8
53
312
3008
1.04
0.28
2.0
2.7
9.65
12.08
umol/l
6.64
295
2746
25
214
1.17
0.28
1.2
1.3
—
—
—
0
0
8
63
1.27
0.27
1.1
1.2
—
—
—
0
0
9
118
0.76
0.27
1.0
1.1
—
—
—
0
0
26
224
1.16
0.27
2.8
2.3
1.20
1.19
mmol/l
0.26
26
224
8
67
1.19
0.26
1.4
1.8
340.00
287.49
mu/l
—
8
47
172
1806
0.95
0.26
3.0
3.4
168.62
292.45
ng/l
7.31
162
1667
5
71
0.70
0.26
1.2
1.3
—
—
—
0
0
104
1109
0.93
0.26
1.8
1.7
1.86
1.67
%
1.14
78
918
10
78
1.28
0.24
1.2
1.1
—
—
—
0
0
58
533
1.09
0.23
2.9
3.3
0.82
0.83
nmol/l
0.12
50
421
5
39
1.28
0.23
3.2
1.2
13.18
16.17
pmol/l
—
5
31
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
7
94
0.74
0.22
1.1
1.1
—
—
—
0
0
7
94
0.74
0.22
1.1
1.1
—
—
—
0
0
189
1814
1.05
0.22
2.0
2.0
70.05
65.61
e9/l
0.81
131
1381
269
2602
1.04
0.22
2.0
2.7
18.43
22.03
%
3.80
251
2378
26
229
1.14
0.21
2.8
2.3
4.15
4.14
mmol/l
0.04
26
229
26
229
1.14
0.21
2.8
2.3
105.23
105.93
mmol/l
0.29
26
229
5
42
1.19
0.21
1.8
2.1
0.57
0.61
mmol/l
—
5
42
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
10.21
—
0
14
0
14
0.00
0.20
0.0
1.0
—
1.26
—
0
6
9
111
0.81
0.20
1.1
1.1
—
—
—
0
0
34
374
0.91
0.19
1.5
1.6
1.15
1.15
g/l
0.03
34
349
7
58
1.21
0.18
1.0
1.1
109.57
271.36
iu/ml
—
7
58
53
569
0.93
0.18
1.9
1.5
0.01
0.02
g/l
0.20
47
510
5
69
0.72
0.17
1.0
1.1
—
—
—
0
0
106
1013
1.05
0.16
4.0
3.0
26.70
25.02
mmol/l
4.57
106
973
8
72
1.11
0.16
1.1
1.3
—
—
—
0
0
8
72
1.11
0.16
1.1
1.3
—
—
—
0
0
286
2792
1.03
0.15
2.0
2.7
2.14
2.20
g/l
0.97
267
2522
42
391
1.08
0.14
1.3
1.4
—
—
—
0
0
7
88
0.79
0.14
1.1
1.1
—
—
—
0
0
7
90
0.78
0.14
1.1
1.1
—
—
—
0
0
549
5570
0.98
0.14
2.4
2.2
162.33
267.54
u/l
3.35
524
5215
56
529
1.06
0.13
1.7
1.7
10.68
7.01
iu/ml
—
10
127
64
672
0.95
0.12
1.9
1.5
1.91
0.45
g/l
0.96
55
568
12
137
0.88
0.12
1.1
1.2
1.86
2.26
u/ml
—
7
50
169
1735
0.97
0.12
5.0
3.6
—
—
—
0
0
75
781
0.96
0.11
1.8
1.5
8.28
7.42
g/l
3.98
67
688
75
780
0.96
0.10
1.8
1.5
4.21
4.14
g/l
0.43
67
690
13
146
0.89
0.10
1.2
1.3
—
—
—
0
0
12
135
0.89
0.09
1.7
1.2
—
—
—
0
0
5
46
1.09
0.09
1.2
1.1
1.08
1.08
ratio
—
5
36
5
47
1.06
0.09
1.0
1.8
512.80
1092.62
u/ml
—
5
47
168
1716
0.98
0.09
3.4
2.9
4.36
4.36
kpa
0.00
161
1643
75
776
0.97
0.09
1.8
1.5
4.37
3.77
g/l
0.79
67
683
5
62
0.81
0.08
1.6
2.3
44.33
55.07
umol/l
—
5
53
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
18
166
1.09
0.07
1.3
2.0
2.17
1.41
u/field
—
6
95
646
6505
0.99
0.06
3.2
3.5
1477.77
2074.40
ng/l
5.45
595
5691
57
589
0.97
0.06
1.6
1.5
4.15
1.64
ratio
0.97
30
349
9
100
0.90
0.06
1.4
2.0
67.89
140.57
ng/l
—
9
100
12
131
0.92
0.05
1.1
1.2
3.71
7.90
u/ml
—
7
62
38
394
0.96
0.05
4.1
3.9
45.03
31.78
mg/l
1.12
33
291
11
120
0.92
0.05
1.3
1.2
—
—
—
0
0
71
726
0.98
0.04
1.8
1.5
3.23
2.93
g/l
1.63
63
635
64
654
0.98
0.04
1.6
1.6
58.11
53.39
mg/l
0.24
48
546
64
653
0.98
0.03
1.6
1.6
32.21
36.97
mg/l
0.63
49
545
11
102
1.08
0.03
1.1
1.3
81.09
96.86
pmol/l
0.57
11
102
15
158
0.95
0.02
2.6
2.4
487.33
611.58
ml
—
9
90
12
127
0.94
0.01
1.2
1.2
8.66
7.81
mmol/l
0.25
12
101
70
692
1.01
0.01
1.7
1.5
10.52
10.36
g/l
0.10
61
596
54
546
0.99
0.00
1.9
1.5
0.00
0.00
g/l
-0.00
47
480
192
1926
1.00
0.00
2.2
2.5
6.70
7.49
ug/l
0.25
172
1641
23
225
1.02
0.00
2.7
2.1
40.89
20.74
mg/l
—
9
66
47
471
1.00
0.00
1.5
1.5
60219.81
15108.48
e6/l
0.72
31
340
11
108
1.02
0.00
2.1
2.4
—
—
—
0
0
15
152
0.99
0.00
1.1
1.0
—
—
—
0
0
52
518
1.00
0.00
2.0
1.5
0.00
0.00
g/l
-0.00
47
478
20
197
1.02
0.00
1.3
1.4
74.50
66.23
%
0.60
12
130
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
22.15
—
0
8
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
21.71
—
0
7
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
74
0.95
-0.00
1.3
1.1
16.43
30.87
u/l
—
7
59
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
62
0.97
-0.00
1.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
65
0.92
-0.00
2.0
1.2
41.72
38.23
g/l
—
6
65
0
6
0.00
-0.00
0.0
4.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
64
0.94
-0.00
1.0
1.3
5.63
6.58
u/l
—
6
57
7
74
0.95
-0.00
1.3
1.1
114.43
95.32
u/l
—
7
63
6
59
1.02
-0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
7.71
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_NSCLC_SQUAM – Non-small cell lung cancer, squamous
GWS hits: 4
This endpoint is excluded from FinRegistry analyses (omitted endpoint).